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Part	  I:	  Introduction	  
	  
1.1	  Protein	  folding	  and	  misfolding	  	  During	  and	  immediately	  following	  its	  translation	  on	  the	  ribosome,	  nascent	  protein	  meets	  the	  first	  major	   hurdle	   of	   its	   life:	   to	   fold	   into	   the	   conformation	   it	   requires	   in	   order	   to	   fulfill	   its	  
raison	  d’être.	  This	  is	  not	  a	  trivial	  task	  because	  the	  number	  of	  theoretical	  interactions	  between	  each	  of	  its	  amino	  acid	  side	  chains	  far	  exceeds	  the	  total	  number	  of	  protein	  molecules	  within	  the	  cell	  and	  establishing	  the	  correct	  interactions	  is	  vital	  for	  proper	  folding.	  Moreover	  the	  crowded	  environment	  of	  the	  cell,	  in	  which	  the	  intracellular	  concentration	  of	  proteins	  can	  be	  as	  high	  as	  350	  mg/mL	   [1],	   increases	   the	   chances	   of	  making	  non-­‐specific	   contacts	  with	   other	  proteins.	  Nevertheless	   the	  driving	   force	   that	  pushes	   the	  protein	   to	  attain	   its	   lowest	   free	  energy	  state	  ensures	   that	   most	   proteins	   fold	   spontaneously	   and	   rapidly	   (in	   the	   order	   of	   micro-­‐	   to	  milliseconds	   depending	   on	   the	   protein	   size	   and	   complexity).	   Thus	   folding	   occurs	   correctly	  most	  of	  the	  time	  [2,3,4].	  Interestingly,	  many	  proteins	  never	  attain	  a	  defined	  conformation,	  but	  remain	   intrinsically	   disordered	   even	   in	   their	   biologically	   active	   state,	   without	   well-­‐defined	  secondary	  and	  tertiary	  structures	  in	  their	  native	  state	  [5,6].	  For	  other	  proteins,	   folding	  does	  not	   occur	   unassisted	   and	   instead	   the	   folding	   process	   is	   guided	   by	   a	   number	   of	   auxiliary	  proteins,	  denoted	  as	  chaperones.	  Although	  occurring	  quickly,	  the	  folding	  pathway	  of	  a	  protein	  typically	  does	  not	  occur	  in	  one	  step	  but	  instead	  proceeds	  through	  a	  number	  of	  intermediately	  folded	   states	   (each	   with	   lower	   energy	   than	   the	   unfolded	   protein).	   This	   process	   is	   well	  described	  by	  the	  zipping	  and	  assembly	  model	  (ZAM),	  were	  on	  fast	  timescales	  a	  few	  key	  initial	  contacts	  are	  established	  that	  are	  crucial	  in	  directing	  the	  correct	  protein	  structure	  (reviewed	  in	  [7]).	   Hydrogen	   bonding	   and	   hydrophobic	   interactions	   enable	   the	   protein	   to	   attain	   its	   fully	  folded	   form.	   Despite	   cellular	  machineries	   checkpoints	   in	   place	   to	   ensure	   proper	   folding	   of	  proteins,	   undesired	   interactions	   during	   folding	  might	   shift	   the	   protein	   folding	   into	   an	   “off-­‐folding”	  pathway	  (figure	  1.1).	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1.1.1 Protein	  misfolding:	  a	  common	  mechanism	  for	  amyloidogenic	  diseases	  	  Since	   the	   discovery	   that	   several	   amyloidogenic	   disorders	   are	   related	   to	   protein	  misfolding	  and	   aggregation,	   increasing	   interest	   and	   efforts	   have	   been	   employed	   to	   understand	   these	  common	  mechanism	  in	  the	  last	  20	  years.	  There	  are	  now	  approximately	  50	  disorders,	  with	  a	  multitude	   of	   disparate	   symptoms,	   which	   are	   associated	   with	   the	   misfolding	   of	   normally	  soluble,	   functional	   peptides	   and	   proteins	   (table	   1.1).	   Protein	   conversion	   to	   insoluble	  aggregates	   is	   related	   to	   loss	  of	   functions	  with	   the	  generation	  of	  often	   toxic,	  gain-­‐of-­‐function	  intermediates	  in	  the	  process	  of	  self-­‐assembly	  [8,9].	  	  Interestingly,	   almost	   half	   of	   the	   proteins	   involved	   in	   these	   diseases	   do	   not	   possess	  globular	   structures	   (unless	   in	   presence	   of	   specific	   interactors),	   classifying	   them	   as	  “intrinsically	   disordered	   protein”	   (IDP).	   Others	   present	   partially	   unstructured	   fold,	   with	   a	  structured	  domain	  and	  an	  intrinsically	  disordered	  domain	  [10,11].	  	  	  
Disease	   Related	  
protein/peptide	  
Polypeptide	  




	   Neurodegenerative	  diseases	   	  Alzheimer’s	  disease	   Amyloid-­‐β-­‐peptide	   37-­‐43	   Intrinsically	  disordered	  Transmissible	  spongiform	  encephalopathies	   Prion	  protein	  	   ~230	   Intrinsically	  disordered	  and	  α-­‐helical	  Parkinson’s	  disease	   α-­‐synuclein	   140	   Intrinsically	  disordered	  Amyotrophic	  lateral	  sclerosis	   Superoxide	  dismutase	  1	   153	   β-­‐sheet,	  Ig-­‐like	  Huntington’s	  disease	   Hungtingtin	  fragments	   variable	   Intrinsically	  disordered	  Familial	  amyloidotic	  polyneuropathy	   Transthyretin	  (mutants)	   127	   β-­‐sheet	  
Non-­‐neuropathic	  systemic	  amyloidosis	  Amyloid	  light	  chain	  amyloidosis	   Immunoglobulin	  (Ig)	  light	  chains	  or	  its	  fragments	   ~90	   β	  -­‐sheet	  and	  Ig	  like	  Amyloid	  A	  amyloidosis	   Serum	  amyloid	  A1	  protein	  fragments	   76–104	   α	  -­‐helical	  Senile	  systemic	  amyloidosis	   Wild-­‐type	  transthyretin	   127	   β	  -­‐sheet	  	  Haemodialysis-­‐related	  amyloidosis	   β2-­‐microglobulin	   99	   β	  -­‐sheet	  and	  Ig	  like	  Lysozyme	  amyloidosis	   Lysozyme	  mutants	   130	   α	  -­‐helical	  and	  β-­‐sheet	  
Non-­‐neuropathic	  localized	  amyloidosis	  Apolipoprotein	  A1	  amyloidosis	   Apo	  A-­‐1	  fragments	   80–93	   Intrinsically	  disordered	  Type	  II	  diabetes	   Amylin	   37	   Intrinsically	  disordered	  Injection-­‐localized	  amyloidosis	   Insulin	   21	  and	  30	   α-­‐helical	  and	  insulin-­‐like	  	  
Table	   1.1	   Diseases	   related	   to	   extracellular	   depositions	   or	   intracellular	   inclusions	   of	   amyloid-­‐like	   aggregates.	  Adapted	  from	  [12].	  	  	  These	   proteins	   may	   fold	   into	   structures	   different	   from	   the	   ones	   present	   in	   the	   on-­‐folding	  pathway,	   a	   process	   common	   addressed	   as	   “misfolding”.	   In	   this	   process,	   the	   individual	  molecules	  may	  form	  new	  interactions	  and	  are	  then	  kinetically	  trapped	  in	  local	  energy	  minima.	  
	   10	  
The	  polypeptide	  chain	  in	  case	  of	  misfolding	  fails	  to	  attain	  its	  closely	  packed	  three-­‐dimensional	  structure,	  by	  loss	  of	  native	  residue	  contacts	  [13]	  and	  as	  a	  result	  of	  that	  partially	  folded	  states	  start	  to	  populate.	  	  These	  states	  can	  be	  associated	  to	  so-­‐called	  molten-­‐globule	  or	  pre-­‐molten	  globule	  intermediate	  states,	  depending	  on	  the	  percentage	  of	  secondary	  structures	  and	  tertiary	  contacts	  that	  are	  still	  present,	  with	  respect	  to	  the	  native	  state	  [14].	  The	  molten-­‐globule	  state	  is	  characterized	  by	  an	  increase	   of	   15%	   in	   the	   hydrodynamic	   radius	   compared	   with	   the	   native	   state,	   which	  corresponds	   to	   a	   volume	   increase	   of	   ∼	  50%	   [14].	   Small	   angle	   X-­‐ray	   scattering	   (SAXS)	   is	   a	  technique	   used	   to	   measure	   the	   shape	   and	   size	   of	   macromolecules	   as	   result	   of	   their	   X-­‐ray	  scattering.	  Studies	  using	   this	   technique	  have	  revealed	   that	  protein	  molecules	   in	   the	  molten-­‐
globule	  state,	  have	  a	  globular	  structure	  typical	  of	  ordered	  globular	  proteins	  [15,16,17,18].	  An	  increased	   affinity	   to	   hydrophobic	   fluorescence	   probes	   such	   as	   8-­‐anilinonaphthalene-­‐1-­‐sulfonate	  (ANS)	  is	  observed	  when	  proteins	  attain	  this	  structural	  ensemble.	  In	  the	  pre-­‐molten	  
globule	   state	   a	   protein	   is	   still	   able	   to	   interact	   with	   ANS,	   but	   it	   does	   not	   exhibit	   a	   globular	  structure	  [18,19].	  The	  pre-­‐molten	  globule	  state	  probably	  represents	  a	  partially	  ordered	  form	  of	  the	  random	  coil	  or	  unfolded	  state	  [19,20].	  	  	   These	   partially	   unfolded	   conformations	   favor	   reciprocal	   and	   specific	   intermolecular	  interactions,	   including	  electrostatic	  attraction,	  hydrogen	  bonding	  and	  hydrophobic	  contacts,	  which	  are	  necessary	  for	  further	  oligomerization	  and	  fibrillation	  [21,22,23].	  On	  the	  other	  hand,	  the	   primary	   step	   in	   the	   fibrillation	   of	   IDPs	   represents	   partial	   folding,	   like	   stabilization	   of	   a	  partially	   folded	  conformation	   [24,25],	  making	   them	  more	  prone	   to	  aggregation.	  Under	   such	  conditions	   intermolecular	   contacts	   with	   other	   misfolded	   proteins	   can	   occur	   [26,27].	  Mutations,	  environmental	  conditions	  such	  as	  stress	  or	  ageing	  play	  major	  roles	  in	  modulating	  the	   conformational	   equilibra	   between	   these	   states,	   increasing	   the	   evidence	   on	   the	   complex	  folding	  dynamics	  and	  conformational	  heterogeneity	  of	  these	  proteins	  [28,29,30].	  	  
1.1.2 Aggregation	  and	  oligomerization	  	  Once	  entered	   in	  a	  off-­‐folding	  pathway,	   the	  misfolded	  protein	  can	   follow	  two	  different	  paths:	  unordered	  or	  high-­‐ordered	  aggregation	  routes.	  Depending	  on	  environmental	  conditions	  and	  primary	   sequence	   of	   the	   protein,	   one	   route	  will	   be	   preferred	   to	   the	   other	   [31,32].	   In	   both	  cases,	  due	  to	  the	  association	  of	  hydrophobic	  surfaces,	  the	  heat	  effects	  associated	  with	  protein	  aggregation	   are	   often	   exothermic,	   analogous	   to	   the	   release	   of	   heat	   upon	   protein	   folding	  [33,34].	   While	   in	   some	   cases,	   thermally	   induced	   aggregation	   is	   reversible,	   more	   often	  aggregation	   is	   at	   least	   partially	   irreversible.	   For	   irreversible	   systems,	   models	   of	   unfolding	  such	  as	  the	  Lumry-­‐Eyring	  model	  may	  be	  applicable,	  where	  a	  reversible	  unfolding/misfolding	  transition	  is	  followed	  by	  an	  irreversible	  aggregation	  step	  [35].	  The	   formation	   of	   amorphous	   aggregates	   is	   characterized	   by	   individual	   monomers	  adding	   to	   the	   growing	   clump	   of	   aggregated	   protein	   through	   a	   random	   process.	   The	  accumulation	  of	  recombinant	  proteins	  inside	  bacterial	  inclusion	  bodies	  is	  a	  typical	  example	  of	  amorphous	  aggregates.	  Once	  purified	   from	  bacteria,	   inclusion	  bodies	  present	   sphere-­‐like	  or	  rod-­‐like	   shapes	   with	   diameters	   ranging	   from	   0.2	   µm	   to	   1.2	   µm	   [36,37].	   Fourier-­‐transform	  infrared	   spectroscopy	   (FTIR)	   has	   been	   extensively	   used	   to	   characterize	   macromolecules	  secondary	   structure	   contents	   by	  measuring	   their	   absorbance	   at	   different	  wavelengths.	   The	  technique	  is	  very	  useful	  since	  it	  can	  be	  applied	  also	  to	  unsoluble	  samples.	  Using	  this	  technique	  it	  has	  been	  shown	  that	  inclusion	  bodies	  present	  newly	  formed	  β-­‐sheet	  structures	  with	  respect	  to	  the	  protein	  monomeric	  native	  state	  [38,39].	  On	  the	  other	  hand,	  some	  proteins	  maintained	  some	  β-­‐sheet	  and	  α-­‐helical	  structures	  of	  their	  soluble	  form	  [40,41].	  	  The	   second	   route	   is	   the	   formation	  of	  high	  ordered	   structures,	   such	  as	   soluble	  proto-­‐fibrils	   or	   oligomers,	   depending	   if	   they	   are	   on-­‐pathway	   to	   fibril	   formation	   [42,43]	   or	   off-­‐
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pathway,	  respectively	  [44,45].	  Oligomers	  and	  protofibrils	  are	  composed	  of	  a	  variable	  number	  of	  monomers,	  usually	  indicated	  as	  n-­‐mer,	  where	  n	  is	  the	  number	  of	  monomers.	  The	  size	  of	  the	  oligomers	  may	  vary	   from	  2-­‐mer	   to	  4-­‐mer,	   in	   case	  of	  β2-­‐microglobulin	   [46],	  up	   to	  8-­‐20	  mer	  like	  Aβ	  peptide	  and	  PrP	   [9,47].	  These	  molecules	   in	   turn	  assemble	   into	   chains	  with	   straight,	  curved	   or	   circular	   shapes	   [47,48].	   The	   structure	   of	   oligomers	   need	   not	   to	   share	   β-­‐sheet	  structures	   that	   are	   found	   in	   amyloid	   fibrils,	   nevertheless	   oligomers	   may	   be	   precursors	   of	  amyloid	   fibrils	   and	   may	   present	   a	   large	   β-­‐sheet	   content.	   Interestingly,	   antibodies	   raised	  against	   pre-­‐fibrillar	   aggregates	   of	   Aβ	   peptides	   cross-­‐react	   with	   similar	   aggregates	   of	   other	  peptides	  or	  proteins	  (such	  as	  amylin,	  α-­‐synuclein,	  and	  the	  amyloidogenic	  prion	  fragment),	  but	  not	   with	   mature	   fibrils	   [49].	   These	   observations	   suggest	   common	   structural	   features	   of	  oligomers,	   differing	   from	   those	   found	   in	   the	   mature	   fibrils.	   In	   fact,	   an	   oligomer	   with	   a	  spherical	   shape	   of	   20	   nm	   diameter	   has	   been	   found	   to	   be	   a	   common	   trait	   of	   many	  amyloidogenic	   proteins	   [50].	   Unlike	   the	   formation	   of	   amorphous	   protein	   aggregates,	   high	  ordered	   oligomer	   formation	   occurs	   more	   slowly	   through	   a	   highly	   ordered,	   nucleation-­‐dependent	  mechanism	  in	  which	  partially	  folded	  forms	  of	  the	  protein	  associate	  to	  form	  a	  stable	  nucleus	   (rate-­‐determining	   step).	   This	   nucleus	   acts	   as	   a	   template	   to	   sequester	   other	  intermediates	   adding	   them	   to	   the	   growing	   thread	   of	   aggregated	   protein	   (protofibril).	   The	  sequential	  addition	  of	   free	  monomers	   to	   the	  ends	  of	   the	  chain	   leads	   to	   the	   formation	  of	   the	  highly	  structured,	  insoluble	  amyloid	  fibrils.	  Such	  a	  mechanism	  explains	  the	  observed	  kinetics	  of	  fibril	  formation	  as	  monitored	  using	  amyloidogenic	  dyes	  such	  as	  thioflavin	  T	  (ThT)	  or	  Congo	  red.	  Both	  the	  length	  of	  the	  lag	  phase	  (i.e.	  the	  time	  required	  to	  form	  a	  stable	  nucleus)	  and	  the	  rate	  of	  elongation	  are	  highly	  dependent	  on	  the	  concentration	  of	  partially	  folded	  intermediates	  present	  at	  any	  given	  time	  [51].	  Recently,	  a	  general	  mathematical	  model	  for	  fibrillation	  kinetics	  has	   been	   proposed	   [52].	   In	   this	   model,	   in	   addition	   to	   the	   classical	   nucleation	   step,	   where	  monomer	   concentration	   is	   critical,	   also	   fragmentation	   and	  monomer-­‐dependent	   elongation	  processes	  are	  taken	  into	  account	  (figure	  1.2).	  	  	  
	  
Figure	   1.2	   Mechanism	   of	   fibril	   formation	   (taken	   from	   [52]).	   On	   the	   left	   the	   three	   processes	   described	   for	  fibrillation:	   nucleation,	   monomer-­‐dependent	   elongation	   and	   fragmentation.	   On	   the	   right	   a	   typical	   example	   of	  fibrillation	  curve,	  with	  three	  distinct	  phases.	  During	  the	  lag-­‐phase,	  a	  stable	  nucleus	  is	  building-­‐up	  to	  initiate	  the	  growth	   of	   fibrils.	   At	   this	   point	   exponential	   growth	   of	   fibers	   occurs	   until	   it	   reaches	   its	   maximal	   growth	   rate.	  Depending	   on	   the	   protein,	   the	   contribution	   of	   the	   three	   above-­‐mentioned	   processes	   may	   vary,	   leading	   to	  different	  fibrillation	  curves.	  	  	  	  
lag phase exponential growth maximal growth rate 
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1.1.3 Amyloid	  fibrils	  morphology	  and	  structure	  	  Diseases	   related	   to	   the	   misfolding	   of	   proteins	   are	   often	   referred	   as	   proteopathies	   or	  proteinopathies.	  Perhaps	  the	  most	  distinctive	  hallmark	  of	  proteopathies	  is	  the	  accumulation	  of	   amyloid	   fibrils	   in	   specific	   tissues.	   Structural	   characterization	   of	   such	   molecules	   is	   very	  challenging	   because	   they	   are	   inherently	   noncrystal-­‐forming,	   which	   precludes	   them	   to	  structural	   elucidation	   by	   X-­‐ray	   crystallography.	   This	   technique	   can	   attain	   structural	  information	   of	   a	   crystallized	   protein	   sample	   at	   the	   atomic	   level	   from	   its	   X-­‐ray	   diffraction	  pattern.	  In	  addition,	  because	  of	  the	  large	  size	  and	  particulate	  nature,	  they	  are	  not	  amenable	  to	  solution	  NMR	  spectroscopy.	  Historically,	  X-­‐ray	   fiber	  diffraction	  has	  been	   the	   first	   technique	  used	   to	  characterize	  amyloid	   filaments	   [53].	  The	  physical	  principle	  behind	   this	   technique	   is	  the	  same	  as	  X-­‐ray	  crystallography	  but	  experiments	  are	  performed	  on	  fibrillar	  macromolecules	  instead.	   Studies	   using	   this	   technique	   showed	   that	   amyloid	   fibrils	   from	   different	   proteins	  presented	   similar	   diffraction	   cross-­‐β	   pattern,	   which	   is	   indicative	   of	   β-­‐strands	   component	  being	  oriented	  perpendicularly	  to	  the	  fibril	  axis	  [23,54,55,56,57,58].	  As	  shown	  in	  figure	  1.3,	  A	  the	   distinctive	   diffraction	   pattern	   shows	   a	   strong	   meridional	   intensity	   at	   about	   4.75	   Å	  resolution	  (corresponding	  to	  the	  inter-­‐β	  strand	  spacing),	  and	  an	  equatorial	  reflection	  at	  about	  10	  Å	  resolution	  (corresponding	  to	  the	  distance	  between	  stacked	  β-­‐sheets).	  	  Transmission	   electron	   microscopy	   (TEM)	   and	   atomic	   force	   microscopy	   (AFM)	   have	  been	   used	   to	   obtain	   qualitative	   structural	   information	   on	   amyloid	   fibrils.	   The	   former	  technique	  requires	  staining	  of	  the	  sample	  with	  heavy	  metals,	  which	  will	  absorb	  and	  reflect	  the	  electrons	   from	   an	   electron	   beam.	   The	   latter	   is	   better	   described	   in	  paragraph	   1.3.1.	   Using	  these	   two	   techniques,	   amyloid	   polymorphisms	   were	   characterized,	   in	   which	   different	  structural	  elements	  are	  propagated	  along	  the	  length	  of	  the	  fibril.	  Protofilaments	  assemble	  as	  fibrils	   by	   twisting	   in	   a	   helix	   fashion	   into	   rope-­‐like	   structures	   5-­‐20	   nm	  wide	   [59,60]	   or	   by	  jointing	   in	  ribbon-­‐like	  structures	  that	  can	  be	  up	  to	  30	  nm	  wide	  [61,62].	  Such	  morphological	  diversity	   is	   a	   common	   characteristic	   of	   amyloids,	   reflecting	   the	   protein	   structural	  heterogeneity.	  	  Recently,	   a	   highly	   detailed	   perspective	   of	   several	   amyloid	   structures	   has	   begun	   to	  emerge,	   employing	   techniques	   such	   as	   site-­‐directed	   spin	   labeling	   (SDSL),	   solid	   state	   NMR	  (ssNMR)	   and	   cryo-­‐electron	  microscopy	   (cryoEM).	   SDSL	   requires	   the	   reaction	   of	   spin	   labels	  with	   amino	   acids	   of	   the	   proteins.	   Labels	   can	   give	   information	   on	   its	   local	   dynamics,	  conformational	   dynamics	   of	   protein	   domains,	   and	   global	   protein	   tumbling.	   In	   ssNMR	  methodology	  amyloid	   fibrils	  are	  obtained	   from	  protein	  samples	   labeled	  with	  carbon-­‐13	  and	  nitrogen-­‐15	   isotopes.	   Structural	   information	   of	   the	   labeled	   residues	   is	   obtained	   from	   their	  resonance	   frequency.	   Finally	   cryoEM	   share	   the	   same	   physical	   principles	   of	   TEM,	   but	   the	  sample	   is	  not	   stained	  and	   is	   studied	  at	   cryogenic	   temperatures.	   It	   is	   important	   to	  point	  out	  that	   these	   techniques	   require	   labeling	   of	   protein	   residues,	   requiring	   their	   heterologous	  expression.	  Thus	  is	  it	  possible	  that	  synthetic	  amyloid	  fibrils	  may	  not	  reflect	  the	  physiological	  ones	  [63].	  	   Parallel	   in-­‐register!β-­‐sheet	   structure	   is	   the	   most	   common	   underlying	   architecture	  observed	   for	   pathological	   amyloid	   (figure	   1.3,	   B).	   These	   fibrils	   are	   composed	   of	   stacked	  polypeptide	   strands	   that	   lie	   perpendicular	   to	   the	   fibril	   axis	   and	   form	   backbone	   hydrogen	  bonds	  with	  the	  adjacent	  strands	  aligned	  in-­‐register	  and	  parallel.	  SDSL	  studies	  on	  recombinant	  fibres	  of	  α-­‐synuclein	  [64,65]	  and	  β2-­‐microglobulin	  [66]	  revealed	  a	  parallel	  in-­‐register	  β-­‐sheet	  structure,	  which,	   for	  example,	   involved	  the	  whole	  99	  residue	  sequence	  of	   the	   latter	  protein.	  ssNMR	   studies,	   combined	   with	   EM	   mass-­‐per-­‐length	   measurements	   revealed	   that	   also	  recombinant	  Aβ	  fibrils	  present	  such	  structure	  [67,68,69],	  with	  the	  monomer	  shaped	  as	  a	  pair	  of	  β-­‐strands,	  encompassing	  residues	  12-­‐24	  and	  30-­‐40	  respectively.	  This	  model	  has	  also	  been	  proposed	  for	  prion	  protein	  in	  vitro	  generated	  amyloids	  [70].	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   Several	  small	  peptides	  that	  form	  amyloid	  fibrils,	  including	  fragments	  of	  Aβ,	  arrange	  in	  antiparallel!β-­‐sheets,	   which	   is	   also	   the	   most	   common!β-­‐sheet	   arrangement	   in	   globular	  proteins	  (figure	  1.3,	  C).	  Using	  ssNMR,	  Aβ16	  –22	  ,	  Aβ11–25	  	  and	  Aβ32-­‐42	  fragments	  were	  shown	  to	  adopt	  antiparallel	  alignment	  of	  the	  peptides	  [71,72,73].	  Regardless,	  no	  full-­‐length	  protein	  up	  to	   now	   has	   shown	   such	   a	   fibrillar	   structure.	   The	   only	   exception	   is	   the	   Aβ1-­‐40	   peptide,	  associated	  to	  early	  onset	  familiar	  Alzheimer’s	  disease,	  which	  adopts	  an	  anti-­‐parallel	  fold	  [74].	  	   The	  strands	   in	  a	  β-­‐helix	   (or	  solenoid)	  align	   to	   form	  parallel	  β-­‐sheets,	  but	   the	  strands	  wrap	   around	   an	   axis	   in	   a	   helical	   arrangement,	   and	   unlike	   parallel	   in-­‐register!β-­‐sheets,	  parallel	   strands	   in	   helices	   have	   intramolecular	   backbone	   hydrogen	   bonds	   (figure	   1.3,	   D).	  NMR	   data	   from	   HET-­‐s(218-­‐289)	   prion	   protein	   of	   Podospora	   anserina	   revealed	   that	   each	  monomer	  makes	  two	  helical	  turns	  around	  the	  filament	  axis,	  and	  the	  strands	  form	  parallel	  β-­‐sheets	   [75].	   A	   similar	   structure	   has	   been	   proposed	   for	   PrP	   27-­‐30	   fibrils	   (discussed	   in	  
paragraph	  1.2.4).	  	  
	  	  
Figure	  1.3	  Amyloid	  fibers	  structures.	  (A)	  Schematic	  diagram	  of	  diffraction	  pattern	  from	  amyloid	  fibrils	  adapted	  from	  [8].	  The	  green	  dashed	  box	  indicates	  the	  band	  relative	  to	  monomers	  interstrand	  spacing	  of	  ~	  5	  Å,	  while	  the	  red	   dashed	   box	   indicates	   the	   equatorial	   band	   relative	   to	   intersheet	   spacing	   of	   ~	   10	   Å.	   (B)	   NMR	   structure	   of	  parallel	   in-­‐register	   β-­‐sheet	   Aβ	  1-­‐42	   amyloid	   fibril	   (PDB	   entry:	   2BEG).	   In	   the	   black	   box	   the	   structure	   of	   single	  monomer.	   (C)	  Model	   of	   anti-­‐parallel	   β-­‐sheet	   fibril	   of	   Abeta1-­‐40.	   The	  model	   is	   based	   on	   [74]	   using	   2BEG	  PDB	  entry	  as	  reference	  structure.	  (D)	  NMR	  structure	  of	  β-­‐solenoid	  HET-­‐s	  218-­‐289	  amyloid	  fibril	  (PDB	  entry:	  2RNM);	  random	  coiled	  residues	  are	  not	  shown	  for	  clarity.	  Lateral	  and	  top	  views	  are	  shown	  for	  B,	  C	  and	  D.	  	  	  	  
A	   B	  
D	  C	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1.2	  Prion	  diseases	  as	  a	  model	  for	  neurodegenerative	  disorders	  	  Prion	   diseases	   correspond	   to	   anatomo-­‐pathologically	   defined	   transmissible	   spongiform	  encephalopathies	  (TSEs)	  of	  infectious,	  genetic,	  or	  sporadic	  etiology.	  They	  are	  characterized	  by	  neurodegeneration	   and	   protein	   aggregation.	   These	   diseases	   include	   kuru	   and	   Creutzfeldt-­‐Jakob	  disease	  (CJD)	  in	  humans,	  scrapie	  in	  sheep	  and	  bovine	  spongiform	  encephalopathy	  (BSE)	  in	  cattle.	   In	  humans,	   these	  diseases	  can	  affect	   subjects	  at	  distinct	  age	  groups,	   course	  with	  a	  variety	  of	  motor	  or	  cognitive	  symptoms.	  Although	  their	  prevalence	  is	  relatively	  low,	  TSEs	  are	  still	  incurable	  and	  invariably	  fatal	  [76].	  The	  pathogenesis	  of	  prion	  diseases	   is	   attributed	   to	  major	   changes	   in	   the	  metabolism	  of	   the	  cellular	   prion	   protein	   (PrPC).	   Current	   understanding	   of	   TSEs	   evolved	   from	   the	   concept	   of	  prions,	   proteinaceous,	   nucleic	   acid-­‐free,	   infectious	   particles	   [77].	   A	  wide	   body	   of	   data	   now	  supports	  the	  idea	  that	  prions	  consist	  principally	  or	  entirely	  of	  an	  abnormal	  isoform	  of	  a	  host-­‐encoded	  protein,	   the	   prion	  protein	   (PrP),	   designated	  PrPSc.	   PrPSc	   is	   derived	   from	  PrPC	   by	   a	  post-­‐translational	  mechanism	  [78,79].	  Neither	  amino	  acid	  sequencing	  nor	  systematic	  study	  of	  known	   covalent	   post-­‐translational	   modifications	   have	   shown	   any	   consistent	   differences	  between	  PrPC	  and	  PrPSc	  [80].	  PrPSc	  acts	  as	  a	  template	  that	  promotes	  the	  conversion	  of	  PrPC	  to	  PrPSc	  and	  this	  conversion	  involves	  only	  conformational	  change.	  In	  fact,	  while	  PrPC	  is	  α-­‐helical	  with	  low	  β-­‐sheet	  content	  (~3%),	  PrPSc	  is	  mainly	  β-­‐sheet	  rich	  (~43%)	  [81].	  Full	  understanding	  of	  prion	  propagation	  requires	  knowledge	  both	  of	   the	  structure	  of	  PrPC	  and	  PrPSc	  and	  of	   the	  mechanism	  of	  conversion	  between	  them.	  	  
1.2.1	  Biogenesis	  and	  function	  of	  PrPC	  	  PrP	  is	  a	  highly	  conserved	  among	  mammals,	  and	  it	  has	  been	  also	  identified	  in	  marsupials	  [82]	  and	  birds	  [83].	  The	  protein	  is	  encoded	  by	  the	  PRNP	  (human)	  or	  Prnp	  (other	  animals)	  gene	  and	  its	  open	  reading	  frame	  (ORF)	  is	  encoded	  within	  a	  single	  exon,	  even	  if	  the	  gene	  itself	  contains	  either	  two	  (in	  hamster,	  humans,	  tamar	  wallaby)	  or	  three	  exons	  (in	  rat,	  mouse,	  bovine,	  sheep)	  [84,85,86,87,88,89].	  Prnp	  is	  often	  considered	  as	  a	  housekeeping	  gene,	  based	  on	  the	  absence	  of	  a	  TATA	  box,	   the	   identification	  of	   several	   Sp1	  binding	   sites	   and	   the	  presence	  of	  CpG	   islands	  [90,91,92].	   It	   is	   expressed	   during	   early	   embryogenesis,	   increasing	   postnatally	  with	   distinct	  time	   courses	   for	   various	   regions	  of	   the	  hamster,	   rat,	   and	  mouse	  brains	   [93,94,95,96,97,98].	  The	  highest	  levels	  of	  expression	  are	  observed	  in	  the	  central	  nervous	  system,	  in	  particular	  in	  association	  with	  synaptic	  membranes.	  After	  protein	  synthesis,	  PrPC	   is	   translocated	  to	  the	  endoplasmatic	  reticulum	  (ER)	  due	  to	  the	  presence	  of	  a	  22	  amino	  acid	  N-­‐terminal	  signal	  peptide.	  Remarkably,	  PrPC	  can	  be	  synthesized	  with	  at	   least	   three	   forms	  in	  the	  ER:	  a	  secreted	  form	  that	  reflects	  the	  main	  pathway	  for	  PrPC	  synthesis	   in	   vivo,	   plus	   C-­‐	   and	   N-­‐terminal	   transmembrane	   forms	   (CtmPrP	   and	   NtmPrP	  respectively).	   These	   latter	   two	   forms	   are	   characterized	   by	   transmembrane	   insertion	   of	   the	  hydrophobic	  pocket	  between	  amino	  acids	  110–134	  and	  their	  relative	  membrane	  orientation	  [99,100].	   The	   role	   of	   these	   two	   forms	   is	   still	   not	   fully	   clarified,	   but	   they	   are	   related	   to	  neurotoxicity	  especially	  in	  inherited	  prion	  diseases	  [101].	  In	  the	  ER	  cellular	  compartment	  the	  pre-­‐pro-­‐prion	  protein	  is	  post-­‐translationally	  modified	  by	  glycosylation	   at	   residues	  Asn180	   and	  Asn196,	   cleaving	   the	  N-­‐terminal	   signal	   peptide	   and	   a	  GPI-­‐anchor	  is	  covalently	  linked	  to	  its	  C-­‐terminal	  [102,103].	  Full-­‐length	  PrPC	  has	  been	  found	  in	  non-­‐,	   mono-­‐	   and	   di-­‐glycosylated	   forms	   [104],	   with	   a	   different	   variety	   of	   N-­‐glycans	   [105],	  which	  may	  be	  differently	  distributed	  in	  the	  CNS	  [106].	  Regarding	   the	   sub-­‐cellular	   environment	  organization,	  PrPC	  molecules	   are	   found	  attached	   to	  lipid	   rafts:	   low-­‐density,	   detergent-­‐insoluble	   membrane	   domains	   (DRM),	   rich	   in	   cholesterol	  and	   sphingolipids	   [107].	   Like	  other	  GPI-­‐linked	  proteins	  PrPC	   can	  be	   internalized,	   and	   it	  has	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been	   shown	   that	   in	   neuronal	   cells	   this	  mechanism	   is	  mediated	   via	   clathrin-­‐coated	   vesicles	  [108,109].	   It	   has	   been	   proposed	   that	   the	   N-­‐terminal,	   a	   positively	   charged	   domain	   of	   PrPC	  (KKRPKP),	  is	  responsible	  for	  the	  constitutive	  endocytosis	  of	  PrPC	  by	  clathrin-­‐coated	  vesicles,	  perhaps	  by	  interacting	  with	  a	  transmembrane	  protein	  [110].	  The	  internalization	  occurs	  with	  a	  t1/2	  of	  5	  minutes	  [108].	  While	  in	  non-­‐neuronal	  internalization	  occurs	  via	  non-­‐clathrin-­‐coated	  vesicles	  [111].	  A	  small	  fraction	  of	  endocytosed	  PrPC	  is	  degraded	  by	  lysosomes,	  but	  large	  fractions	  return	  to	  the	  cell	  surface.	  Previous	  studies	  originally	  intended	  to	  understand	  the	  intercellular	  transfer	  of	   PrPSc	   have	   led	   to	   evidence	   that	   part	   of	   the	   recycled	   PrPC	   may	   be	   secreted	   to	   the	  extracellular	   medium	   associated	   with	   exosomes	   [112].	   Thus,	   it	   is	   possible	   that	   such	   a	  mechanism	   could	   be	   one	   of	   the	   possible	   pathways	   to	   spread	   PrPSc	   in	   the	   extracellular	  environment,	  leading	  to	  cell	  death	  and	  neurodegeneration.	  	  Defining	   PrPC	   function	   is	   one	   of	   the	   major	   issues	   in	   prion	   biology.	   The	   first	   attempt	   to	  understand	   the	   possible	   function	   of	   the	   prion	   protein	   was	   done	   by	   generating	   a	   PrP-­‐null	  mouse	  strain	  in	  a	  mixed	  C57BL/6J	  129/Sv(ev)	  background,	  by	  replacement	  of	  codons	  4–187	  with	   a	   neomycin	   phosphotransferase	   (neo)	   expression	   cassette.	   These	   animals,	   designated	  Prnp0/0	  or	  Zurich	  I	  (ZrchI),	  showed	  no	  remarkable	  anatomical	  abnormalities.	  Also,	  cognitive	  tests	  revealed	  no	  defects	   in	  behavior	  or	   learning	  [113].	  Remarkably,	  grafting	  Prnp-­‐knockout	  mice	  with	  PrPSc	  material	  from	  PrPC-­‐expressing	  tissue,	  did	  not	  result	  in	  neuronal	  damage	  [114].	  Also	  progressive	  accumulation	  of	  PrPSc	  in	  glial	  cells	  around	  PrPC-­‐null	  neurons	  did	  not	  induce	  cell	  death	  in	  the	  knockout	  neurons,	  suggesting	  that	  PrPSc	  does	  not	  mediate	  a	  direct	  cytotoxic	  effect	  [115,116].	  It	  is	  likely	  that	  conversion	  of	  PrPC	  to	  PrPSc	  results	  in	  both	  a	  loss-­‐of-­‐function	  of	  the	  cellular	  form	  and,	  in	  parallel,	  a	  gain-­‐of-­‐function	  of	  the	  infectious	  one.	  The	  presence	  of	  PrPC	   in	  both	  pre-­‐	  and	  post-­‐synaptic	  structures	  raised	  the	  hypothesis	  that	   PrPC	   plays	   a	   role	   in	   neuronal	   communication	   [117,118].	   A	   functional	   role	   of	   PrPC	   in	  synapses	  was	   suggested	  on	   the	  basis	  of	   the	  ability	  of	  PrPC	   to	  bind	   copper	   released	   into	   the	  synaptic	  cleft	  during	  depolarization	  [119].	  Since	  high	  extracellular	  levels	  of	  Cu2+	  could	  induce	  the	  endocytosis	  of	  PrPC	   to	   intracellular	  organelles	  and	   the	  Golgi	  apparatus	   [120,121,122],	   it	  was	  proposed	  that	  presynaptic	  PrPC	  may	  buffer	  Cu2+	  levels	  in	  the	  synaptic	  cleft	  and	  ensure	  its	  transport	  back	  into	  the	  presynaptic	  cytosol.	  This	  mechanism	  could	  also	  have	  a	  protective	  role	  against	  reactive	  oxygen	  species	  generated	  by	  Fenton-­‐type	  redox	  reactions.	  On	  the	  other	  hand,	  several	  experimental	  studies	  suggest	  that	  PrPC	  could	  play	  a	  role	  in	  synaptic	   structure,	   function	   and	  maintenance.	   In	   particular,	   these	   studies	   have	   shown	   that	  PrPC	   is	   distributed	   on	   all	   portions	   of	   neurons,	   without	   any	   preferential	   synaptic	   targeting	  [123].	  The	  observation	  that	  PrPC	  is	  important	  for	  synapse	  formation	  and	  function	  is	  supported	  by	   a	  wealth	   of	   evidence	   on	   synapse	   loss	   and	   PrPSc	   deposition	   in	   synaptic	   terminals	   during	  prion	  diseases	  [124,125].	  PrPC	  expression	  in	  defined	  brain	  regions	  seems	  to	  corroborate	  the	  importance	   of	   these	   findings.	   Indeed,	   during	   brain	   early	   postnatal	   development	   PrPC	   is	  strongly	   expressed	   in	   the	   hippocampus.	   Within	   this	   brain	   region,	   the	   stratum	   lacunosum-­‐moleculare	   revealed	   the	   highest	   PrPC	   expression.	   Since	   this	   is	   a	   synapse	   rich	   region	  where	  hippocampal	   interneurons	   and	   afferent	   neuronal	   inputs	   make	   connections,	   it	   has	   been	  inferred	  that	  the	  relatively	  high	  expression	  of	  PrPC	  in	  this	  region	  could	  possibly	  be	  necessary	  for	  the	  correct	  development	  of	  synapses	  [96].	  	  
1.2.2	  Structure	  of	  PrPC	  	  Structural	   information	   on	   PrPC	   is	   mainly	   derived	   from	   recombinant	   protein	   expressed	   in	  bacterial	   cells.	   Although	   post-­‐translational	   modifications	   like	   N-­‐glycosylation	   and	   GPI-­‐anchoring	   were	   lacking,	   it	   has	   been	   shown	   that	   native	   structure	   and	   stability	   [126]	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comparable	   to	   PrPC	   extracted	   directly	   from	   healthy	   calf	   brains	   [127].	   In	   general,	   PrPC	   is	  composed	  of	  an	  N-­‐terminal	  unstructured	  domain	  and	  a	  C-­‐terminal	  globular	  folded	  domain.	  	  More	   in	   detail	   the	   N-­‐terminal	   domain	   can	   be	   divided	   into	   four	   different	   consecutive	   sub-­‐domains:	  a	   first	  charged	  cluster	  (CC1),	   the	  octapeptide	  repeat	  (OR),	  a	  second	  charge	  cluster	  (CC2),	  and	  a	  hydrophobic	  domain	  (HD)	  (figure	  1.5,	  A).	  The	  high	  degree	  of	  conservation	  of	  this	  unstructured	   domain	   between	   species,	   suggests	   a	   strong	   functional	   significance	   [128,129].	  The	  flexibility	  and	  little	  secondary	  structure	  characterizing	  the	  N-­‐terminal	  moiety	  in	  solution	  render	   PrPC	   as	   a	   partially	   intrinsically	   unstructured	   or	   disordered	   protein. Under	   acidic	  conditions,	  the	  N-­‐terminal	  region	  encopassing	  residues	  23-­‐120,	  does	  not	  fold	  spontaneously	  into	   a	   folded	   domain	   [130,131,132].	   On	   the	   other	   hand,	   it	   has	   been	   observed	   that	   the	   OR	  region	   acquires	   transient	   structures	   at	   neutral	   pH	   [133],	   and	   Cu2+	   is	   able	   to	   induce	   the	  formation	  of	  beta	  enriched	  structures	  in	  two	  different	  regions	  [134,135].	  CC1	   and	   CC2	   domains	   seem	   to	   be	   involved	   in	   the	   binding	   of	   glycosaminoglycans	  (GAGs)	   [105]	  and	  nucleic	  acids	   [136,137],	  but	  evidence	  at	   the	  cellular	   level	  are	   lacking.	  The	  CC1	  region	  was	  also	  identified	  as	  polypeptide	  sequence	  involved	  in	  endosome	  internalization	  of	  PrPC	  [110].	  	  	   The	   octapeptide	   region	   (OR)	   contains	   four	   or	   five	   repeats	   of	   eight	   residues	  (PHGGGWGQ),	  binds	  Cu2+	  [138,139].	  Coordination	  of	  Cu2+	  likely	  occurs	  with	  residues	  HGGGW	  [140,141];	   histidine	   and	   amide-­‐nitrogen	   coordination	   from	   the	  Gly	   residues	  were	   detected,	  making	  the	  coordination	  site	  likely	  composed	  of	  three	  nitrogen	  and	  one	  oxygen	  atoms	  (figure	  
1.5,	   A,	   upper	  panel).	   In	  vitro,	   the	   octarepeats	   appear	   to	   strictly	  prefer	  Cu2+!over	  Cu1+!	   and	  other	  metal	   ions,	   but	   lower	   affinity	   binding	   of	   other	  metals	   has	   also	   been	   detected	   in	   full-­‐length	  PrPC	  (reviewed	  in	  [142]).	  Cooperative	  binding	  of	  four	  Cu2+	  was	  shown	  to	  occur	  in	  these	  octarepeats.	  A	  range	  of	  binding	  affinities	  for	  interactions	  of	  PrPC	  and	  Cu2+	  were	  estimated	  in	  the	   low	  micromolar	  range.	  Binding	  efficiency	  of	  Cu2+	   to	  PrPC	  was	  higher	  at	  neutral	  pH,	  with	  reduced	  affinity	  at	  lower	  pH	  (reviewed	  in	  [143]).	  This	  enhances	  the	  hypothesis	  that	  PrPC	  acts	  as	   a	   copper	   transporter,	   from	   the	  extracellular	  matrix	   to	   the	   endosomes.	  Two	  extra	   copper	  coordination	   sites	   were	   identified	   at	   His-­‐96	   [144]	   and	   His-­‐111	   [135]	   in	   HuPrPC	   ,	   and	   it	   is	  possible	  that	  up	  to	  six	  copper	  ions	  can	  be	  present	  in	  a	  fully	  copper-­‐loaded	  PrPC	  [145].	  These	  can	   bind	   two	   Cu2+	   with	   an	   estimated	   affinity	   in	   the	   nanomolar	   range,	   which	   has	   been	  proposed	  to	  be	  the	  biologically	  relevant	  mode	  of	  Cu2+	  coordination,	  given	  the	  affinity	  of	  other	  proteins	   for	   copper	   [146].	   Interestingly,	   pathological	   mutations	   in	   the	   C-­‐terminal	   domain	  changed	   drastically	   the	   coordination	   geometry	   in	   the	   non-­‐octapeptide	   region	   [147],	  suggesting	  an	  alteration	  of	  PrPC-­‐mediated	  copper	  homeostasis	  in	  pathological	  conditions.	  	   The	   palindromic	   sequence	   (AGAAAAGA)	   encompassing	   residues	   112-­‐119	   is	   also	  denoted	  as	  “toxic	  peptide”,	  because	  short	  peptides	  corresponding	  to	  this	  segment	  form	  fibrils	  in	   solution	   with	   β-­‐sheet	   structure	   that	   are	   toxic	   to	   cultured	   mouse	   hippocampal	   cells	  [148,149,150].	   During	   the	   conversion,	   the	   region	   encompassing	   the	   CC2	   and	   HD	   is	   not	  accessible	   to	   antibodies	   recognizing	   this	   epitope	   in	  PrPC	   [151],	   indicating	   that	   this	   segment	  undergoes	   profound	   conformational	   changes.	   These	   data	   suggest	   that	   such	   a	   sequence	   is	  essential	  for	  PrPC	  to	  PrPSc	  transition.	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Figure	  1.5	   (A)	  Structure	  of	  the	  N-­‐terminal	  domain.	  On	  top	  the	  coordination	  geometry	  of	  HGGGT	  peptide	  of	  the	  OR	   region	   (modified	   from	   [172]).	   On	   bottom	   alignment	   of	   human	   (Hu),	   mouse	   (Mo),	   syrian	   hamster	   (Sha),	  bovine	  (Bov)	  and	  sheep	  (Sh)	  N-­‐terminal	  region	  protein	  sequences;	  in	  the	  purple	  box	  the	  CC1	  and	  CC2	  regions,	  in	  green	  the	  OR	  region	  and	  in	  grey	  the	  HD	  region.	  (B)	  On	  top	  NMR	  structure	  of	  MoPrP	  C-­‐terminal	  globular	  domain	  from	  residue	  121	  to	  230	  (PDB	  entry:	  2L39),	  with	  the	  disulfide	  bond	  highlighted	  in	  purple.	  On	  bottom	  alignment	  of	  the	  C-­‐terminal	  domain	  sequences	  with	  beta	  strands	  in	  red	  and	  alpha	  helices	  in	  yellow.	  	  	  The	   structure	  of	   the	  PrP	  C-­‐terminal	   region	  has	  been	  obtained	  mainly	  by	  NMR	  experiments,	  from	   several	   mammalian	   species	   [126,152,153,154].	   It	   is	   composed	   by	   three	   α-­‐helices,	  corresponding	  to	  aa	  143-­‐153,	  172-­‐193	  and	  199-­‐227,	  interspersed	  with	  an	  antiparallel	  β-­‐sheet,	  formed	  by	  β-­‐strands	  at	  residues	  129-­‐131	  and	  161-­‐163	  (figure	  1.5,	  B).	  A	  single	  disulfide	  bond	  between	  Cys179	  and	  Cys214	  bridges	  α2	  with	  α3.	  This	  type	  of	  structure	   is	  conserved	  also	   in	  non	  mammalian	  species	  [155],	  regardless	  there	  is	  ~30%	  identity	  and	  50%	  conservation	  of	  the	  primary	  sequence.	  	   The	   structured	   C-­‐domain	   folds	   and	   unfolds	   reversibly	   in	   response	   to	   chaotropic	  denaturants	   [156].	   The	   protein	   displays	   unusually	   rapid	   rates	   of	   folding	   and	   unfolding	  without	   populated	   intermediates	   in	   the	   folding	   reaction	   [157].	   Moreover,	  hydrogen/deuterium	  exchange	  measurements	  on	  the	  human	  protein,	  showed	  that	  the	  overall	  equilibrium	  constant	  describing	  the	  distribution	  of	  folded	  and	  unfolded	  states	  was	  the	  same	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as	  the	  protection	  factor	  [158].	  This	  shows	  that	  no	  partially	  unfolded	  forms	  or	   intermediates	  have	  a	  population	  greater	  than	  the	  unfolded	  state.	  These	  data	  suggest	  that	  PrPSc	  is	  unlikely	  to	  be	   formed	   from	   a	   kinetic	   folding	   intermediate,	   as	   has	   been	   hypothesized	   in	   the	   case	   of	  amyloid	   formation	   in	  other	  systems,	   rather	  PrPSc	   conformers	  are	   formed	   from	  the	  unfolded	  state	  of	  the	  molecule.	  On	  the	  other	  hand,	  recent	  studies	  claim	  that	  folding	  intermediates	  are	  present	   [159].	   The	   disulfide	   bridge	   is	   essential	   for	   protein	   stability	   [160],	   reducing	   the	  conformational	   entropy	  of	   the	  unfolded	   state	   [161].	  Moreover,	   it	   has	  been	   shown	   that	  Cu2+	  had	  a	  destabilizing	  effect	  on	  the	  folding	  reaction	  of	  recombinant	  full-­‐length	  mouse	  PrP	  [162].	  	   Prion	   protein	   stability	   is	   strongly	   related	   to	   pH.	   Several	   studies,	   which	   employed	  different	   biophysical	   techniques,	   have	   pointed	   out	   that	   mild-­‐acidic	   and	   acidic	   pH	   values	  (~5.5-­‐3)	   have	   a	   destabilizing	   effect	   on	   the	   protein	   [159,163,164,165].	   Molecular-­‐dynamics	  (MD)	   simulations	   support	   this	   hypothesis	   [166].	   These	   results	   are	   consistent	   with	   the	  hypothesis	   that	   structural	   conversion	   of	   PrP	   into	   PrPSc	   taking	   place	   at	   acidic	   pH,	   along	   the	  endosomic	   pathway,	   making	   this	   environmental	   factor	   a	   key	   element	   in	   prion	   structural	  biology	  (see	  paragraph	  1.2.4).	  	  	   Mutations	  have	  been	  invaluable	  tools	   for	  understanding	  prion	  protein	  stability,	  and	  its	  possible	   effect	   on	   subsequent	   conversion	   to	   PrPSc.	   It	   has	   been	   shown	   that	   some	   mutation	  located	   in	   the	   C-­‐terminal	   domain,	   involved	   in	   inherited	   prion	   diseases	   in	   humans,	   did	   not	  change	   the	   prion	   protein	   folding,	   rather	   they	   had	   a	   destabilizing	   effect	   on	   the	   native	   state	  [167].	   This	   was	   confirmed	   by	   NMR	   studies	   on	   human	   PrP	   V210I	   and	   Q212P	   mutants	  [168,169],	  supported	  by	  MD	  simulations	  [170].	  Interestingly,	  deletion	  mutants	  in	  the	  114-­‐121	  region,	  encompassing	  the	  toxic	  peptide,	  have	  a	  stabilizing	  effect	  on	  the	  folded	  domain	  without	  affecting	  its	  structure	  [171].	  	  
1.2.3	  The	  protein-­‐only	  hypothesis	  	  	  According	   to	   the	   protein-­‐only	   hypothesis	   the	   central	   molecular	   event	   in	   the	   replication	   of	  prions	   is	   the	   self-­‐propagating	   conversion	  of	   PrPC	   to	  PrPSc	   [173].	   Two	  different	  mechanisms	  have	  been	  proposed	  (figure	  1.6).	  	   The	  nucleation-­‐polymerization	  model	  states	  that	  PrPC	  and	  PrPSc	  are	  at	  equilibrium,	  but	  that	   the	   latter	   is	   less	   stable,	   shifting	   the	   equilibrium	   toward	   the	   cellular	   form.	   Stabilization	  occurs	   only	   when	   a	   stable	   oligomeric	   nucleus	   appears	   [174].	   After	   this	   passage,	   PrPC	   can	  adopt	  the	  scrapie	  conformation.	  The	  rate-­‐limiting	  step	  is	  the	  formation	  of	  the	  stable	  nucleus.	  This	   step	   of	   stable	   nucleus	   reflects	   the	   lag	   phase	   of	   spontaneous	   conversion	   and	   it	   is	  accelerated	  by	  adding	  preformed	  PrPSc	  seeds.	  	   The	   template	   assisted	   model	   instead	   expects	   that	   PrPC	   can	   rarely	   adopt	   the	   PrPSc	  conformer,	   which	   is	   more	   thermodynamically	   stable	   but	   kinetically	   inaccessible	   [175].	  Whenever	   PrPSc	   occurs	   spontaneously	   or	   is	   provided	   exogenously,	   it	   can	   template	   the	  misfolding	   of	   PrPC	   with	   a	   direct	   interaction.	   The	   rate-­‐limiting	   state	   in	   this	   model	   is	  represented	  by	  the	  dimerization	  between	  PrPC	  and	  PrPSc	  monomers,	  or	  the	  formation	  of	  a	  less	  stable	  folding	  intermediate	  denoted	  PrP*.	  	   The	   two	  models	   are	  mutually	   exclusive;	   in	   fact	   the	   nucleation-­‐polymerization	  model	  could	   explain	   the	   initial	   formation	   of	   the	   seed,	  while	   the	   template-­‐assisted	  model	   could	   be	  involved	   in	   the	   elongation	   of	   fibrils.	   However,	   in	   both	   cases	   the	   formation	   of	   oligomeric	  structures	   or	   amyloid	   fibrils	   represents	   thermodynamic	   minima,	   with	   respect	   to	   PrPC	   and	  PrPSc,	  making	  this	  process	  spontaneous.	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Figure	  1.6.	  A)	  template-­‐assisted	  model	  and	  B)	  nucleation-­‐polymerization	  model.	  Images	  captured	  and	  adapted	  from	  [172].	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conformation	  (55%	  of	  non–glycine/proline	  residues).	   In	  view	  of	   this	  property,	   it	   is	  possible	  that	   the	   PrP	  molecule	   is	   delicately	   balanced	   between	   radically	   different	   folds	   with	   a	   high-­‐energy	  barrier	  between	   them:	  one	  dictated	  by	   local	   structural	  propensity	   (β-­‐conformation),	  and	  one	  requiring	  the	  precise	  docking	  of	  side	  chains	  (native	  α-­‐conformation).	  Many	   efforts	   have	   been	   carried	   out	   aiming	   at	   characterize	   PrP	   oligomers.	   Such	  structures	  can	  be	  easily	  generated	   in	  vitro	  and	  due	  to	  their	  small	  size,	  ranging	  from	  8	  to	  20-­‐mer,	   they	   are	   soluble	   [178].	   In	   presence	   of	   copper	   and	   oxidizing	   environment,	   oligomers	  showed	  a	  high	  heterogeneity	  in	  their	  radius	  and	  sedimentation	  coefficient	  [179],	  making	  their	  structural	   characterization	   challenging.	   This	   is	   expected	   since	   depending	   on	   the	   solution	  conditions	  of	  the	  initial	  state,	  the	  folding	  trajectories	  of	  a	  protein	  can	  be	  extremely	  different	  [180,181].	   Nevertheless,	   all	   in	   vitro	   generated	   PrP	   oligomers	   presented	   β-­‐rich	   spectra	  [182,183]	  and	  they	  co-­‐existed	  with	   the	  monomeric	  soluble	   form	  at	   low	  pH.	  NMR	  studies	  on	  HuPrP(91–231)	  have	  pointed	  out	  that	  the	  monomeric	  soluble	  form,	  present	  in	  the	  oligomeric	  mixture,	  showed	  characteristic	  molten-­‐globule	  state	   features,	  with	  a	  partial	  unfolding	  of	   the	  native	  structure	  [184].	  On	  the	  other	  hand,	  it	  has	  been	  shown	  that	  such	  a	  molten-­‐globule	  state	  is	   rich	   in	   α-­‐helices	   [185].	   Recent	   studies	   using	   19F-­‐labeled	   HuPrP(90–231)	   showed	   that	  association	  of	  monomers	  is	  entropically	  driven,	  suggesting	  	  burial	  of	  hydrophobic	  groups	  that	  have	  been	  exposed	  following	  the	  loss	  of	  native	  structure,	  and	  a	  concomitant	  desolvation	  of	  the	  oligomer	   [186].	   Subsequent	   formation	   of	   the	   larger	   oligomers	   is	   enthalpically	   driven,	  indicating	  that	  this	  process	  represents	  addition	  of	  octamers	  and	  monomers	  to	  a	  stable	  β-­‐sheet	  core.	  Despite	  the	  evidence,	  it	  is	  still	  debated	  whether	  the	  formation	  of	  such	  oligomers	  are	  on	  the	   pathway	   to	   fibrillization	   [185,187]	   or	   are	   off-­‐pathway	   intermediates,	   requiring	  dissociation	   and	   conformational	   rearrangement	   of	   the	  monomer	   before	   fibril	   assembly	   can	  take	  place	  [47,188,189].	  A	  defining	  feature	  of	  PrPSc	  is	  the	  unusual	  high	  resistance	  to	  degradation	  by	  proteolytic	  enzymes	   such	   as	   the	   proteinase	   K	   (PK).	   Limited	   proteolysis	   on	   PrPSc	   usually	   generates	   a	  smaller	  C-­‐terminal	  PK-­‐resistant	  molecule	  composed	  by	  approximately	  142	  residues	  starting	  from	   residue	  ~90	   to	  230.	  These	   residues	   are	   involved	   in	   the	   formation	  of	   the	  hydrophobic	  core	  of	  prion	  fibrils.	  Historically,	  PK-­‐resistant	  PrPSc	  is	  denoted	  also	  as	  PrP27-­‐30	  because	  of	  its	  electrophoretic	  mobility,	  which	  encompasses	  a	  molecular	  weight	  from	  27	  to	  30	  kDa	  [190].	  In	  the	  presence	  of	  either	  anionic	  detergents	  or	  nonionic	  detergents	  PrP27-­‐30	  polymerizes	   into	  rod-­‐shaped	  particles,	  which	  present	  tintorial	  and	  morphological	  features	  typical	  of	  amyloids	  [191].	  The	  unique	  properties	  of	  prion	  aggregates	  pose	  challenges	  for	  X-­‐ray	  crystallization	  and	  NMR.	  Three	  models	  of	  PrPSc	  amyloids	  have	  been	  described.	  	  1. The	  β-­‐helix	  model	  has	  been	  proposed	  on	  the	  basis	  of	  EM	  data	  from	  2D	  crystals	  [192].	  A	  model	   of	   a	   left	   handed	   β-­‐helix	   was	   constructed	   by	   threading	   the	   PrP	   sequence	   through	   a	  known	  β-­‐helix	  motif	  from	  uridyltransferase	  of	  S.	  pneumoniae	  [192].	  In	  this	  model,	  a	  trimeric	  arrangement	  constitutes	  the	  basic	  symmetrical	  unit	  for	  PrPSc,	  with	  the	  N-­‐terminal	  residues	  of	  PrP27-­‐30	  (~90–175)	  forming	  left-­‐handed	  β-­‐helices	  that	  are	  horizontally	  stacked	  and	  include	  a	  long	  unstructured	  loop	  encompassing	  residues	  145–163	  (figure	  1.7,	  A).	  Larger	  aggregates	  are	  formed	  by	  vertically	  stacking	  PrP	  trimers	  along	  the	  β-­‐helical	  axis.	   In	  addition	  to	  a	  major	  refolding	  within	  the	  N-­‐terminal	  region	  of	  PrP27-­‐30,	  the	  model	  is	  characterized	  by	  only	  minor	  structural	   rearrangements	   in	   the	   C-­‐terminal	   part	   of	   the	   protein,	   which	   retains	   most	   of	   its	  native	   secondary	   structure,	   except	   for	   the	   first	   small	   α-­‐helix	   that	   switches	   to	   a	   loop.	  Interestingly,	  the	  β-­‐helical	  motif	  has	  been	  observed	  in	  other	  proteins	  that	  exhibit	  biochemical	  features	   reminiscent	   of	   PrPSc,	   such	   as	   partial	   resistance	   to	   protease	   degradation	   and	  aggregation	  propensity	  [193,194].	  Remarkably,	  the	  fungal	  prion	  HET-­‐s	  was	  shown	  to	  form	  a	  β-­‐solenoid	  arrangement	  of	  β-­‐sheets	  that	  is	  structurally	  similar	  to	  β-­‐helices	  [75].	  On	  the	  other	  hand,	   the	   β-­‐helix	  model	   is	   not	   consistent	  with	   antibody	  mapping	   studies,	   enzyme	   cleavage	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sites	  and	  unit	  cell	  packing	  dimension	  of	  the	  EM	  data	  [195].	  2. The	   β-­‐spiral	   model	   (figure	   1.7,	   B)	   consists	   of	   a	   spiraling	   core	   of	   extended	   sheets,	  comprising	  three	  short	  β-­‐strands	  (spanning	  residues	  116–119,	  129–132	  and	  160–164)	  and	  an	  isolated	   strand	   (residues	   135–140).	   It	   has	   been	   proposed	   from	   MD	   simulations	   of	   PrP	  conformational	  fluctuations	  under	  low	  pH,	  using	  the	  natively	  folded	  structure	  as	  the	  starting	  point	  [196].	  As	  with	  the	  β-­‐helical	  model,	  formation	  of	  β-­‐strands	  involves	  the	  natively	  unfolded	  N-­‐terminal	  region	  of	  PrP27-­‐30,	  whereas	  most	  of	  the	  C-­‐terminal	  remains	  intact,	  preserving	  the	  three	   α-­‐helices	   characteristic	   of	   PrPC.	   The	   model	   does	   not	   fit	   well	   with	   experimental	  proteolysis	  experiments	  and	  the	  HX-­‐MS	  data.	  3. The	  extended	  in-­‐register	  β-­‐sheet	  consists	  of	  β-­‐strands	  and	  relatively	  short	  turns	  and/or	  loops,	   with	   no	   α-­‐helices	   present	   (figure	   1.7,	   C).	   Therefore,	   PrP	   conversion	   would	   involve	  refolding	  of	   the	  entire	  protein,	  and	  PrPSc	  would	  not	  preserve	  any	  of	   the	  structural	  motifs	  of	  PrPC.	  This	  model	   is	  based	  on	  structural	   constraints	  obtained	  by	  HX-­‐MS	  studies	   from	  recPrP	  fibrils	   [197]	   and	   with	   PrPSc	   derived	   from	   prion	   infected	   transgenic	   mice	   expressing	   PrP	  lacking	   GPI	   anchor	   [198].	   The	   major	   weakness	   of	   this	   model	   is	   the	   absence	   of	   α-­‐helical	  structures,	  which	  is	  in	  conflict	  with	  CD	  and	  FTIR	  data	  [81,199].	  Recently,	  X-­‐ray	  diffraction	  data	   from	  both	  natural	   and	  synthetic	  prions	  was	  obtained	   [200],	  including	  the	  Syrian	  hamster	  (SHa)	  Sc237	  PrP27-­‐30	  strain	  (SHaSc237),	  the	  mouse	  RML	  prion	  (MoRML),	   the	   mouse	   adapted	   synthetic	   prion	   (MoSP1),	   mouse	   truncated	   recombinant	  PrP(89-­‐230)	  and	  truncated	  recombinant	  SHa(90-­‐231)	  amyloids.	  Fiber	  diffraction	  patterns	  of	  SHaSc237,	  MoRML	  and	  MoSP1	  exhibited	  a	  marked	   intensity	  maximum	  at	  4.8	  Å	   resolutions,	  confirming	   the	   presence	   of	   β-­‐strands	   running	   perpendicular	   with	   respect	   to	   filament	   axis,	  typical	   for	   amyloid	   structures.	   Equatorial	   maxima,	   diminished	   in	   intensity	   with	   increasing	  resolution.	   Equatorial	   diffraction	   from	   natural	   brain	   isolates	   and	   synthetic	   prions	   also	  included	  an	   intense,	  moderately	  sharp,	   low-­‐angle	  reflection	  (63.3	  Å),	   characteristic	  of	   fibers	  with	  poorly	  ordered	  para-­‐crystalline	  packing.	  These	  data	  are	  more	  consistent	  with	  β-­‐helical	  model.	   Contrarily,	   diffraction	   patterns	   from	   both	   recombinant	   MoPrP(89-­‐230)	   and	  recombinant	   SHa(90-­‐231)	   showed	   a	   well-­‐defined	   4.8	   Å	   meridional	   layer	   line,	   but	   with	   an	  equatorial	  broad	  maximum	  at	  10.5	  Å.	  This	  diffraction	  pattern	  is	  consistent	  with	  a	  stacked	  β-­‐sheet	   structure	   for	   the	  major	   component	   of	   recPrP	   amyloids.	   These	   differences	   imply	   that	  recPrP	  fibrils	  do	  not	  have	  the	  same	  amyloid	  structure	  as	  brain	  adapted	  prions.	  This	  structural	  information	  might	  also	  explain	  the	  substantial	  differences	  in	  their	  infectivity.	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Figure	  1.7	  (A)	  The	  PrPSc	  monomer	  and	  the	  β-­‐helical	  model.	  Residues	  ~90-­‐175	  are	  shown	  to	  form	  left-­‐handed	  β-­‐helices	  that	  associate	  into	  trimers,	  leaving	  the	  α-­‐2	  and	  α-­‐3	  helices	  of	  PrPC	  intact.	  (B)	  In	  the	  spiral	  model	  the	  two	  native	   β-­‐sheets	   elongate	   in	   a	   longer	   single	   β-­‐strand,	   which	   forms	   intermolecular	   β-­‐sheets	   with	   other	   PrPSc	  molecules.	  (C)	  Parallel	  and	  in-­‐register	  β-­‐structure	  model	  including	  a	  continuum	  of	  short	  β-­‐strands	  from	  residue	  ~90	  to	  the	  entire	  C-­‐terminal	  region.	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1.3.1	  Single-­‐molecule	  techniques	  	  In	  the	  last	  30	  years,	  there	  have	  been	  an	  increasing	  number	  of	  studies	  aimed	  at	  characterizing	  bio-­‐molecules	   using	   single-­‐molecule	   (SM)	   techniques.	   The	   three	   major	   single-­‐molecule	  techniques	   are	   atomic	   force	  microscopy	   (AFM)	   imaging,	   SM	   fluorescence	   resonance	   energy	  transfer	   (SM-­‐FRET)	   and	   SM	   force	   spectroscopy	   (SMFS).	   The	   first	   uses	   a	   probe	   to	   obtain	  topographical	  images	  of	  the	  sample	  deposited	  on	  a	  surface	  [203,204],	  but	  it	  can	  also	  be	  used	  to	  measure	  physico-­‐chemical	  parameters	  such	  as	  axial	  elastic	  modulus	  [205].	  Usually	  little	  or	  no	  modification	  of	  the	  sample	  is	  required,	  and	  experiments	  can	  be	  performed	  in	  air,	  in	  liquid	  or	   in	   vacuum.	   In	   SM-­‐FRET	   the	   intesity	   of	   the	   energy	   transfer	   between	   fluorophores	   is	  measured,	   obtaining	   information	   on	   their	   respective	   distance.	   Usually,	   if	   the	   sample	   is	   a	  protein,	  two	  cysteines	  are	  added	  in	  specific	  positions	  and	  fluorophores	  are	  added	  via	  cysteine	  chemistry.	  By	  calculating	   the	  relative	  distance	  between	   fluorophores,	   information	  regarding	  proteins	  structural	  changes	  can	  be	  obtained.	  	   In	   SMFS	   experiments,	   the	   molecule	   of	   interest	   is	   directly	   manipulated,	   applying	  mechanical	  force	  to	  it	  in	  real	  time,	  inducing	  some	  form	  of	  structural	  transition.	  Depending	  on	  the	   time	   derivative	   of	   applied	   force,	   the	   observed	   event	   can	   occur	   in	   quasi-­‐equilibrium	  conditions	   or	   in	   out-­‐of-­‐equilibrium	   conditions.	   Structural,	   thermodynamic,	   and	   kinetic	  information	   about	   the	   transition	   can	   be	   inferred	   from	   the	   force	   required	   to	   induce	   it	  [206,207].	   The	   two	   most	   used	   SMFS	   techniques	   are	   AFM	   based	   SMFS	   (AFM-­‐SMFS)	   and	  optical-­‐tweezers	  based	  SMFS	  (OT-­‐SMFS),	  and	  their	  application	   is	  mainly	   focused	  on	  DNA	  or	  protein	  molecules.	  	   In	  SMFS	  experiments,	  performed	  with	   laser	  optical	   tweezers,	   the	  protein	  molecule	   is	  modified	   by	   adding	   covalently	   long	   molecular	   handles.	   These	   handles	   are	   usually	   double	  stranded	  DNA	  molecules,	  which	  are	  attached	  to	  protein	  termini	  (or	  in	  other	  specific	  positions	  of	  the	  primary	  sequence)	  using	  cysteine	  chemistry	  [208].	  The	  termini	  of	  the	  handles	  that	  are	  not	  bound	  to	  the	  protein	  are	  linked	  to	  polystyrene	  beads.	  The	  beads	  are	  then	  “trapped”	  using	  a	  near-­‐infrared	  laser	  beam	  with	  a	  Gaussian	  intensity,	  and	  when	  the	  spherical	  particles	  become	  subject	   to	   radiation	   pressure	   from	   the	   beam,	   their	   trajectories	   are	   modified	   due	   to	  conservation	   of	   momentum	   [209].	   The	   small	   variation	   of	   position	   induced	   by	   the	   bead,	   is	  directly	  applied	  to	  the	  protein	  molecule,	  applying	  a	  stretching	  force	  (or	  a	  torque).	  For	  small	  displacements	   the	  restoring	   force	  has	  an	  approximately	   linear	  dependence	  on	  displacement	  and	  the	  optical	  trap	  can	  be	  modeled	  as	  a	  Hookean	  spring.	  The	  spring	  constant	  of	  the	  trap	  in	  typical	  OT	  apparatuses	  has	  a	  range	  of	  0.01−0.2	  pN	  nm−1,	   increasing	  the	  signal-­‐to-­‐noise	  ratio	  dependent	   on	   thermal	   fluctuations	   and	   allowing	   the	   clear	   detection	   of	   mechanical	   events	  occurring	   at	   tenths	   of	   pN	   [210].	   Therefore	   OT-­‐SMFS	   is	   well	   suited	   for	   studies	   under	   near-­‐equilibrium	  conditions	  due	  to	  the	  low	  force	  applied	  to	  the	  molecule	  [211,212].	  On	  the	  other	  hand,	   the	   functionalization	   using	   dsDNA	   poses	   the	   experimental	   limitation	   of	   forces	   lower	  than	  65	  pN,	  due	  to	  overstretching	  transition	  of	  the	  DNA	  double	  helix	  [213].	  	   In	   AFM	   based	   SMFS	   an	   interaction	   of	   the	   analyte	   between	   a	   probe	   and	   a	   surface	   is	  employed.	   During	   the	   AFM-­‐SMFS	   experiment,	   the	   relative	   position	   of	   the	   cantilever	   tip	  (probe)	  and	  the	  surface	  is	  controlled	  via	  a	  piezo-­‐electric	  actuator,	  while	  the	  analyte	  molecule	  bridges	   the	   gap	   and	   distributes	   the	   mechanical	   stress	   between	   the	   two.	   Measuring	   the	  deflection	   induced	   by	   the	   flexible	   cantilever	   tip	  with	   known	  mechanical	   characteristics	   can	  continuously	   monitor	   the	   force	   applied	   on	   the	   analyte.	   The	   behavior	   of	   the	   cantilever	   is	  usually	   approximated	   to	   that	   of	   a	   single	   Hookean	   spring,	   and	   its	   single	   elastic	   constant	  parameter	   can	  be	  measured	  with	   the	   thermal	   noise	  method	   [214].	   Several	   possible	   sample	  preparations	   can	  be	  used	   to	   perform	  AFM	  SMFS.	  Different	   chemical	   functionalization	   of	   tip	  and/or	  surface	  can	  be	  employed,	  in	  order	  to	  control	  orientation,	  position	  and	  area	  density	  of	  the	  molecules	   of	   interest	   [215,216,217].	   Another	  method	   is	   adding	  well-­‐known	  mechanical	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“markers”	   or	   “fingerprints”	   as	   handles	   of	   the	   analyte,	   the	   so	   called	   “polyprotein	   approach”	  (discussed	   in	  paragraph	   1.3.3).	   Commercial	   cantilevers	   used	   in	  AFM	  FS	   experiments	   have	  elastic	  constant	  values	  with	  50−150	  pN	  nm−1	  range,	  which	  for	  kbT	  ≈	  4	  pN	  nm	  correspond	  to	  thermal	   force	  fluctuations	  of	  around	  15−25	  pN.	  This	  makes	  the	  measurement	  of	  mechanical	  events	  reliable	  above	  20	  pN,	  due	  to	  a	  low	  signal-­‐to-­‐noise	  (SN)	  ratio	  [218],	  with	  a	  millisecond	  time	   resolution	   [210].	   AFM-­‐SMFS	   is	   well	   suited	   for	   far-­‐from-­‐equilibrium	   transitions,	   like	  folding/unfolding	  of	  structured	  protein	  domains	  [210].	  	  
	  
Figure	  1.8	  Single-­‐molecule	  force	  spectroscopy	  techniques.	  (A)	  Main	  components	  of	  AFM	  based	  SMFS	  apparatus.	  The	  analyte	  is	  tethered	  to	  a	  surface	  and	  a	  sharp	  tip	  present	  on	  a	  flexible	  cantilever.	  The	  surface	  is	  mounted	  on	  a	  piezoelectric	  stage.	  A	  laser	  beam	  is	  focused	  on	  the	  tip,	  which	  reflects	  the	  light	  to	  a	  photodiode.	  When	  the	  surface	  is	   retracted	   away	   from	   the	   tip,	   the	   tethered	   molecule	   will	   be	   put	   under	   tension.	   The	   applied	   force	   and	   its	  variation	  are	  measured	  by	  tip	  deflection.	  (B)	  OT	  force	  spectroscopy	  apparatus	  main	  components.	  The	  analyte	  is	  tethered	  between	  two	  microbeads.	  At	  least	  one	  of	  the	  beads	  is	  optically	  trapped	  via	  a	  focused	  laser	  beam,	  while	  the	   other	   is	   usually	   attached	   by	   suction	   to	   a	   micropipette	   tip.	   The	   micropipette	   is	   usually	   mounted	   on	   a	  piezoelectric	  stage.	  Position	  of	  AFM	  surface	  and	  OT	  micropipette	  tip	  are	  both	  controlled	  via	  active	  feed-­‐back	  loop.	  One	  micro	  image	  captured	  and	  adapted	  from	  [208,219].	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shearing	   geometry	   (figure	   1.9,	   B),	   the	   force	   vector	   lies	   parallel	  with	   respect	   to	   the	   strand,	  putting	  all	  the	  hydrogen	  bonds	  under	  tension.	  Thus,	  unfolding	  the	  protein	  requires	  that	  many	  bonds	  have	  to	  break	  at	  the	  same	  time.	  Such	  an	  event	  is	  exponentially	  less	  probable	  to	  happen	  at	   a	   given	   force,	   with	   respect	   to	   the	   breaking	   of	   a	   single	   bond,	   therefore	   a	   higher	   force	   is	  required	  to	  break	  all	   the	  structure.	  However,	  using	  molecular	  dynamics	  (MD)	  simulations	   it	  has	  been	  calculated	  that	  even	  in	  this	  case	  the	  rupture	  can	  occur	  in	  a	  sequential	  manner,	  but	  the	   discrete	   number	   of	   hydrogen	   bonds	   broken	   is	   3-­‐4,	   instead	   of	   one	   as	   in	   unzipping	  geometry	  [224].	  	  However,	   taking	   into	   account	   only	   secondary	   structure	   in	   protein	   mechanical	   unfolding	   is	  reductive,	   since	   hydrogen	   bonds,	   hydrophobic	   interactions	   and	   Van	   der	   Waals	   forces	   of	  tertiary	   and	   quaternary	   structures	   are	   involved	   in	   the	   formation	   and	   maintenance	   of	   the	  native	  fold	  as	  well.	  AFM	  SMFS	  studies	  have	  shown	  that	  even	  α-­‐helix	  rich	  protein	  such	  as	  T4	  lysozyme	   [226]	   and	   Notch-­‐1	   [227],	   which	   in	   theory	   should	   unfold	   at	   very	   low	   forces	  compared	  to	  β-­‐enriched	  structures,	  are	  still	  able	  to	  unfold	  at	  considerable	  force	  values	  (~	  50	  -­‐	  150	   pN).	   Myosin	   α-­‐helices	   in	   a	   coiled-­‐coil	   topology	   could	   elicit	   considerable	   force	   in	   AFM	  SMFS	  experiments	   [228],	  with	  a	  plateau-­‐like	   force	  extension	  curves	   (FEC)	  similar	   to	  dsDNA	  overstretching	  [213,229].	  In	  contrast,	  studies	  on	  α-­‐helix	  spectrin	  heterodimers	  [230]	  revealed	  a	   sawtooth	   like	   pattern,	   similar	   to	   β-­‐sheet	   rupture	   events	   but	  with	   lower	   unfolding	   forces.	  Single	  α-­‐helix	  domains	  (SAH)	  unfolded	  at	  forces	  lower	  than	  30	  pN	  instead,	  without	  unfolding	  peaks	  [231].	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force	   to	   it.	   This	  means	   that	   the	   apparent	   length	  of	  unfolding	   is	   shorter	   than	   the	   theoretical	  unfolding	   length	   of	   the	  whole	   protein	   or	   domain	   (figure	   1.9,	   C).	   The	   presence	   of	   reducing	  agents	   can	   lead	   to	   the	   reduction	   of	   the	   disulfide	   bridge,	   and	   concomitant	   extension	   of	   the	  hidden	  loop.	  This	  behaviour	  has	  been	  observed	  on	  mammalian	  Ig	  protein	  domains	  such	  as	  V-­‐CAM	   [232],	   on	   angiostatin	   [233,234],	   and	   on	   engineered	   I27	   domains	   with	   an	   artificial	  disulfide	   bond	   [235].	   Further	   studies	   have	   shown	   that	   the	   reduction	   of	   disulfide	   bridge	   is	  force	   dependent	   [236],	   and	   that	   different	   reducing	   agents	   have	   different	   energy	   activation	  barriers	  (Ea),	  depending	  on	  their	  solvation	  and	  their	  structure	  [237].	  	  
1.3.3	  Mechanical	  unfolding	  of	  proteins	  with	  AFM-­‐SMFS	  	  In	  AFM	  single-­‐molecule	   force	   spectroscopy	   experiments	   the	  unfolding	  processes	  previously	  described	   are,	   with	   a	   certain	   approximation,	   thermodynamically	   reversible.	   Hysteresis	   is	   a	  measure	  of	   the	  energy	  dissipated	   in	   the	  process,	  which	   can	  be	   identified	   in	   force-­‐extension	  curves	  as	  the	  difference	  between	  the	  approach	  and	  retraction	  curve	  of	  a	  stretched	  molecule.	  Only	   few	   proteins	   have	   a	   true	   Hookean	   elastic	   nature,	   with	   little	   heat	   dissipation;	   some	  examples	  are	  PEVK	  and	  N2B	  domains	  of	  cardiac	  titin	  [238,239]	  and	  elastin	  [240]	  (figure	  1.10,	  
A).	  Most	   proteins	   analyzed	   by	   AFM-­‐SMFS	   display	   equilibration	   transition	   rates	   slower	   than	  timescales	   of	   SMFS	   experiments,	   making	   virtually	   impossible	   to	   discern	   the	   collapse	   of	  tertiary	   structures,	   followed	   by	   the	   unfolding	   of	   secondary	   ones.	   Usually	   the	   unfolding	   is	  cooperative,	  seen	  as	  a	  single	  global	  collapse	  of	  all	   the	  bonds	   involved	   in	   the	  structure.	  With	  this	   assumption	   it	   is	   possible	   to	   describe	   the	   unfolding	   process	   as	   a	   bond,	  with	   an	   energy	  profile	   where	   the	   barrier	   separates	   the	   associated	   (native)	   and	   the	   dissociated	   state	  (unfolded).	   Applying	   a	   force	   f	   that	   induces	   dissociation	   of	   the	   bond,	   diminishes	   the	   bond	  lifetime	  as	  described	  by:	  	  
	   	   	   	   	   [6.1]	  	  where	  koff	   is	  the	  diffusive	  relaxation	  time	  and	  Eb	   is	  the	  height	  of	  the	  energy	  barrier	  between	  the	  two	  states.	  As	  described	  by	  Evans	  and	  Richtie	  [206],	  on	  the	  basis	  of	  Bell’s	  model	  [241],	  the	  energy	  barrier	  between	  the	  two	  states	  is	  reduced	  by	  the	  application	  of	  the	  external	  force.	  The	  energy	   distorsion	   is	   quantitatively	   change	   in	   an	   exponential	   way	   (eq.	   6.1),	   with	   an	   Eb	  decrease	   in	   function	  of	   the	  work	  performed	  by	   force	   f	   along	   the	  distance	  xb	  on	   the	  reaction	  coordinate	  (xb	  is	  the	  distance	  of	  the	  barrier	  from	  the	  minimum).	  This	  can	  be	  described	  by:	  	   	   	   	   [6.2]	  	  The	  effective	  result	  is	  a	  tilt	  of	  the	  energy	  landscape.	  In	  order	  to	  relate	  the	  bond	  lifetime	  with	  the	   force	  of	  dissociation,	   it	   is	  necessary	   to	   consider	   the	  dissociation	  equation	  of	  an	   isolated	  pair	  of	  reacting	  molecules:	  	   	   	   	   	   [6.3]	  	  with	  pb(t)	   is	   the	   likehood	  of	  being	   in	   the	  bound	  state	  and	  p0(t)	  =	  1	  -­‐	  pb(t)	   is	   the	   likehood	  of	  being	   dissociated;	   koff	   and	   kon	   are	   the	   dissociation	   and	   association	   constants.	   By	   the	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application	  of	  a	  force	  the	  second	  term	  of	  the	  sum	  goes	  to	  zero,	  due	  to	  the	  reduction	  of	  binding	  probability,	  giving:	  	   	   	   	   	   	   [6.4]	  	  When	  an	  elastic	  probe	  acts	  as	  a	  pulling	  spring	  at	  constant	  speed,	  the	  applied	  force	  increases	  as	  a	  function	  on	  time:	  	   	   	   	   	   [6.5]	  	  where	  ks	  is	  the	  spring	  constant	  of	  the	  fetched	  molecule	  and	  of	  the	  probe,	  and	  vs	  is	  the	  pulling	  speed.	   By	   introducing	   the	   force	   dependent	   expression	   koff(f)	   in	   eq	   6.5,	   and	   solving	   the	  resulting	  differential	  equation,	  the	  probability	  density	  of	  the	  dissociation/unfolding	  force	  is:	  	  
	  	   	   [6.6]	  	  By	  calculating	  the	  maximum	  value	  of	  the	  distribution,	  the	  most	  probable	  unfolding	  force	  can	  be	  obtained:	  	  
	   	   	   	   [6.7]	  	  The	   unfolding	   force	   is	   directly	   dependent	   on	   loading	   rate	   (the	   speed	   at	   which	   molecule	  stretching	  is	  performed),	  so	  that	  at	  higher	  loading	  rates	  higher	  dissociations	  forces	  are	  more	  frequent.	  It	   is	   important	   to	  notice	   that	   the	  unfolding	   force	   is	  a	   thermally	  driven	  probabilistic	  process.	  The	   force	   applied	   to	   the	   molecule,	   by	   tilting	   it’s	   energy	   landscape,	   shifts	   the	   barrier	   of	  unfolding	   in	   the	   order	   of	  kbT	   or	   less.	   The	  distribution	  of	   unfolding	   forces	   are	  not	  Gaussian,	  with	  a	  skewed	  distribution	  towards	   lower	  force	  values	  [206].	   It	   is	  possible	  to	  extrapolate	  xb	  and	  koff,	  with	  experiments	  performed	  at	  different	  loading	  rates.	  This	  approach	  is	  also	  named	  dynamic	  force	  spectroscopy	  (DFS)	  [242].	  	   Considering	  an	  ideal	  random	  chain	  molecule,	  its	  deformability	  is	  controlled	  by	  entropic	  elasticity.	  By	  stretching	  the	  polymer	  the	  total	  number	  of	  degrees	  of	  freedom	  diminishes,	  until	  ideally	   only	   the	   straight	   line	   conformation	   is	   possible.	   Ideally,	   every	   polymer	   could	   be	  described	  as	  several	  monomers	  joined	  one	  to	  another,	  with	  a	  certain	  flexibility.	  In	  the	  freely-­‐jointed	  chain	  (FJC)	  model	  monomers	  are	  randomly	  oriented	  it	  the	  space,	  without	  taking	  into	  account	  any	  forces	  acting	  between	  them.	  This	  model	  is	  not	  used	  for	  stiffer	  polymers,	  such	  as	  biological	  macromolecules.	   The	  worm-­‐like	   chain	   (WLC)	  model	   instead	   is	  widely	   used	   since	  segments	  are	  correlated.	  The	  chain	  is	  treated	  as	  an	  isotropic,	  homogeneous	  elastic	  rod	  whose	  trajectory	  varies	  continuously	  and	  smoothly	  through	  space,	  opposed	  to	  the	  jagged	  contours	  of	  the	   FJC	   polymer	   chains.	   Therefore	   the	   polymer	   behaviour	   can	   be	   considered	   intermediate	  between	  a	  rigid	  rod	  and	  a	  flexible	  coil	  [229].	  The	  force	  F	  at	  a	  given	  extension	  x	  is	  described	  as:	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  where	  L	  is	  the	  contour	  length,	  and	  p	  is	  the	  persistence	  length.	  The	  latter	  represents	  the	  length	  at	  which	   correlations	   between	   the	   direction	   of	   two	   segments	   are	   lost;	   basically	   for	   lengths	  longer	  than	  p	  the	  polymer	  can	  be	  described	  statistically	  as	  a	  random	  walk.	  As	  long	  as	  L	  >>	  p,	  the	  WLC	  model	  describes	  with	  a	  good	  approximation	   the	  entropic	  elasticity	  of	   the	  polymer.	  The	  precise	  value	  of	  persistence	   length	   is	  not	  known,	  since	   it	  depends	  on	  polymer	  unit	  and	  other	  factors.	  In	  general,	  in	  SMFS	  experiments	  of	  proteins	  p	  is	  considered	  between	  0.3	  nm	  and	  0.5	  nm,	  which	  is	  approximately	  the	  length	  of	  a	  peptide	  bond	  [243].	  Calculating	  the	  difference	  between	  the	  L	  values	  of	   two	  separated	  rupture	  events,	   the	  delta	  contour	   length	  (Δcl)	  can	  be	  obtained.	  This	  parameter	  gives	  the	  exact	  length	  of	  an	  unfolded	  protein	  module.	  The	   WLC	   describes	   only	   the	   entropic	   elasticity	   of	   the	   polymer,	   but	   enthalpic	  contributions	   can	   be	   involved	   in	   the	   rupture	   of	   protein	   structures.	   In	   practice,	   a	   deviation	  from	   the	  WLC	  can	  be	   considered	  as	   a	   result	  of	   enthalpic	   interactions.	  Typical	   examples	  are	  dsDNA	  overstretching	  transition	  [244]	  and	  polysaccharides	  [245]	  (figure	  1.10,	  B).	  In	  proteins	  such	  events	  were	  observed	  in	   few	  cases	  as	  a	  “hump”	  transition,	  over	  the	  WLC	  profile	  of	   I27	  domains	  [221]	  and	  GFP	  protein	  [246]	  (figure	  1.10,	  C).	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1.3.4	  Heteropolyprotein	  strategy	  for	  AFM-­‐SMFS	  	  AFM-­‐SMFS	   is	   a	   “blind”	   single-­‐molecule	   technique.	   In	   the	   simplest	   experimental	   setup,	   the	  sample	  is	  adsorbed	  on	  a	  surface.	  The	  tip	  is	  then	  ramped	  in	  order	  to	  push	  first	  on	  it	  and	  then	  is	  retracted,	  resulting	  in	  a	  force	  extension	  curve	  (FEC)	  like	  the	  one	  shown	  in	  figure	  1.12.	  During	  the	  retraction	  a	  molecule	  may	  be	  bridged	  between	  the	  surface	  and	   the	  probe,	  but	   this	   is	  an	  infrequent	  event	  since	  most	  of	  the	  curves	  (70-­‐90%)	  do	  not	  contain	  any	  relevant	  signal.	  While	  this	   type	   of	   events	   can	   be	   easily	   discarded	   automatically	   by	   appropriate	   software,	   the	  interpretation	  of	  the	  remaining	  curves	  can	  be	  very	  challenging.	   In	  general	  this	  experimental	  approach	  has	  several	  weaknesses:	  	  	   1-­‐ The	  bridged	  molecule	  can	  be	  bound	  between	  two	  (or	  more)	  random	  points	  of	  its	  chain,	  making	  the	  guess	  whether	  it	  has	  been	  pulled	  from	  the	  two	  termini	  not	  trivial.	  	  	  2-­‐ Usually	   protein	   molecules	   are	   very	   small	   objects	   when	   folded,	   with	   length	   ranging	  from	  a	  few	  nanometers	  up	  to	  ten	  nanometers.	  The	  typical	  curvature	  radius	  of	  an	  AFM	  FS	  probe	  is	  10	  –	  100	  nm	  (depending	  on	  the	  cantilever	  tip).	  Thus	  it	  is	  possible	  that	  more	  than	   one	   molecule	   could	   be	   picked	   by	   the	   tip,	   giving	   a	   “double	   featured”	   force	  extension	  curve,	  which	  is	  theoretically	  indistinguishable	  from	  a	  single	  molecule	  curve.	  	  3-­‐ The	   region	   proximal	   to	   the	   surface	   often	   shows	   non-­‐specific	   signals	   due	   to	   the	  interaction	  between	  the	  tip	  and	  the	  surface.	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the	  main	  advantage	  that	  the	  analyte	  requires	  little	  modifications.	  Cysteine	  chemistry	  is	  widely	  used	  to	  cross-­‐link	  the	  analyte	  with	  the	  spacers,	  by	  simply	  adding	  one	  or	  two	  cysteine	  residues	  in	  specific	  positions	  of	  the	  protein	  primary	  sequence	  [248].	  Amide	  cross-­‐linking	  chemistry	  can	  also	  be	  used	  but	  since	  amide	  groups	  are	  present	  not	  only	  in	  the	  protein	  backbone,	  but	  also	  in	  side	   chains	   of	   some	   amino	   acids	   (i.e	   arginine),	   the	   selectivity	   of	   the	   binding	   geometry	   is	  drastically	  reduced.	  Double	  functionalization	  of	  tip	  and	  surface	  with	  the	  same	  protein	  is	  also	  employed	   to	   characterize	   dimerization	   processes,	   but	   the	   orientation	   of	   the	   two	   proteins	  involved	  in	  the	  complex	  could	  not	  be	  controlled	  [249,250].	  	   The	   second	   approach	   is	   the	   “polyprotein”	   approach	   which	   requires	   a	   drastic	  modification	  of	  the	  analyte,	  but	  it	  also	  includes	  major	  benefits.	  The	  simplest	  polyprotein	  is	  the	  homopolymeric	   protein,	   where	   a	   protein	   domain	   is	   repeated	   in	   tandem	   over	   the	   same	  polypeptide	   sequence.	   Proteins	   used	   in	   this	   approach	   have	   a	   related	   in	   vivo	   mechanical	  function,	  like	  the	  domain	  I27	  of	  titin	  protein	  [251]	  or	  the	  fibronectin	  domain	  III	  [252].	  These	  two	  proteins	  are	  arranged	  in	  tandem	  repeats	  in	  titin	  protein	  of	  cardiac	  muscle	  cells,	  acting	  as	  molecular	  mechanical	  shock	  absorbers	  [252,253].	  Other	  proteins	  instead	  have	  been	  found	  to	  have	  mechanical	  properties,	  despite	  their	  different	  function,	  such	  as	  ubiquitin	  [254]	  and	  small	  ubiquitin-­‐like	   modifier	   protein	   (SUMO)	   [255].	   Polyproteins	   of	   prokaryotic	   streptococcal	  protein	   G	   immunoglobulin-­‐binding	   domain	   B1	   showed	   mechanical	   performances	   than	  surpassed	   the	   ones	   from	   I27	   protein	   domain	   [256].	   Interestingly,	   all	   the	   above	  mentioned	  protein	  share	  the	  α/β	  fold	  structure,	  where	  an	  α-­‐helical	  region	  creates	  an	  hydrophobic	  pocket	  with	   a	   β-­‐sheet	   composed	   of	   4-­‐5	   β-­‐strands.	   The	   β-­‐sheet	   has	   a	   shearing	   pulling	   geometry.	  Stretching	   this	   construct	   result	   in	   a	   typical	   “sawtooth”	   pattern,	  where	   every	   single	   domain	  unfolding	  event	  is	  characterized	  by	  a	  peak	  (figure	  1.12).	  The	  delta	  contour	  length	  (Δcl)	  from	  adjacent	  peaks	  fits	  very	  well	  with	  the	  theoretical	  unfolding	  length	  of	  the	  folded	  domain.	  These	  protein	   modules	   are	   usually	   mechanically	   strong,	   with	   unfolding	   forces	   in	   the	   order	   of	  hundreds	   of	   pN.	   The	   unfolding	   of	   protein	   domains	   within	   the	   polypetide	   chain	   follows	   a	  memoryless	   markovian	   process,	   since	   the	   unfolding	   of	   one	   domain	   is	   not	   dependent	   on	  previous	  unfolding	  events	  [257].	  Thus,	  it	  is	  not	  possible	  to	  correlate	  the	  rupture	  events	  with	  their	  specific	  unfolded	  domains	  by	  simply	  looking	  at	  the	  unfolding	  pattern.	  	  In	   the	   heteropolymeric	   protein	   approach	   the	   protein	   under	   investigation	   is	   added	   to	   the	  polypeptide	   chain	   of	   a	   homopolymeric	   protein	   construct,	   and	   is	   “sandwiched”	   between	  marker	  domains.	  Therefore	  every	  signal	  that	  could	  not	  be	  associated	  to	  the	  marker,	  is	  related	  to	   the	  analyte.	   In	  general	   two	  types	  of	  patterns	  between	  the	  analyte	  and	  the	  marker	  can	  be	  adopted	  using	  this	  approach:	  1-­‐ Sandwiched	  pattern	  (figure	  1.13,	  A):	  one	  analyte	  moiety	  is	  flanked	  generally	  by	  two	  to	  four	  marker	  domains.	   It	   is	  possible	   to	  know	   that	   the	  analyte	  have	  been	  stretched	  by	  counting	  the	  number	  of	  marker	  unfolding	  events	  [227,231,238,258,259].	  2-­‐ Alternate	   pattern	   (figure	   1.13,	   B):	   analyte	   and	   marker	   are	   repeated	   in	   tandem	  [231,260].	   The	   advantage	   is	   that	   more	   than	   one	   unfolding	   event	   of	   the	   analyte	   is	  present.	  If	  the	  analyte	  has	  a	  weak	  mechanical	  resistance,	  it	  can	  be	  seen	  at	  the	  beginning	  of	  the	  FEC	  as	  multiple	  independent	  unfolding	  event.	  Usually	   the	  most	  used	  approach	   is	   the	   first	  one.	  These	  approaches	  have	   the	  advantage	   that	  FEC	  of	  protein	  construct	  can	  be	  easily	  distinguished;	  also	  by	   increasing	  protein	  size,	  signals	  from	   domains	   unfolding	   are	   located	   distantly	   from	   the	   non-­‐specific	   interaction	   at	   the	  beginning	   of	   the	   retraction	   curve	   respect	   to	   functionalization	   approaches.	   Recently,	   a	   third	  approach	  was	   established	  where	   the	   analyte	   protein	   is	   inserted	   inside	   a	   loop	   region	   of	   the	  marker	  named	  “carrier”	  [261],	  based	  on	  a	  previous	  work	  by	  Li	  et	  al.	   [262].	   In	  this	  construct	  the	   force	   can	  be	   applied	   to	   the	   analyte	   prior	   the	  unfolding	   of	   the	   “carrier”,	  which	   acts	   as	   a	  spacer	   that	   bypass	   the	   non-­‐specific	   interaction	   noisy	   region	   (figure	   1.13,	   C).	   On	   the	   other	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hand,	  in	  this	  approach,	  guest’s	  termini	  are	  extremely	  near	  to	  each	  other,	  imposing	  structural	  constraints	  which	  are	  much	  less	  pronounced	  in	  the	  alternate	  and	  sandwiched	  patterns.	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performed	  as	  well	   [237,254].	   In	   these	  experiments	   the	  protein	   is	  kept	  under	  constant	   force	  via	  feed-­‐back	  loop	  on	  piezo	  actuator,	  following	  molecule	  elongation	  over	  time.	  Each	  unfolding	  event	   is	   seen	   as	   a	   “jump”	   in	   height,	   with	   the	   same	   delta	   contour	   length	   of	   velocity-­‐clamp	  experiments.	  	  
1.3.5	  State	  of	  the	  art	  in	  SMFS	  of	  amyloidogenic	  proteins	  	  Despite	   single-­‐molecule	   force	   spectroscopy	   techniques	   have	   been	   employed	   to	   study	   bio-­‐molecules	  since	  the	  mid	  90’s,	  they	  have	  only	  been	  used	  for	  analysis	  of	  amyloidogenic	  proteins	  less	   than	   ten	   years	   ago.	   The	   first	   insights	   were	   obtained	   using	   AFM	   SMFS	   on	   α-­‐synuclein	  molecule,	   at	   the	  monomeric	   level	   by	   Sandal	  et	  al.	   [258].	  Using	   the	   heteropolymeric	   protein	  approach	  authors	  have	  found	  that	  α-­‐synuclein,	   is	  able	  to	  adopt	  at	  least	  three	  conformations,	  namely	   “random	   coil”,	   “weak”	   and	   “strong”.	   Weak	   interaction	   conformers	   were	   extremely	  heterogeneous,	  while	  strong	  conformers	  showed	  up	  as	  a	  homogeneous	  class	  of	  conformations	  having	   SMFS	   signals	   compatible	  with	   extensive	   acquisition	   of	   β	   structure.	   Surprisingly,	   the	  strong	  compact	  conformers	  were	  present	  in	  a	  high	  proportion.	  The	  authors	  proposed	  that	  this	  observation	   showed	   the	   ability	   of	   the	   α-­‐synuclein	   monomer	   to	   sporadically	   populate	   a	   β-­‐containing	  form	  that	  could	  be	  relevant	  in	  fibrillation	  processes.	  The	  same	  approach	  was	  used	  to	   show	   that	   factors	   linked	   to	   enhanced	   Parkinson	   pathogenicity,	   such	   as	   the	   presence	   of	  metal	   ions	   or	   familial	   α-­‐synuclein	   point	   mutations,	   substantially	   increased	   the	   amount	   of	  observed	   compact	   structures	   [259].	   In	   parallel,	   an	   experimental	   SMFS	   approach	   previously	  employed	  to	  characterize	  intermolecular	  interactions	  between	  fragments	  of	  α-­‐synuclein	  was	  modified	   by	   Lyubchenko	   and	   co-­‐workers	   and	   applied	   to	   the	   same	   protein	   [250].	   This	  approach	  required	  the	  covalent	  tethering	  of	  α-­‐synuclein	  molecules	  via	  their	  flexible	  C-­‐termini	  to	   both	   the	   AFM	   cantilever	   tip	   and	   the	   mica	   surface,	   using	   silane	   chemistry.	   The	   velocity	  clamp	  SMFS	  data	  collected	  by	  repeating	  approach/retraction	  cycles	  revealed	  an	  occasionally	  enhanced	  interprotein	  interaction	  attributed	  by	  the	  authors	  to	  the	  acquisition	  of	  structure	  by	  the	   transiently	   formed	   α-­‐synuclein	   dimers.	   DFS	   allowed	   them	   to	   observe	   two	   different	  lifetimes	   for	   the	   transient	   interactions,	   both	  of	  which	  were	  measured	   to	   fall	   in	   the	   seconds	  time	   range.	   Since	   these	   values	   are	   much	   higher	   than	   is	   characteristic	   for	   the	   dynamics	   of	  monomeric	  α-­‐synuclein,	  one	  interpretation	  of	  these	  results	  could	  be	  that	  occasionally	  formed	  stable	   α-­‐synuclein	   dimers	   might	   function	   as	   nuclei	   for	   amyloidogenic	   aggregation.	  Interestingly,	   these	   associations	  were	   observed	  only	   at	   acidic	   pH	   (2.7−5.1).	  Using	   the	   same	  experimental	  approach,	   the	  authors	  evaluated	  the	   impact	  of	  metal	   ions	  on	  the	  phenomenon	  [264,265].	  Taking	   advantage	   of	   the	   carrier/guest	   approach,	  Hervàs	   et	  al.	   [263]	   probed	   the	  mechanical	  features	   of	   several	   amyloidogenic	   IDPs:	   polyglutamine	   (polyQ)	   stretches	   of	   three	   different	  lengths,	  β-­‐amyloid	  1−42	  (Aβ42),	  α-­‐synuclein	  ,	  and	  a	  yeast	  prion	  extensively	  used	  as	  a	  human	  prion	   model	   (Sup35NM).	   While	   the	   percentage	   of	   different	   kinds	   of	   conformers	   was	  comparable	   to	  previous	   studies	  on	  monomeric	  α-­‐synuclein	  mentioned	  above,	  differences	   in	  Δcl	   distributions	   of	   mechanically	   β-­‐sheet	   like	   structures	   were	   observed.	   Moreover,	   a	   small	  population	   of	   hyper	  mechanostable	   conformers,	  with	   unfolding	   forces	   higher	   than	   400	   pN,	  were	  detected	  using	  the	  carrier/guest	  approach.	  This	  suggests	  that	  using	  different	  construct	  strategies	  could	  lead	  to	  a	  different	  behaviour	  of	  the	  protein.	  AFM	   SMFS	   experiments	   performed	   on	   the	   polyQ-­‐containing	   pFS	   construct	   allowed	   the	  authors	  to	  show	  that	  the	  Q19	  tract,	  which	  has	  a	  length	  considered	  to	  be	  sub-­‐threshold	  for	  the	  triggering	  of	  polyQ	  diseases,	  showed	  no	  detectable	  mechanostable	  conformations.	  Conversely,	  the	   Q35	   (near-­‐threshold)	   and	   Q62	   (super-­‐threshold)	   tracts	   showed	   increasingly	   common	  mechanostable	   and	   hyper	   mechanostable	   conformations	   whose	   unfolding	   required	   the	  application	  of	   forces	   in	  excess	  of	  400	  pN.	  On	  the	  basis	  of	   these	  results,	   the	  authors	  propose	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that	  polyQ	  tracts	  with	  lengths	  of	  more	  than	  35	  amino	  acids	  can	  undergo	  a	  transient,	  sporadic	  acquisition	   of	   structure	   that	   might	   correspond	   to	   β-­‐sheet-­‐containing	   conformations.	   In	  contrast	   AFM	   SMFS	   studies	   of	   polyQ	   tracts	   performed	   by	   Dougan	   et	   al.	   [266]	   showed	   that	  irrespective	   of	   their	   lengths,	   all	   polyQ	   tracts	   offered	   significant	   resistance	   to	   mechanical	  elongation	   under	   applied	   load,	   with	   total	   inextensibility	   of	   Q50	   traits	   up	   to	   800	   pN.	   The	  authors	   suggest	   that	   polyQ	   peptides	   can	   form	   a	   heterogeneous	   ensemble	   of	   mechanically	  stable	   collapsed	  structures	  and	  with	  an	  extensive	  network	  of	   intrachain	   interactions,	  which	  should	  cause	  the	  distribution	  of	  the	  applied	  force	  over	  several	  points	  simultaneously.	  	  Even	  Aβ42	  showed	  a	  high	  degree	  of	  conformational	  heterogeneity,	  characterized	  by	  a	  broad	  distribution	   of	   unfolding	   Δcl	   from	   mechanostable	   conformers.	   Familial-­‐disease	   Arc	   Aβ42	  (E22G)	   mutant	   was	   observed	   to	   assume	   mechanostable	   and	   even	   hyper-­‐mechanostable	  conformations	   more	   than	   its	   wild-­‐type	   (WT)	   counterpart,	   while	   the	   double	   mutant	  F19S/L34P,	   known	   to	   be	   less	   prone	   to	   fibrillogenesis,	   showed	   complete	   absence	   of	  mechanical	   events.	   Recently	   Lv	   et	  al.	   have	   further	   investigated	   the	   dimerization	   process	   of	  Aβ42,	  Aβ40	  and	  corresponding	  [VPV]	  mutants	  [249],	  using	  the	  functionalization	  approach	  as	  previously	  described	  [250].	  Data	  showed	  that	  different	  type	  of	  dimers	  could	  be	  obtained,	  due	  to	  a	  broad	  distribution	  of	  Δcl	  rupture	  events.	  Surprisingly,	  the	  force	  distribution	  for	  Aβ40	  and	  [VPV]	   Aβ40	   dimers	   was	   quite	   narrow	   for	   both	   proteins,	   63.4	   ±	   3.2	   pN	   and	   79.3	   ±	   1.5	   pN,	  respectively,	  showing	  that	  [VPV]	  mutation	  could	  adopt	  more	  stable	  structures.	  	  Recently	   an	   alternative	   approach	   to	   study	   oligomerization	   processes	   was	   introduced	   by	  Woodside	   and	   co-­‐workers	   [267],	   where	   multiple	   α-­‐synuclein	   molecules	   were	   arranged	   in	  
tandem	   over	   the	   same	   polypeptide	   chain	   and	   analyzed	   by	   OT	   SMFS.	   Analysis	   of	   the	  monomeric	  form	  of	  α-­‐synuclein	  led	  to	  different	  results	  compared	  to	  previous	  works	  with	  AFM	  SMFS	  [258,263],	  since	  the	  presence	  of	  mechanically	  relevant	  signals	  could	  be	  observed	  only	  in	  15%	  of	  the	  overall	  FEC.	  Also,	  the	  distribution	  of	  Δcl	  from	  these	  structures	  was	  different	  (figure	  
1.14),	  suggesting	  that	  different	  constructs	  could	  lead	  to	  different	  conformational	  transitions	  of	  the	  same	  analyte.	  Analysis	  of	  two	  and	  four	  tandem	  α-­‐synuclein	  moieties	  revealed	  that	  the	  frequency	  of	  mechanical	  unfolding	  events	  was	  still	  15%,	  regardless	  of	  the	  number	  of	  analyte	  moieties.	   Authors	   concluded	   that	   these	   structures	   were	   not	   thermodynamically	   stable,	   but	  rather	   of	   kinetically-­‐trapped	   conformations	   that	   were	   only	   metastable.	   Such	   states	   should	  form	  transiently	  as	  the	  protein	  underwent	  thermally-­‐driven	  conformational	  fluctuations,	  with	  a	  frequency	  and	  duration	  determined	  by	  the	  relative	  free	  energy	  of	  the	  state	  and	  the	  height	  of	  the	   energy	   barrier.	   The	   unfolding	   force	   of	   the	   overall	   events	   increased	   by	   increasing	   the	  number	  of	  α-­‐synuclein	  moieties,	  with	  average	  values	  of	  9	  pN,	  10	  pN	  and	  14	  pN	  for	  monomer,	  dimer	   and	   tetramer	   respectively.	   Moreover	   the	   rate	   at	   which	   structures	   of	   a	   given	   total	  contour	   length	   change	   occurred	   is	   similar	   for	   all	   constructs,	   but	   declines	   roughly	  exponentially	  with	  increasing	  length.	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using	   OT	   SMFS	   by	   Yu	   et	   al.	   [270].	   Almost	   3000	   FEC	   recorded	   from	   the	   unfolding	   of	   nine	  molecules	  showed	  that	  the	  prion	  protein	  folded	  and	  unfolded	  with	  a	  two	  state	  mechanism,	  as	  a	   result	   of	   single	   transition	   of	   34.1	   ±	   0.4	   nm.	   The	   energy-­‐landscape	   was	   reconstructed,	  including	   diffusion	   constants	   for	   barrier	   crossing	   and	   the	   transition	   path	   times	   across	   the	  barriers [271].	  Using	  force-­‐clamp	  mode	  and	  signal-­‐pair	  correlation	  analysis	  [272],	  the	  authors	  managed	   to	   identify	   three	   rarely	   populated	   states,	   named	   M1,	   M2	   and	   M3,	   that	   were	  accessible	   only	   from	   the	   unfolded	   state	   (figure	   1.15,	   B).	   M1	   and	  M2	   states	   were	   3	   and	   5	  kcal/mol	  more	   stable	   than	   the	   unfolded	   state,	  with	   45	   aa	   and	   65	   aa	   folded,	  while	  M3	  was	  approximately	  stable	  as	  the	  unfolded	  state,	  with	  35	  aa	  folded	  (figure	  1.15,	  A).	  The	  combined	  calculated	   values	   for	   the	   formation	   rates	   of	   such	   off-­‐pathway	   intermediates	   implied	   that	  around	  90%	  of	  the	  structure	  acquisition	  attempts	  by	  unfolded	  PrP	  led	  to	  non-­‐native,	  transient	  conformations.	   A	   PrP	   double	   mutant	   (C179A/C214A),	   known	   to	   form	   oligomers	   rich	   in	   β	  structure,	   was	   also	   investigated	   with	   the	   same	   methodology,	   revealing	   an	   increased	  occupancy	  of	  the	  same	  off-­‐pathway	  misfolded	  states	  respect	  to	  WT	  PrP,	  suggesting	  that	  they	  could	  act	  as	  intermediates	  leading	  to	  oligomerization.	  Finally,	   the	   authors	   employed	   the	   same	   approach	   used	   for	   oligomeric	   constructs	   of	   α-­‐synuclein	   [267]	   with	   ShaPrP,	   showing	   a	   similar	   pattern	   of	   unfolding	   transitions	   due	   to	  monomer	  associations	  (figure	  1.15,	  C)	  [211].	  These	  data	  taken	  together	  shows	  how	  SMFS	  can	  directly	  investigate	  the	  complex	  and	  rugged	  energy	   landscape	   of	   amyloidogenic	   proteins,	   both	   at	   the	  monomeric	   and	   at	   the	   oligomeric	  level.	  
	  
Figure	   1.15	  OT	  SMFS	  studies	  on	  ShaPrP90-­‐231	   from	  [211,270].	   (A)	  Passive	   force-­‐clamp	  at	  9	  pN	  on	  ShaPrP.	  The	  protein	  populates	  mostly	  the	  unfolded	  state	  (named	  “U”,	  at	  ~	  630	  nm	  extension)	  and	  the	  native	  state	  (named	  “N”,	  at	  ~	  615	  nm	  extension);	  from	  the	  U	  state	  the	  protein	  explores	  ~	  90%	  of	  the	  time	  three	  metastable	  states	  (M1,	  M2	  and	  M3),	  indicated	  by	  small	   jumps	  towards	  extensions	  with	  values	  between	  N	  and	  U.	  (B)	  Model	  obtained	  from	  OT	  experiments	  of	  the	  folding/unfolding	  transition	  of	  ShaPrP	  showing	  no	  intermediates	  between	  N	  and	  U,	  and	  three	  metastable	  states	  accessible	  only	  from	  U.	  (C)	  OT	  SMFS	  experiments	  on	  two	  (left)	  and	  three	  (right)	  tandem	  repeats	  of	  ShaPrP90-­‐231	  molecules,	  revealing	  rupture	  events	  longer	  than	  the	  theoretical	  length	  of	  a	  fully	  stretched	  monomer,	  as	  a	  result	  of	  associations	  between	  PrP	  molecules.	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2.	  Aim	  of	  the	  research	  	  Neurodegenerative	   disorders,	   including	   prion	   diseases,	   are	   associated	   with	   protein	  aggregation.	  Considerable	  evidence	  indicates	  that	  the	  extent	  of	  neurotoxicity	  or	  infectivity	  of	  the	  oligomeric	  or	  aggregated	  proteins	  is	  strictly	  dependent	  on	  their	  structures.	  The	  proteins	  involved	  in	  these	  diseases	  are	  conformationally	  heterogeneous	  and,	  according	  to	  an	  emerging	  view,	   can	   switch	   back-­‐and-­‐forth	   between	   functional	   and	   various	   amyloidogenic	  conformations	   (strain	   conformations).	   Since	   the	   various	   conformations	   present	   in	   these	  heterogeneous	   ensembles	   lead	   to	   different	   aggregated	   forms,	   characterizing	   the	   monomer	  conformational	   space	   is	   critical	   to	   understand	   their	   pathogenicity.	   However,	   the	  characterization	   of	   the	   conformational	   heterogeneity	   of	   monomeric	   proteins	   by	   standard	  structural	   biological	   methods	   has	   proven	   to	   be	   extremely	   challenging.	   Single-­‐molecule	  methodologies	   offer	   exciting	   opportunities	   to	   increase	   our	   understanding	   of	   protein	  conformational	  equilibria.	  This	  project	  is	  aimed	  at	  using	  a	  novel	  approach	  that	  combines	  the	  two	   main	   methods	   for	   single-­‐molecule	   force	   spectroscopy	   manipulation,	   Optical	   Tweezers	  and	  Atomic	  Force	  Microscopy,	  to	  map	  the	  conformational	  energy	  landscapes	  of	  the	  truncated	  mouse	   prion	   protein	   (PrP),	   as	   well	   as	   their	   monomer	   conformations	   that	   promote	   the	  aggregation	   process.	   Truncated	   mouse	   PrP	   is	   an	   ideal	   candidate	   for	   prion	   conformational	  studies	  due	  to	  the	  possibility	  of	  creating	  different	  infectious	  conformations	  in	  a	  test	  tube	  and	  of	  introducing	  them	  in	  mice	  to	  develop	  novel	  prion	  diseases.	  The	  protein	  also	  represents	  the	  minimal	  unit	  to	  generate	  a	  prion.	  The	  synergic	  integration	  of	  these	  single-­‐molecule	  techniques	  will	   make	   it	   possible	   to	   explore	   conformational	   properties	   of	   mammalian	   PrP	   that	   are	  inaccessible	  to	  more	  classical	  in-­‐bulk	  ensemble-­‐averaged	  methods,	  and	  to	  study	  the	  nature	  of	  the	  energy	  surfaces	  over	  which	  these	  molecules	  diffuse	  as	  they	  move	  between	  their	  different	  strain	   conformations	   and	   towards	   those	   that	   are	   responsible	   for	   triggering	   the	   aggregation	  processes	  and	  pathogenesis.	  	  Specifically,	  we	  attempted	  to	  address	  here	  the	  following	  questions:	  	  	  1.	  How	  does	  the	  conformational	  polymorphism	  of	  the	  monomer	  is	  related	  to	  the	  structures	  of	  oligomers	  and	  amyloid	  species?	  	  2.	   How	   do	   various	   reaction	   conditions	   such	   as	   the	   polarity	   of	   the	   interaction	   between	  monomers	  (C-­‐to-­‐C	  terminus	  vs.	  N-­‐to-­‐C	  terminus),	  their	  relative	  concentration,	  and	  their	  rate	  of	   refolding	   and	   contact,	   affect	   the	   structure,	   yield,	   minimum	   size,	   and	   propagation	   of	   the	  early	  aggregation	  nucleus	  at	  the	  beginning	  of	  polymerization?	  	  	  Ultimately,	   this	   proposal	   aims	   at	   relating	   conformational	   space,	   folding	   intermediates,	   and	  protein	  dynamics	  to	  the	  oligomer	  structure,	  amyloid	  conformation	  and	  strain	  phenotype.	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Part	  II:	  Materials	  and	  Methods	  	  	  
3.1	  Molecular	  biology	  	  	  Omopolymeric	   GB1x8	  constructs	   and	   heteropolymeric	   GB1x4-­‐(MoPrP(89-­‐230))x1-­‐GB1x4	  constructs	  cloning	  strategy	  was	  adapted	  from	  previous	  protocol	  	  [256].	  	  	  
3.1.1	  Cloning	  	  	  Plasmid	   vector	   pQE-­‐80L	   ::	   GB1x4	   was	   kindly	   provided	   by	   the	   group	   of	   Prof.	   Bubacco	  (University	   of	   Padua).	   Cloning	   of	   GB1x4-­‐(MoPrP(89-­‐230))x1-­‐GB1x4	   was	   performed	   by	   Dr.	  Federico	  Benetti	  and	  Eleonora	  Carboni.	  Plasmid	  vectors	  were	  amplified	  by	  transforming	  50µl	  aliquots	  of	  DH5α	  E.coli	  cells	  with	  0.5µl	  of	  plasmid;	  after	  incubating	  competent	  cells	  in	  ice	  for	  30’,	  heat-­‐shock	  was	  performed	  at	  42°C	  for	   90	   seconds,	   followed	   by	   other	   5’	   in	   ice.	   Transformed	   cells	   were	   grown	   at	   37°C	   for	   45	  minutes	   in	   900µl	   of	   LB	  medium,	   then	   plated	   on	   LB	   agar	   plates	  with	   ampicillin	   (100µl/ml).	  Single	   colonies	  were	   expanded	   in	  5ml	   LB	  +	  Amp	   (100µg/ml)	   and	   the	  plasmid	  was	  purified	  using	  QIAGEn	  Plasmid	  Mini	  Kit	  (QIAGEN).	  pQE-­‐80L::GB1x8	   construct	   (figure	   3.1)	  was	   obtained	  by	   adding	  GB1x4	   sequence	   to	  the	  pQE-­‐80L::GB1x4	   linearized	  plasmid.	  Plasmid	  and	  insert	  were	  obtained	  by	  enzymatic	  cleavage	  and	  isolated	  (table	  3.1)	  using	  QIAquick	  Gel	  Extraction	  Kit	  (QIAGEN).	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Reagents	   Final	  concentration	  or	  volume	   Final	  concentration	  or	  volume	  
	   Linearization	   Excision	  
pQE-­‐80L::GB1x4	   100-­‐300	  ng	   100-­‐300	  ng	  
BglII	   1	  µl	   1	  µl	  
BamHI	   -­‐	   1	  µl	  
NEB	  buffer	  3	  
(10X)	  
2	  µl	   2	  µl	  
MilliQ	  water	   until	  20	  µl	   until	  20	  µl	  	  
Table	  3.1	  Enzymatic	  restriction	  reaction	  used	  for	  cloning.	  The	  first	  reaction	  was	  used	  to	  linearize	  the	  plasmid,	  the	  second	  was	  used	  for	  isolating	  the	  insert	  sequence,	  which	  was	  inserted	  in	  the	  linearized	  plasmid.	  	   Reagents	   Final	  concentration	  or	  volume	   Final	  concentration	  or	  volume	  
	   5:1	   7:1	  
Linearized	  plasmid	   100	  ng	   100	  ng	  
Insert	   25	  ng	   40	  ng	  
T4	  DNA	  ligase	  
(Roche)	  
1	  µl	   1	  µl	  
Ligase	  buffer	  (10X)	   1	  µl	   1	  µl	  
MilliQ	  water	   until	  10	  µl	   until	  10	  µl	  
	  
Table	  3.2	  Ligation	  reactions.	  5:1	  and	  7:1	  refers	  to	  insert:linearized	  plasmid	  molar	  ratios	  respectively.	  	  For	  GB1x4-­‐MoPrP(89-­‐230)-­‐GB1x4	  plasmid,	   specific	  primers	  were	  designed	  on	   the	  nucleotide	  sequence	  NM_011170.2	  (NCBI	  accession	  number)	  to	  amplify	  the	  MoPrP(89-­‐230)	  (MoPrP	  Tr)	  gene	  while	  adding	  Bgl	  II	  and	  Bam	  HI	  restriction	  sites.	  The	  gene	  was	  subcloned	  into	  the	  pGEM-­‐T	   vector	   (Promega),	   amplified	   and	   double	   digested	   with	   both	   restriction	   enzymes.	   A	   first	  round	   of	   ligation	   of	   the	   linearized	   pQE-­‐80L::GB1x4	   plasmid	   with	   MoPrP(89-­‐230)	   gene	   was	  performed	  (figure	  3.2).	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QuikChange	  Site	  Directed	  Mutagenesis	  kit	  (Agilent).	  For	  OT	  experiments	  pET11a::MoPrP(89-­‐230)	   and	   pET11a::MoPrP(23-­‐230)	   plasmids	  were	  mutated	   adding	   two	   cysteine	   residues	   at	  positions	  91,	  229	  and	  25,	  229,	  respectively,	  using	  primers	  in	  table	  3.3.	  Correct	   construct	   formation	   and	   gene	   orientation	  was	   checked	  by	   restriction	   reactions	   and	  sequencing.	  	   Construct	   Mutation	   Sequence	  GB1x4-­‐(MoPrP(89-­‐230))x1-­‐GB1x4	   Fwd	  	  R2_G3InsC	   5'	  GAAATTAACTATGAGATGCGGATCGCATCACCATC	  3'	  “	   Rev	  	  
R2_G3InsC	  
5'	  GATGGTGATGCGATCCGCATCTCATAGTTAATTTC	  3'	  MoPrP(89-­‐230)	   Fwd	  Q91_G92InsC	   5'	  GATATACATATGGGCCAATGCGGAGGGGGTACCCATAATC	  3'	  “	   Rev	  	  Q91_G92InsC	   5'	  GATTATGGGTACCCCCTCCGCATTGGCCCATATGTATATC	  3'	  MoPrP(23-­‐230)	   Fwd	  K24_R25InsC	   5'	  GATATACATATGAAAAAGTGCCGGCCAAAGCCTGGAGG	  3'	  “	   Rev	  	  
K24_R25InsC	  
5'	  CCTCCAGGCTTTGGCCGGCACTTTTTCATATGTATATC	  3'	  MoPrP(89-­‐230)	  &	  MoPrP(23-­‐230)	   Fwd	  R228_S229InsC	   5'	  CTATTACGACGGGAGAAGATGCTCCAGCTAATAGGATCCG	  3'	  “	   Rev	  R228_S229InsC	   5'	  CGGATCCTATTAGCTGGAGCATCTTCTCCCGTCGTAATAG	  3'	  
	  
Table	  3.3:	  Primer	  sequences	  for	  mutagenensis.	  For	  each	  mutation	  forward	  (Fwd)	  and	  reverse	  (Rev)	  primers	  are	  annotated.	  Aminoacid	  numbers	   for	  optical	   tweezers	  constructs	  are	  referred	  to	  the	  pre-­‐maturation	  sequence	  of	  MoPrP	  protein.	  	  	  	  
3.1.2	  Sequence	  design	  	  Plasmids	  of	  heteropolymeric	  constructs	  carrying	  multiple	  copies	  of	  MoPrP(89-­‐230)have	  been	  designed,	   optimized	   and	   synthesized	   by	   GenScript.	   The	   synthetic	   genes	  were	   cloned	   inside	  pET-­‐11a	  plasmid	  (Addgene)	  and	  an	  His6	  tag	  was	  added	  to	  the	  C	  terminus	  of	  the	  construct	  to	  facilitate	  purification	  steps.	  	  In	  figure	  3.3	  a	  schematic	  representation	  of	  all	  protein	  constructs	  used	  for	  SMFS	  AFM	  experiments.	  
	  
Figure	  3.3:	  Representation	  of	  polypeptide	  sequence	  of	  SMFS	  AFM	  constructs.	  The	  green	  rectangle	  is	  the	  His6	  tag,	  the	  red	  rectangles	  are	  GB1	  domains	  and	  the	  light	  blue	  arrow	  is	  MoPrP(89-­‐230);	  the	  arrow	  direction	  indicates	  the	  orientation	  of	  the	  peptide	  bond	  from	  N-­‐terminal	  to	  C-­‐terminal.	  Insertion	  of	  cysteines	  for	  two	  protein	  mutants	  are	  showed.	  For	  the	  Ins231C	  GB1x4-­‐(MoPrP(89-­‐230))x1	  the	  black	  arrows	  indicate	  the	  resulting	  protein	  in	  presence	  of	  oxidative	  or	  reducing	  conditions.	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AFM	   protein	   constructs	   expressed	   from	   respective	   plasmids	   are	   named	   depending	   on	   the	  number	  of	  MoPrP	  moiety/moieties	  for	  clarity.	  Constructs	  with	  one	  MoPrP	  moiety	  are	  named	  MoPrP	  Trx1	  while	  the	  cysteine	  insertion	  mutant	  name	  is	  MoPrP	  Trx1-­‐PEG.	  Dimeric	  constructs	  with	  two	  MoPrP	  moieties	  are	  named	  depending	  on	  the	  orientation	  of	  the	  two	  prion	  molecules.	  In	  MoPrP	  Trx2	  H-­‐T	  the	  C-­‐terminal	  globular	  domain	  of	  the	  first	  MoPrP	  moiety	  contacts	  the	  N-­‐terminal	   domain	   of	   the	   following	   MOPrP	   moiety,	   while	   in	   MoPrP	   Trx2	   H-­‐H	   the	   C-­‐terminal	  domains	  of	  the	  two	  MoPrP	  moieties	  are	  adjacent.	  The	  production	  of	  the	  latter	  was	  achieved	  by	  dimerization	  through	  a	  terminal	  cysteine	  added	  in	  position	  231	  of	  Ins231C	  GB1x4-­‐(MoPrP(89-­‐230))x1	  protein	  (figure	  3.3).	  Finally	  constructs	  with	  three	  and	  four	  prion	  protein	  moieties	  are	  named	  MoPrP	  Trx3	  and	  MoPrP	  Trx4	  respectively.	  	  	  
3.2	  Protein	  expression	  	  The	   expression	   of	   all	   the	   constructs	   was	   carried	   out	   in	   BL21	   (DE3)	   E.coli	   cells.	   After	  transformation,	   colonies	  were	   resuspended	   in	   LB	  media	  +	  Amp	   (100µg/ml)	   and	   inoculated	  directly	  in	  the	  flask	  for	  standard	  growth.	  For	  fermentation,	  a	  pre-­‐inoculum	  of	  200	  mL	  of	  the	  same	  medium	  was	  prepared.	  	  	  
3.2.1	  E.coli	  cells	  growth:	  flasks	  	  Cells	   were	   grown	   in	   Luria	   Bertani	   medium	   (table	   3.4)	   with	   ampicillin	   as	   antibiotic	   (final	  concentration	  of	  100µg/ml)	  at	  +37°C,	  150	  rpm	  until	  O.D	  was	  ~	  0.6.	  Cells	  were	  induced	  with	  Isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  (IPTG)	  and	  culture	  was	  grown	  at	  30°C	  o/n.	  To	  harvest,	  cells	  were	  centrifuged	  at	  3500	  g,	  45’	  at	  +4°C,	  washed	  twice	  with	  200ml	  of	  Lysis	  buffer	  (Trizma	  Base	   25mM,	   sodium	   deoxycholate	   w/v	   0.4%,	   Triton	   X-­‐100	   v/v	   0.5%	   pH	   8.0)	   to	   remove	  growth	  medium;	  and	  resuspended	  in	  100mL	  of	  the	  same	  buffer.	  	  
3.2.2	  E.coli	  cells	  growth:	  fermentation	  	  The	   pre-­‐inoculum	   was	   inoculated	   in	   10L	   vessels	   of	   BioStat-­‐Plus	   (Sartorius)	   containing	  autoclavated	   Zym-­‐5052	   autoinduction	   medium	   (table	   3.4)	   [273];	   with	   feed-­‐back	   controls	  oxygen	   levels	   were	   kept	   between	   26-­‐32%	   modifying	   stirrer	   velocity,	   while	   with	   acetic	  acid/ammonium	  hydroxide	  pH	  was	  kept	  at	  ~7.2.	  Growth	  was	  carried	  out	  at	  37°C	  for	  16	  hours,	  cells	  were	  then	  harvested,	  washed	  and	  resuspended	  as	  indicated	  in	  paragraph	  3.2.1.	  	   Luria-­‐Bertani	  medium	   Zym-­‐5052	  autoinduction	  medium	  Yeast	  extract	  	  	  	  	  	  	  	  	  5g	   NZ	  Amine	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  w/v	  1%	  Bacto	  Tryptone	  	  	  	  10g	   Bacto	  Yeast	  extract	  	  	  	  	  	  	  	  	  	  w/v	  0.5%	  NaCl	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10g	   Glycerol	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  v/v	  0.5%	  ddH2O	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  until	  1L	   Glucose	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  w/v	  0.05%	  	   Lactose	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  w/v	  0.2%	  	   Macroelements	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  X	  	   Microelements	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.2	  X	  
	  
Table	  3.4	  Expression	  media	  recipes	  for	  bacteria	  cell	  cultures.	  Zym-­‐5052	  macro	  and	  microelements	  composition	  are	  indicated	  in	  detail	  in	  [273].	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Cells	  were	  lysed	  using	  Panda	  Homogenizer	  (GEA	  Niro	  Soavi)	  at	  1500	  bar	  for	  3’,	  added	  EDTA	  free	  Protease	  Inhibitor	  cocktail	  (Roche)	  and	  separated	  supernatant	  from	  inclusion	  bodies	  by	  centrifugation	  at	  15000g,	  60’	  at	  +4°C.	  	  	  
3.3	  Protein	  purification	  	  Protein	  purity	  after	  each	  purification	  step	  was	  checked	  on	  SDS-­‐PAGE	  gel	  with	  corresponding	  acrylamide	   concentration	   depending	   on	   the	   molecular	   weight	   of	   the	   protein.	   Wild	   type	  MoPrP(89-­‐230)	   and	   MoPrP(23-­‐230)	   were	   purified	   with	   a	   protocol	   adapted	   from	   previous	  works	  [147,274]	  therefore	  this	  will	  not	  be	  described	  in	  this	  thesis.	  	  
3.3.1	  Purification	  of	  soluble	  proteins	  	  Supernatant	   from	   lysed	   cells	   was	   loaded	   slowly	   (0.5	   mL/min)	   onto	   HisTrap	   crude	   FF	   (GE	  Healthcare)	   nickel	   affinity	   column	   mounted	   on	   Akta	   Purifier	   system	   (GE	   Healthcare)	  previously	   equilibrated	  with	   binding	   buffer	   (Trizma-­‐Base	   25	  mM	  pH	  8.0).	   The	   column	  was	  washed	   with	   washing	   buffer	   (Trizma-­‐Base	   25	   mM,	   NaCl	   150	   mM,	   pH	   8.0)	   to	   remove	   non	  specifically	   bound	   proteins	   and	   then	   elution	   was	   performed	   with	   a	   linear	   or	   a	   step-­‐wise	  gradient	  of	  elution	  buffer	  (Trizma-­‐Base	  25	  mM,	  NaCl	  150	  mM,	  Imidazole	  500	  mM,	  pH	  8.0).	  A	  second	   purification	   step	  was	   performed	   using	   Sephacryl	   S-­‐300	   10/60	   (GE	  Healthcare)	   size	  exclusion	  column	  for	  multimeric	  MoPrP	  AFM	  constructs	  or	  Superdex	  200	  26/60	  HiPrep	  (GE	  Healthcare)	   for	   monomeric	   MoPrP	   AFM	   constructs.	   Both	   columns	   were	   equilibrated	   in	  washing	  buffer.	  Mutant	  Ins3C	  MoPrP	  Trx1	  construct	  was	  purified	  as	  MoPrP	  Trx1	  except	  that	  1	  mM	  DTT	  was	  added	  in	  each	  buffer	  to	  prevent	  protein	  concatenation.	  The	  purification	  of	  MoPrP	  Trx2	  H-­‐H	  was	  performed	  with	  a	  first	  step	  on	  HisTrap	  column.	  The	  purified	  protein	  was	  allowed	  to	  spontaneously	  dimerize	  in	  an	  oxidizing	  environment	  at	  +4°C	  for	  24-­‐48	  hrs.	  Separation	  of	  reaction	  products	  was	  performed	  by	  Sephacryl	  S-­‐300	  10/60	  size-­‐exclusion	  chromatography	  column.	  	  
3.3.2	  Purification	  from	  inclusion	  bodies	  	  Proteins	  that	  were	  not	  localized	  in	  the	  supernatant	  fraction	  accumulated	  in	  inclusion	  bodies.	  A	   common	   inclusion	   bodies	   extraction	   protocol	  was	   developed.	   The	   pellet	   from	   lysed	   cells	  was	   resuspended	   in	  Tris-­‐HCl	  25mM,	  5mM	  EDTA,	  0.8%	  Triton	  X-­‐100,	  pH	  8.0,	   pelleted	   again	  and	  washed	  several	  times	  with	  distilled	  water.	  Pure	  inclusion	  bodies	  were	  solubilized	  12	  hrs	  at	  37°C	  in	  5	  volumes	  of	  Tris-­‐HCl	  25mM	  GndHCl	  8M	  pH	  8.0	  and	  centrifuged	  30	  min,	  10000	  g,	  4°C	  to	  remove	  bacterial	  debris.	  	  Solubilized	  inclusion	  bodies	  were	  loaded	  on	  Superdex	  200	  26/60	  HiPrep	  (GE	  Healthcare)	  SEC	  column	   equilibrated	  with	  washing	   buffer	   (Trizma-­‐Base	   25	  mM,	  NaCl	   150	  mM,	  GndHCl	   6	  M	  pH8.0).	  Refolding	  and	  purification	  was	  adapted	  from	  [275]	  and	  achieved	  in	  a	  single	  step	  using	  5mL	  HisTrap	  crude	  FF	  (GE	  Healthcare)	  nickel	  affinity	  column	  as	  follows.	  Protein	  was	  loaded	  on	  the	  column	  equilibrated	  washing	  buffer,	  then	  a	  linear	  gradient	  of	  200	  minutes	  at	  1mL/min	  to	  refolding	  buffer	  (Trizma-­‐Base	  25	  mM,	  NaCl	  150	  mM,	  pH	  8.0)	  was	  used	  to	  remove	  guanidine	  and	  refold	   the	  protein	  while	  keeping	   it	  attached	   to	   the	  resin.	  Finally	   the	  protein	  was	  eluted	  with	  a	  linear	  gradient	  with	  elution	  buffer	  (Trizma-­‐Base	  25	  mM,	  NaCl	  150	  mM,	  Imidazole	  500	  mM,	  pH	  8.0).	  OT	   proteins	   inclusion	   bodies	  were	  washed	   and	   size-­‐exclusion	   chromatography	  was	   carried	  out	   as	  previously	  described	   in	   this	  paragraph,	   except	   that	   inclusion	  body	   resuspension	  and	  SEC	  equilibration	  buffers	  were	  MOPS	  10	  mM	  Urea	  8	  M	  NaCl	  150	  mM	  DTT	  1	  mM	  pH	  8.0.	  After	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24	   hrs	   fresh	   DTT	   was	   added	   to	   buffers	   to	   a	   final	   concentration	   of	   1	   mM	   to	   maintain	   the	  reducing	   environment.	   A	   second	   step	   of	   purification	   was	   achieved	   by	   diluting	   protein	  fractions	   from	  SEC	  1:10	   in	  MOPS	  10	  mM,	  Urea	  8	  M,	  DTT	  1	  mM	  then	   loading	   the	   sample	  on	  HiPreP	  Q	  FF	  (GE	  Healthcare)	  cation	  exchange	  chromatography.	  Elution	  was	  achieved	  using	  a	  linear	  gradient	  to	  equilibration	  buffer	  with	  NaCl	  1	  M.	  Fractions	  containing	  pure	  protein	  were	  pooled,	  dialyzed	  to	  MilliQ	  water	  using	  3.5	  kDa	  dialysis	  membranes	  (SpectraPore)	  and	  finally	  lyophilized	  for	  -­‐80°C	  storage.	  	  	  
3.4	  Sample	  preparation	  and	  characterization	  	  Purified	  proteins	  were	  concentrated	  using	  Amicon	  Ultra	  30-­‐50kDa	  MWCO	  (Merck-­‐Millipore)	  tubes	   until	   desired	   concentration	   and	   dialyzed	   with	   buffer	   of	   choice.	   Typically,	   AFM	  experiment	  storage	  buffer	  was	  Trizma	  Base	  20mM	  pH7.4	  NaN3	  0.05%	  while	  that	  for	  circular	  dichroism	  experiments	  was	  Na2HPO4/NaH2PO4	  20mM	  pH	  7.4.	  or	  NaOAc	  20	  mM	  pH	  5.5	  	  	  
3.4.1	  Protein	  refolding	  	  Two	  milligrams	  of	  OT	  lyophilized	  samples	  were	  resuspended	  in	  Trizma-­‐Base	  25	  mM,	  GndHCl	  6	  M	  DTT	  1	  mM,	  pH	  8.0.	  Then	  a	  rapid	  dilution	  to	  0.1	  mg/mL	  in	  Trizma-­‐Base	  25	  mM,	  DTT	  1mM	  pH	  8.0	  was	  performed	  followed	  by	  dialysis	  with	  5	  L	  of	  NaOAc	  20	  mM,	  DTT	  1	  mM	  pH	  5.5.	  The	  pellet	   was	   separated	   by	   centrifugation	   50’,	   2000	   g,	   4°C.	   Supernatant	   was	   concentrated	   as	  previously	  described.	  	  
3.4.2	  Protein	  concentration	  measurements	  	  Concentration	   was	   calculated	   measuring	   absorbance	   at	   280	   nm	   with	   theoretical	   molar	  extinction	  coefficient	  calculated	  from	  ProtParam	  Tools	  software	  (table	  3.5).	  	  	   Protein	   N°	  residues	   Molecular	  weight	  (kDa)	   ε0	  (M-­‐1	  ×	  cm-­‐1)	  GB1x4	   250	   27.767	   40005	  GB1x8	   486	   53.912	   79885	  GB1x4-­‐(MoPrP(89-­‐230))x1-­‐GB1x4	   631	   70.423	   107400	  GB1x4-­‐(MoPrP(89-­‐230))x2-­‐GB1x4	   770	   86.357	   134915	  GB1x4-­‐(MoPrP(89-­‐230))x3-­‐GB1x4	   915	   102.813	   162430	  GB1x2-­‐(MoPrP(89-­‐230))x4-­‐GB1x2	   824	   93.125	   150065	  GB1x4-­‐(MoPrP(89-­‐230))x1	  cys231	   387	   43.487	   67395	  
	  
Table	  3.5	  Protein	  constructs	  with	  relative	  parameters.	  Parameters	  were	  derived	  from	  the	  amino	  acid	  sequence.	  Cysteine	  residues	  were	  assumed	  to	  be	  oxidized.	  	  	  
3.4.3	  Protein	  functionalization	  	  Ins3C	  GB1x4-­‐MoPrP(89-­‐230)-­‐GB1x4	  protein	  was	  dialyzed	  with	  Tris-­‐HCl	  10	  mM	  TCEP	  1	  mM	  pH	  7.4,	  added	  10k	  Mal-­‐PEG	  (Nanocs)	  with	  1:50	  molar	  ratio	  and	  incubated	  at	  room	  temperature	  for	  4	  hrs.	  Excess	  PEG	  was	  removed	  using	  Superdex	  200	  Increase	  10/300	  GL	  (GE	  Healthcare)	  size-­‐exclusion	  chromatography.	  Optical	   tweezers	   MoPrP	   constructs	   were	   activated	   by	   reacting	   with	   DTDP	   as	   previously	  described	  [208]:	  proteins	  were	  loaded	  three	  times	  on	  Zeba	  Spin	  Desalting	  Columns	  7	  MWCO	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(Thermo-­‐Pierce)	   previously	   equilibrated	   with	   Na2HPO4/NaH2PO4	   100	   mM,	   DTDP	   2	   mM,	  Acetonitrile	  15%	  v/v,	  pH	  5.5.	  Excess	  DTDP	  was	  removed	  by	  dialysis	  with	  NaOAc	  20	  mM	  pH	  5.5	  and	  protein	  was	  stored	  at	  +4°C.	  DNA	  handles	  1000	  bp	   long	  were	  obtained	  by	  PCR	   from	  pET11a	  empty	  plasmid	   (amplifying	  position	  1	  to	  1000)	  using	  5’	  thiol	  conjugated	  primers,	  purified	  using	  QIAGEN	  Plasmid	  Maxi	  kit	  (QIAGEN),	   concentrated	   using	   Amicon	   Ultra	   10	   MWCO	   devices.	   Finally	   DNA	   handles	   were	  stored	  in	  buffer	  Na2HPO4/NaH2PO4	  100	  mM,	  TCEP	  1	  mM	  pH	  7.4.	  	  
3.4.4	  SDS-­‐PAGE	  and	  Western-­‐blot	  	  Protein	  purity	  was	  assessed	  by	  SDS-­‐PAGE	  gel	  as	  well	  as	  by	  Western-­‐blot	  (WB).	  Briefly,	  protein	  was	   boiled	   in	   loading	   buffer	   (Tris-­‐HCl	   50	  mM,	   glycerol	   10%	  v/v,	   SDS	   2%	  w/v,	   5	  mM	  DTT,	  0.005%	  bromophenol	   blue,	   pH	   6.8)	   and	   loaded	   on	   SDS-­‐PAGE	   gel	  with	   different	   acrylamide	  concentration	   depending	   on	   protein	  molecular	   weight.	   Gels	   were	   stained	   20	  minutes	   with	  staining	  buffer	   (MilliQ	  water	  45	  %	  v/v,	  methanol	  45	  %	  v/v,	   acetic	   acid	  10%	  v/v,	   Comassie	  Brilliant	   blue	   R	   0.04%	  w/v)	   and	   destained	  with	   destaining	   buffer	   (MilliQ	  water	   45	  %	   v/v,	  methanol	  45	  %	  v/v,	  acetic	  acid	  10%	  v/v).	  Images	  were	  acquired	  with	  ChemiDoc	  XRS	  system	  (BioRad).	  Western-­‐blotting	   (WB)	  was	  performed	  by	   transferring	  proteins	  onto	  nitrocellulose,	  blocked	  with	   blocking	   solution	   (TBST	   +	   milk	   2%	   w/v)	   and	   incubated	   o/n	   at	   +4°C	   with	   primary	  antibody.	  Typically,	  HisProbe-­‐HRP	  (ThermoScientific)	  was	  used	  for	  GB1	  only	  constructs	  and	  1	  µg/mL	  anti-­‐PrP	  Fab	  D18	  (InPro	  Biotech)	  for	  PrP	  bearing	  constructs.	  Membranes	  were	  washed	  with	  TBST,	  incubated	  45	  minutes	  with	  secondary	  antibodies	  conjugated	  with	  HRP,	  developed	  using	  ECL	  detection	  reagent	  (GE	  Healthcare)	  and	  images	  acquired	  with	  digital	  imaging	  system	  Alliance	  4.7	  (UVITEC).	  	  
3.4.5	  Circular	  dichroism	  	  Typically	   200	   µl	   of	   protein	   samples	   were	   loaded	   inside	   0.1	   cm	   quartz	   cuvettes	   (Hellma	  Analytics)	  and	  mounted	  on	   Jasco	   J-­‐715	  CD	  spectrometer	  (Jasco).	  Spectra	  of	  protein	  samples	  and	  blanks	  were	   acquired	  with	  wavelength	   intervals	  between	  190	  and	  260	  nm	  at	  20	  nm/s	  scan	  rate.	  The	  resulting	  spectra	  were	  an	  average	  of	  three	  subsequent	  scans.	  Blank	  subtraction	  and	  smoothing	  using	  Savitzkey-­‐Golay	  filter	  with	  25	  nm	  smoothing	  window,	  were	  performed	  using	  SpectraManager	  software	  (Jasco).	  Normalized	  spectra	  were	  obtained	  using	  Dichroweb	  software	   (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml)	   with	   CDSSTR	   7	   or	   K2D	   as	  reference	  set.	  	  	  
3.5	  Protein-­‐protein	  and	  protein-­‐DNA	  interaction	  
	  
3.5.1	  Size-­‐exclusion	  chromatography	  	  Purified	  GB1x4	  and	  WT	  MoPrP(89-­‐230)	  were	  incubated	  with	  a	  1:10	  molar	  ratio	  concentration	  in	  Trizma-­‐base	  20mM	  pH7.4	  and	  NaOAc	  20	  mM	  pH	  5.5	  buffer	  for	  1	  hour,	  at	  room	  temperature,	  in	   protein	   low-­‐binding	   tubes	   (Eppendorf).	   Samples	   of	   100µl	   volume	   were	   injected	   in	  Superdex	  200	  Increase	  10/300	  GL	  (GE	  Healthcare)	  column	  equilibrated	  in	  the	  same	  protein	  incubation	  buffer	  with	  NaCl	  150	  mM.	  Fractions	  were	  then	  analyzed	  by	  western-­‐blot,	  developing	  first	  using	  the	  HisProbe-­‐HRP.	  Then	  the	  membrane	  	  was	  stripped	  for	  4	  hrs	  with	  TBST	  +	  NaN3	  0.05%	  and	  developed	  using	  Fab	  D18	  antibody	  
	   44	  
3.5.2	  Co-­‐immunoprecipitation	  	  Pure	  Proteome	  Protein	  A	  Magnetic	  beads	  (Millipore)	  were	  previously	  washed	  with	  PBS	  pH	  7.4	  and	  then	  incubated	  with	  102	  µl	  of	  washing	  buffer	  (PBS	  pH7.4,	  Tween	  20	  0.1%	  v/v)	  with	  10	  µl	  of	  anti	  Histidine	  6	  tag	  1:1000	  (AbD	  Serotec)	  antibody	  on	  rotating	  mixer	  for	  10’	  at	  RT.	  Beads	  were	  washed	  three	  times	  with	  washing	  buffer	  and	  added	  500	  µl	  of	  protein	  mixture:	  0.5	  µg	  of	  GB1x4	   and	   MoPrP	   were	   mixed	   together,	   while	   negative	   controls	   were	   prepared	   without	  adding	  GB1x4.	  Protein	  mixtures	  were	  incubated	  1	  hour	  at	  +4°C,	  removed	  and	  washed	  3	  times	  with	   washing	   buffer.	   Samples	   were	   then	   loaded	   on	   SDS-­‐PAGE	   gel	   and	  WB	   was	   developed	  using	  Fab	  D18	  antibody.	  	  
3.5.3	  ELISA	  	  Nunc-­‐Immuno	  Microwell	  96	  well	  solid	  plates	  (Falcon)	  were	  coated	  o/n	  at	  +4°C	  with	  100µl	  of	  WT	  MoPrP(89-­‐230)	  or	  GB1x4	  proteins	   in	  PBS.	  Wells	  were	   then	  washed	   five	   times	  with	  PBS	  and	  blocked	  with	  PBS	  +	  milk	  2%	  w/v	  for	  2	  hours	  at	  room	  temperature.	  After	  washing	  wells	  five	   times	   with	   PBS,	   GB1x4	   in	   PBS	   buffer	   was	   added	   to	   MoPrP(89-­‐230)	   coated	   wells	   at	  increasing	  molar	  concentrations	  and	   incubated	   for	  1	  hr	  at	  RT.	  Rinsed	  with	  PBS	  +	  Tween-­‐20	  0.05%	  v/v,	  incubated	  1	  hr	  with	  Fab	  D18	  for	  PrP	  or	  anti	  Histidine	  6	  tag	  1:1000	  (AbD	  Serotec)	  for	  GB1x4.	  Secondary	  antibody	  goat	  anti	  human	  HRP	  or	  rabbit	  anti	  mouse	  AP	  were	  used	   for	  PrP	  and	  GB1	  respectively.	  The	   former	  secondary	  antibody	  was	  developed	  using	  2mg/mL	  p-­‐nitrophenyl	   phosphate	   (Thermo-­‐Scientific)	   in	   developing	   buffer	   (Tris-­‐HCl	   100	  mM,	  MgCl	   5	  mM,	  NaCl	  100	  mM,	  pH	  9.2)	  while	   the	   latter	  with	  3,3’,5,5’-­‐tetramethylbenzidine	   (Sigma)	  and	  stopped	  with	  100µl	  0.16	  M	  H2SO4.	  Plates	  were	  read	  on	  Spectramax	  M5	  (Molecular	  Devices)	  at	  405	  nm	  and	  450	  nm	  wavelengths	  respectively.	  	  
3.5.4	  Electrophoretic	  mobility	  shift	  assay	  	  DNA	  handles	  were	  incubated	  with	  increasing	  stoichiometric	  amounts	  of	  wild	  type	  MoPrP(89-­‐230)	  and	  MoPrP(23-­‐230)	  for	  1	  hr	  at	  RT	  in	  buffer	  Hepes	  10	  mM,	  KCl	  500	  mM,	  MgCl2	  5	  mM	  pH	  7.4.	   Samples	  were	   loaded	  on	  agarose	  1%	  w/v	  gel	  with	  2	  µl	   ethidium	  bromide	  and	   checked	  DNA	  migration.	  dsDNA	  used	  will	  be	  the	  handles	  for	  OT	  experiments.	  	  	  
3.6	  Single-­‐molecule	  force	  spectroscopy	  	  Constant	  velocity	  mechanical	  unfolding	  experiments	  were	  performed	  with	  a	  Veeco	  Picoforce	  AFM	   on	   a	   Multimode	   Nanoscope	   IIIa	   (Bruker)	   equipped	   with	   PicoForce	   196	   PF	   (Bruker)	  piezo-­‐stage.	   Gold-­‐coated	   triangular	   silicon	   nitride	   cantilevers	   (NPG,	   Bruker)	   with	   nominal	  spring	   constants	   of	   0.06	  N/m	  were	  used.	   The	   effective	   spring	   constant	  was	  determined	   for	  each	  of	  them	  by	  their	  thermal	  noise	  spectrum	  [276].	  All	  the	  experiments	  were	  carried	  out	  at	  room	  temperature,	  with	  an	  estimated	  fluid-­‐cell	  temperature	  of	  28°C.	  	  
3.6.1	  Sample	  preparation	  	  Ten	  microliters	  of	  protein	  specimen	  were	  deposited	  for	  30	  minutes	  on	  a	  flame-­‐cleaned	  glass	  coverslip	  or	   freshly	  peeled	  TSG	  surface	  and	  mounted	  on	  a	   fluid	   cell.	  The	  buffers	  used	  were	  Trizma-­‐base	  20	  mM	  pH	  7.4,	  Trizma-­‐base	  20	  mM	  NaCl	  150	  mM	  pH	  7.4,	  NaOAc	  20	  mM	  pH	  5.5	  and	  NaOAc	  20	  mM	  pH	  4.0.	  A	  double	   inlet	   device	  was	  used	   to	   switch	   from	  neutral	   to	   acidic	  buffer,	  directly	  inside	  the	  fluid	  cell	  in	  the	  case	  of	  experiments	  with	  pH	  lower	  than	  7.4.	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3.6.2	  Unfolding	  experiments	  	  Velocity-­‐clamp	  experiments	  were	   carried	  out	  by	   iterating	  approach/retraction	   cycles	  of	   the	  tip	   (figure	   3.4)	   with	   fixed	   500	   nm	   ramp	   and	   10	   nm	   push	   on	   the	   surface.	   Protein	   sample	  concentration	  was	   usually	   0.5-­‐7	   µM.	   Pulling	   velocities	  were	   2180,	   4360	   and	   8720	   nm/s	   in	  order	  to	  compare	  results	  with	  previous	  studies	  [299,	  300].	  Typically	  ~30-­‐100k	  curves	  were	  obtained	   from	   each	   experimental	   setup	   but,	   on	   the	   average,	   only	   0.03%	   of	   them	   normally	  could	   be	   associated	   to	   an	   interpretable	   FEC	   and	   therefore	  only	   these	  were	   considered	   and	  analyzed.	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3.6.3	  Double-­‐pulse	  refolding	  experiments	  	  Double-­‐pulse	   refolding	  experiments	   (figure	   3.5)	  were	  performed	  using	   in-­‐house	  developed	  software	   [277]	   in	   conjunction	   with	   Nanoscope	   v6	   software.	   Experimental	   ramping	  parameters	   were	   set	   according	   to	   the	   theoretical	   length	   of	   protein	   constructs,	   using	  crystallographic	  contour	   length	  of	  an	  amino	  acid	  Lcaa	  =	  0.36	  nm/aa	  [243],	  as	  shown	  in	  table	  
3.6.	  A	  fixed	  fetch	  distance	  was	  chosen	  in	  order	  to	  be	  sure	  that	  the	  MoPrP	  domain/s	  within	  the	  fetched	  molecules	  were	  stretched.	  A	  refolding	  time	  of	  50	  ms	  was	  chosen	  because	  it	  is	  sufficient	  to	  refold	  all	  GB1	  domains	  [256]	  and	  to	  refold	  alfa-­‐helix	  rich	  proteins	  [7].	  Refolding	  took	  place	  at	  ~5-­‐10	  nm	  distance	  from	  the	  surface.	  Retraction	  velocity	   for	   fetch	  and	  break-­‐away	   traces	  was	   set	   at	  2180	  nm/s	  whereas	  the	   velocity	   for	   the	   refolding	   approach	   trace	   was	   set	   at	   8720	   nm/s.	   Protein	   sample	  concentration	  was	  10-­‐15µM,	   to	   increase	   the	  probability	   of	   protein	   fetching.	  Usually	   10-­‐30k	  curves	  were	  obtained	  from	  each	  experimental	  setup,	  with	  an	  average	  efficiency	  of	  ~0.008%.	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3.6.4	  Multi-­‐pulse	  refolding	  experiments	  	  Multi-­‐pulse	   refolding	   experiments	   were	   performed	   using	   a	   home-­‐built	   software	   as	   in	   the	  previous	  paragraph.	  Initially,	  molecules	  were	  picked	  and	  stretched	  to	  a	  fixed	  length	  indicated	  in	  table	  3.6	   (“fetch”	  curve,	  figure	  3.6	  B).	  Subsequently	  10	  approach/retraction	  cycles	  were	  performed	  to	  unfold	  and	  refold	  the	  tethered	  molecule	  (“refold”	  curves,	  figure	  3.6	  C).	  This	  step	  was	  iterated	  up	  to	  six	  times,	  each	  time	  the	  extension	  was	  increased	  by	  10	  nm	  only	  if	  the	  force	  of	  the	  last	  peak	  was	  lower	  than	  500	  pN.	  Finally,	  the	  protein	  was	  detached	  from	  the	  tip/surface	  with	   a	   1	   µm	   retraction	   ramp	   (“loose”	   curve,	   figure	   3.6	   D).	   Retraction	   velocity	   for	   fetch,	  
refolding	  and	  loose	  curves	  was	  set	  at	  2180	  nm/s,	  while	  velocity	  for	  refolding	  approach	  trace	  at	  8720	   nm/s.	   Protein	   sample	   concentration	   was	   ~20	   µM,	   as	   to	   increase	   the	   probability	   of	  protein	   fetching.	  Usually	  2-­‐6k	   curves	  were	  obtained	   from	  each	  experimental	   setup,	  with	  an	  average	  efficiency	  of	  0.00014%.	  	  












Figure	  3.6	  Multi-­‐pulse	  refolding	  scheme.	  (A)	  Piezo	  position	  over	  time.	  (B)	  fetch	  curve;	  (C)	  refolding	  curve;	  (D)	  
loose	  curve.	  Colours	   in	  panel	  A	  of	  piezo	  movements	  and	  curves	   in	  panel	  B,	  C,	  D	  are	  the	  same.	  Step	  1	  and	  2	  are	  identical	   to	   the	   double-­‐pulse	   refolding.	   On	   step	   3	   the	   piezo	   moved	   repeatedly	   10	   times	   from	   the	   refolding	  position	  to	  the	  fetching	  position	  (refold).	  This	  cycle	  was	  iterated	  N	  times	  and	  each	  time	  the	  fetching	  position	  was	  increased	  of	  10	  nm	  only	  if	  the	  last	  peak	  force	  was	  lower	  than	  500	  pN.	  In	  step	  4	  the	  piezo	  stage	  moves	  away	  from	  the	  tip,	  fully	  stretching	  the	  molecule	  and	  detaching	  it	  from	  the	  tip	  (loose).	  	  	  
3.7	  Data	  analysis	  	  Curve	  filtering	  and	  peak	  fitting	  was	  performed	  by	  in-­‐house	  developed	  software	  [277].	  Briefly,	  curve	  peaks	  were	  fitted	  using	  the	  Worm	  Like	  Chain	  (WLC)	  model	  [229]:	  	  
	  	  where	   kb	   	   is	   Boltzman	   constant,	   T	   is	   temperature	   and	   L	   is	   contour	   length	   and	   p	   is	   the	  persistence	  length.	  In	  our	  studies	  we	  set	  p	  =	  0.4	  nm.	  We	  considered	  1	  nm	  spatial	  sensitivity,	  as	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result	   of	   an	   overestimation	   by	   a	   factor	   of	   two	   the	   sum	  of	   the	   experimental	   error	   and	  WLC	  fitting.	  Curves	   were	   first	   selected	   automatically	   on	   the	   basis	   of	   the	   three	   parameters	   reported	   in	  
table	  3.6.	  The	  first	  is	  the	  minimum	  and	  maximum	  number	  of	  unfolded	  GB1	  modules	  (n)	  in	  the	  retraction	  trace,	  sufficient	  to	  claim	  that	  also	  the	  MoPrP	  moiety/ies	  in	  the	  construct	  was/were	  stretched:	  	  	   	  	  where	  M	  is	  the	  number	  of	  GB1	  modules	  on	  the	  construct	  polypeptide	  chain.	  	  The	  other	   two	  parameters	  are	   the	  maximum	  and	  minimum	  length	  of	   the	   fetched	  molecules,	  depending	   on	   n,	   in	   retraction	   traces.	   Selection	   was	   performed	   in	   the	   retraction	   trace	   for	  unfolding	   experiment,	   whereas	   for	   double-­‐pulse	   and	   multi-­‐pulse	   refolding	   curves	   the	  selection	  was	  applied	  on	  the	  break	  away	  and	  refolding	  traces	  respectively.	  	  A	   second	   round	   of	   manual	   selection	   was	   carried	   out	   as	   to	   save	   only	   FEC	   that	   were	  unequivocally	  related	  to	  single-­‐molecule	  stretching	  events	  with	  the	  typical	  sawtooth	  pattern	  and	  with	  low	  or	  absent	  non-­‐specific	  interaction.	  WLC	  peak	  fitting	  adjustment	  was	  performed	  where	  needed,	  outside	  the	  non-­‐specific	  interaction	  region.	  Delta	  contour	  length	  (Δcl)	  and	  force	  values	  of	  every	  peak	  from	  FEC	  where	  used	  for	  subsequent	  analysis.	  	   Protein	   n	   Min.	  molecule	  	  length	  (nm)	   Max.	  molecule	  	  length	  (nm)	  GB1x8	   5/8	   110.52	   174.96	  GB1x4-­‐(MoPrP(89-­‐230))x1-­‐GB1x4	   5/8	   150.48	   214.92	  GB1x4-­‐(MoPrP(89-­‐230))x2	  H-­‐T-­‐GB1x4	   5/8	   185.38	   254.88	  GB1x4-­‐(MoPrP(89-­‐230))x2	   H-­‐H-­‐GB1x4	   5/8	   185.38	   258.48	  GB1x4-­‐(MoPrP(89-­‐230))x3-­‐GB1x4	   5/8	   225.26	   294.84	  GB1x2-­‐(MoPrP(89-­‐230))x4-­‐GB1x2	   3/4	   222.84	   247.68	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Part	  III:	  Results	  and	  discussion	  
	  
4.1	   Cloning,	   expression,	   purification	   and	   characterization	   of	   GB1x4	   and	   GB1x8	  
constructs	  
	  In	   our	   studies	   we	   decided	   to	   take	   advantage	   of	   the	   heteropolymeric	   protein	   approach	  [246,249,258,263]	   to	   investigate	   structural	   properties	   of	  MoPrP(89-­‐230)	  using	  AFM	   single-­‐molecule	   force	   spectroscopy.	  We	   used	   streptococcal	   protein	   G	   domain	   B1	   as	   a	  mechanical	  fingerprint	  and	  to	  build	  up	  a	  protein-­‐handle	  flanking	  the	  MoPrP	  moieties	  under	  investigation.	  pQE-­‐80L::GB1x8	  was	  obtained	  as	  indicated	  in	  paragraph	  3.1	  by	  using	  pQE-­‐80L::GB1x4	  as	  the	  starting	   cloning	   vector.	   BglII	   and	   BamHI	   restriction	   enzymes	   produced	   5’	   overhanging	  filaments	  that	  were	  complementary	  and	  their	  ligation	  generated	  a	  BstI	  restriction	  site,	  leaving	  the	  Bgl	  II	  and	  Bam	  HI	  sites	  at	  the	  3’	  and	  5’	  termini	  of	  the	  gene.	  Enzymatic	  cleavage	  of	  resulting	  clones	  using	  BglII	  and	  BamHI	  restriction	  enzymes	  was	  used	  to	  check	  if	  concatenation	  of	  two	  Gb1x4	  DNA	  sequences	  occurred	  (see	  figure	  4.1).	  	  
	  
Figure	   4.1:	  Agarose	  1%	  gel	  of	  double	  enzymatic	  digestion	  of	  pQE-­‐80L::GB1x8	  positive	  clones;	  on	   the	   right	   the	  control	  using	  pQE-­‐80L::GB1x4.	  The	  positive	  clones	  show	  a	  band	  at	  1440	  bp.	  	  	  Orientation	  of	  insertion	  in	  the	  positive	  clones	  was	  checked	  by	  sequencing.	  Expression	  of	  both	  constructs	   was	   achieved	   by	   adapting	   to	   a	   previous	   protocol	   [256].	   Bacterial	   cells	   were	  induced	   at	  ~0.5-­‐0.6	  O.D600nm	  with	   1mM	   IPTG	   and	   grown	   at	   37°C	   o/n.	   After	   cell	   disruption,	  both	  proteins	  were	   localized	   in	   the	   soluble	   fraction,	   and	  purification	  was	  carried	  out	  under	  native	   conditions.	   The	   first	   step	   of	   purification	   was	   achieved	   using	   Ni2+-­‐affinity	   columns	  (figure	   4.2)	   which	   yielded	   a	   large	   amount	   of	   protein	   Major	   contaminants	   included	   lower	  molecular	  weight	  protein	  bands	  and	  a	  band	  at	  twice	  the	  theoretical	  molecular	  weight	  of	  the	  protein	   construct.	   The	   latter	  was	   likely	   due	   to	   dimerization	   of	   the	   construct	   by	   C-­‐terminal	  cysteine	   residues.	   A	   second	   step	   of	   purification	   was	   carried	   out	   by	   size	   exclusion	  chromatography	   (figure	   4.3)	  which	   increased	   the	   purity	   of	   GB1x4	   and	  GB1x8	   to	  ~97%	  and	  ~94%,	  respectively.	  Circular	   dichroism	   data	   showed	   that	   both	   proteins	   had	   a	   typical	   α-­‐β	   spectra	   (figure	   4.4),	  comparable	   to	   previous	   studies	   [278].	   Normalized	   spectra	   of	   the	   two	   proteins	   were	   not	  superimposable,	  with	  an	   intensity	  of	  ~2000	  deg×cm2/dmol	   (208	  nm	  wavelength)	   lower	   for	  the	  octameric	  construct.	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Figure	  4.2:	  Top	  panel:	  HisTrap	  chromatography	  of	  (A)	  GB1x4	  and	  (B)	  GB1x8.	  Bottom	  panel:	  SDS-­‐PAGE	  12%	  gel	  of	  t0	  and	  to/n	  LB	  culture	  of	  GB1x4	  and	  GB1x8,	  supernatant	  fraction	  and	  HisTrap	  elution	  fractions.	  	  
	  
	  
Figure	  4.3:	  Top	  panel:	  HisTrap	  chromatography	  of	  (A)	  GB1x4	  and	  (B)	  GB1x8.	  Bottom	  panel:	  SDS-­‐PAGE	  12%	  gel	  of	  t0	  and	  to/n	  LB	  culture	  of	  GB1x4	  and	  GB1x8,	  supernatant	  fraction	  and	  HisTrap	  elution	  fractions.	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Figure	  4.4:	  	  Normalized	  Far-­‐UV	  CD	  spectra	  of	  (A)	  GB1x4	  and	  (B)	  GB1x8	  in	  Na2HPO4-­‐/NaH2PO4-­‐	  20	  mM	  pH	  7.4.	  	  	  
4.2	  Expression	  and	  purification	  of	  MoPrP	  Trx1,	  MoPrP	  Trx2H-­‐T	  and	  MoPrP	  Trx3	  	  	  	  Since	   expression	   of	   truncated	   recombinant	   PrP	   in	   E.	   coli	   cells	   usually	   results	   in	   the	  accumulation	   of	   the	   recombinant	   protein	   in	   inclusion	   bodies,	   it	   is	   necessary	   to	   purify	   the	  protein	   under	   denaturing	   conditions	   [274,279].	   Strikingly,	   the	   MoPrP	   Trx1	   recombinant	  protein	  was	  localized	  only	  in	  the	  soluble	  fraction	  and	  not	  in	  the	  inclusion	  bodies,	  suggesting	  that	  flanking	  the	  prion	  protein	  with	  GB1	  domains	  increased	  the	  solubility	  of	  the	  fusion	  protein.	  This	   behaviour	   was	   previously	   described	   for	   other	   insoluble	   proteins	   [280,281].	   Previous	  work	  done	  by	  Dr.	  Federico	  Benetti	  and	  Eleonora	  Carboni	  showed	  that	  the	  73	  kDa	  band	  was	  immunoreactive	  toward	  Fab-­‐D18	  and	  Anti	  His6	  tag	  antibodies,	  showing	  that	  MoPrP(89-­‐230)	  moiety	   was	   present.	   Protein	   purification	   was	   carried	   out	   under	   native	   conditions.	   Major	  contaminants	   were	   lower	   molecular	   weight	   products	   recognized	   by	   His6	   tag	   antibody,	  suggesting	  premature	  translation	  ending	  of	  the	  protein	  or	  low	  mRNA	  stability	  [282].	  	  	  
	  
Figure	  4.5:	  	  Top	  panel:	  HisTrap	  chromatography	  on	  the	  left	  and	  HiPrep	  S300	  16/60	  on	  the	  right	  of	  MoPrP	  Trx1.	  Bottom	  panel:	  SDS-­‐PAGE	  showing	  expression	  of	  the	  protein	  construct	  and	  its	  localization	  in	  the	  soluble	  fraction,	  as	  well	  as	  protein	  purification	  steps.	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During	   size-­‐exclusion	   chromatography,	   the	   recombinant	   protein	   eluted	   at	   void	   volume,	  probably	  due	  to	  its	  non-­‐globular	  shape	  (figure	  4.5).	  SDS-­‐PAGE	  gel	  of	  the	  corresponding	  peak	  revealed	  a	  protein	  purity	  of	  ~90%.	  Purification	  of	  MoPrP	  TRx1-­‐PEG	  performed	  with	  the	  same	  protocol	   under	   reducing	   conditions,	   reacted	   with	   PEG	   and	   unreacted	   molecules	   were	  separated	  with	  size-­‐exclusion	  chromatography.	  Since	   low	  molecular	  weight	  contaminants	  were	  still	  able	   to	  bind	  to	   the	  Ni2+-­‐affinity	  column,	  for	   the	   multimeric	   MoPrP	   constructs	   the	   His6	   tag	   was	   placed	   on	   the	   C-­‐terminus.	   In	   case	  premature	  translation	  occurred,	  only	  the	  complete	  translated	  molecules	  would	  have	  had	  the	  tag.	  	  Expression	   trials	   on	   dimeric	  MoPrP	   Trx2	   H-­‐T	   and	   trimeric	  MoPrP	   Trx3	   were	   carried	   out	   in	  order	   to	   find	   the	  best	  conditions	   that	  resulted	   in	  high	  over-­‐expression	  (figure	   4.6).	  Protein	  expression	  was	  then	  performed	  in	  250	  ml	  LB-­‐medium	  flasks.	  	  
	  	  
Figure	  4.6:	  	  Expression	  trials	  at	  different	  temperatures	  and	  different	  IPTG	  concentrations	  of	  (A)	  MoPrP	  Trx2	  H-­‐T	  	  and	  (B)	  MoPrP	  Trx3.	  Arrows	  indicate	  the	  appearance	  of	  the	  protein	  band	  after	  induction,	  respect	  to	  t0.	  	  	  	  In	  both	  cases	  the	  protein	  was	  localized	  in	  the	  supernatant	  fraction	  and	  native	  purification	  was	  performed,	  similarly	  to	  MoPrP	  Trx1.	  During	  affinity	  chromatography	  lower	  molecular	  weight	  products	  were	   still	   present	   but	   during	   the	   second	   step	   of	   purification	   they	  were	   removed.	  Both	  proteins	  in	  size-­‐exclusion	  chromatography	  eluted	  in	  two	  different	  fractions.	  One	  at	  void	  volume	  (~	  41	  ml)	  and	  one	  at	  retention	  volume	  of	  ~	  60	  ml	  and	  ~	  62	  ml	   for	  MoPrP	  Trx2	  H-­‐T	  (figure	  4.7)	  and	  MoPrP	  Trx3	  (figure	  4.8)	  respectively.	  No	  clear	  difference	  between	  these	  two	  fractions	   on	   SDS-­‐PAGE	   was	   detected.	   Nevertheless,	   circular	   dichroism	   experiments	   were	  carried	  out	  on	  both	  fractions	  of	  MoPrP	  Trx3	  revealing	  no	  differences	  in	  the	  overall	  fold	  (figure	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Figure	  4.7:	  On	  top	  panel	  HisTrap	  chromatography	  on	  the	  left	  and	  HiPrep	  S300	  16/60	  on	  the	  right	  of	  MoPrP	  Trx2.	  On	  bottom	  panel	  SDS-­‐PAGE	  showing	  expression	  of	  the	  protein	  construct,	   its	   localization	  in	  the	  soluble	  fraction	  and	  purification	  steps;	  the	  green	  and	  red	  box	  refers	  to	  the	  elution	  peaks	  of	  size-­‐exclusion	  chromatography.	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Protein	  purity	  of	  MoPrP	  Trx2	  H-­‐T	  and	  MoPrP	  Trx3	  was	  assessed	  by	  SDS-­‐PAGE	  and	  WB	  (figure	  
4.9)	  and	  it	  was	  estimated	  ~	  90%.	  
	  
Figure	   4.9:	   Western	   blot	   of	   purified	   samples	   of	   MoPrP	   Trx2H-­‐T,	   MoPrP	   Trx3	   and	   MoPrP	   Trx4	  using	   Fab	   D18	  antibody.	  	  	  Circular	  dichroism	  spectra	  of	  the	  three	  constructs	  showed	  that	  both	  proteins	  were	  structured	  with	  similar	  secondary	  structure	  contents	  (figure	  4.10).	  	  	  
	  	  
Figure	   4.9:	  Normalized	  Far-­‐UV	  CD	  spectra	  acquired	   in	  phosphate	  buffer	  20	  mM,	  pH7.4.	   (A)	  Overlay	  of	  MoPrP	  Trx1,	  MoPrP	  Trx2H-­‐T,	  MoPrP	  Trx3.	  (B)	  Overlay	  between	  MoPrP	  Trx3	  from	  60	  ml	  (MoPrP	  Trx3)	  and	  40	  ml	  (MoPrP	  Trx3	  HMW)	  peaks:	  the	  latter	  shows	  similar	  secondary	  structure	  content	  but	  lower	  MRE.	  	  	  
4.3	  Expression,	  purification	  and	  assembly	  of	  MoPrP	  Trx2	  with	  Head-­‐to-­‐Head	  orientation	  	  	  The	   dimeric	  MoPrP	   construct	   with	   the	   two	   C-­‐terminal	   globular	   domains	   facing	   each	   other	  (MoPrP	  Trx2H-­‐H)	  was	  obtained	  by	  purification	  of	  Ins231C	  GB1x4-­‐(MoPrP(89-­‐230))x1	  protein.	  	  Ins231C	   GB1x4-­‐(MoPrP(89-­‐230))x1	   over-­‐expression	   was	   checked	   under	   different	   growth	  temperature	   and	   IPTG	   concentrations.	   Protein	   was	   initially	   purified	   by	   affinity	  chromatography	  (figure	  4.11):	  two	  bands	  at	  44	  kDa	  and	  ~90	  kDa	  were	  present	  in	  the	  eluate,	  presumably	  the	  monomer	  and	  the	  homo-­‐dimer	  respectively.	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Figure	  4.11:	  (A)	  Expression	  trials	  of	  Ins231C	  GB1x4-­‐(MoPrP(89-­‐230))x1.	  (B)	  HisTrap	  chromatography	  of	  soluble	  fraction	  of	  induced	  bacteria,	  the	  arrows	  indicate	  the	  monomer	  and	  the	  dimer.	  	  	  After	   the	   first	   purification	   passage,	   the	   protein	   was	   left	   oxidizing	   spontaneously,	   then	  products	   of	   the	   reaction	   were	   separated	   depending	   on	   their	   size	   (figure	   4.12,	   A).	   Three	  species	  eluted	  from	  the	  column	  at	  void	  volume,	  at	  60	  ml	  and	  at	  75	  ml	  respectively.	  On	  SDS-­‐PAGE	   the	   first	   peak	   showed	   two	   bands	   corresponding	   to	   the	   theoretical	  MW	   of	   unreacted	  monomer	  and	  dimer	  respectively.	  The	  second	  showed	  only	  a	  band	  of	  the	  protein	  dimer.	  The	  third	  peak	  presented	  unreacted	  monomer	  and	  small	  amounts	  of	  dimer.	  	  	  
	  
	  
Figure	   4.12:	   (A)	  Purification	  of	  oxidized	   Ins231C	  GB1x4-­‐(MoPrP(89-­‐230))x1	  and	  corresponding	  SDS-­‐PAGE:	   the	  colored	   boxes	   reflect	   the	   chromatographic	   fractions.	   (B)	  WB	   of	   Ins231C	   GB1x4-­‐(MoPrP(89-­‐230))x1	   after	   S300	  purification:	   in	   presence	   of	   excess	   TCEP,	   the	   dimer	   (upper	   arrow)	   reverted	   to	   unreacted	   monomer	   (lower	  arrow).	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Fractions	  from	  relative	  elution	  peaks	  were	  analyzed	  on	  WB	  with	  Fab	  D18	  antibody	  confirming	  the	  presence	  of	  MoPrP	  moiety.	  Incubating	  the	  purified	  dimer	  with	  reducing	  agents	  resulted	  in	  the	  appearance	  of	  the	  monomer	  band	  only,	   indicating	  that	  the	  disulfide	  bridge	  between	  two	  monomeric	  molecules	  was	   disrupted	   (figure	   4.12,	   B).	   The	   overall	   yield	   of	   the	   purification	  was	  very	  low	  (0.06	  µg/L	  culture).	  CD	  spectra	  were	  acquired	  from	  the	  unreacted	  monomer	  and	  dimer	  (figure	  4.13).	  Secondary	  structure	  contents	  were	  similar	  to	  MoPrP	  Trx1,	  MoPrP	  Trx2	  H-­‐T	  and	  MoPrP	  Trx4	  protein	  constructs.	  	  
	  	  
Figure	  4.13:	  Normalized	  far-­‐UV	  CD	  spectra	  acquired	  in	  phosphate	  buffer	  20	  mM,	  pH7.4.	  (A)	  Unreacted	  monomer	  of	   GB1x4-­‐(MoPrP(89-­‐230))x1cys231.	   (B)	   MoPrP	   Trx2H-­‐H	   spectra:	   the	   scattered	   signal	   was	   due	   to	   the	   low	  concentration	  of	  the	  protein	  sample.	  	  	  
4.4	  Expression	  and	  purification	  of	  MoPrP	  Trx4	  	  	  Since	   very	   large	   proteins	   (>100	   kDa)	   are	   poorly	   expressed	   in	   E.	   coli	   cells,	   the	   construct	  containing	   four	   tandem	  copies	  of	  MoPrP(89-­‐230)	  was	   flanked	  only	  by	   two	  GB1	  domains.	   It	  has	   been	   shown	   that	   such	   number	   of	   marker	   domain	   was	   still	   sufficient	   for	   correct	  identification	  of	  molecules	  in	  AFM	  SMFS	  [227].	  	  Expression	   trials	   and	   fermentation	   were	   carried	   out	   in	   Zym5052	   autoinduction	   medium:	  unlike	  previous	  discussed	  proteins,	  MoPrP	  Trx4	  expression	  always	  led	  to	  the	  accumulation	  of	  the	   recombinant	   protein	   in	   inclusion	   bodies	   (figure	   4.14,	   A).	   Purification	   was	   performed	  under	   non-­‐native	   conditions	   with	   size-­‐exclusion	   as	   first	   step	   (figure	   4.14,	   B)	   and	  refolding/purification	   with	   affinity	   chromatography	   as	   second	   step	   (figure	   4.14,	   C).	   The	  advantage	  of	  using	  on-­‐column	  refolding	  was	  reducing	  molecular	  crowding	  by	  binding	  protein	  molecules	  to	  the	  resin,	  giving	  them	  enough	  time	  to	  refold	  autonomously.	  Interestingly	   the	   purified	   protein	   showed	   a	   strong	   pH-­‐dependence	   solubility.	   Aliquots	   of	  100µl	  MoPrP	  Trx4	  were	  dialyzed	  with	  four	  different	  buffers	  (Tris	  20	  mM	  pH	  7.4,	  Tris	  20	  mM	  pH	  6.5,	  NaOAc	  20	  mM	  pH	  5.5	  and	  NaOAc	  20	  mM	  pH	  4.0).	  Samples	  were	  centrifuged	  and	  the	  pellet	  was	  resuspended	  in	  Loading	  Buffer	  1X	  Urea	  8M,	  while	  the	  supernatant	  was	  lyophilized	  and	  resuspended	  in	  the	  same	  buffer.	  Samples	  were	  analyzed	  on	  SDS-­‐PAGE	  (figure	  4.16).	  At	  neutral	   pH	   the	   protein	   was	   completely	   soluble,	   while	   decreasing	   pH	   to	   5.5	   diminished	   its	  solubility	   as	   protein	   aggregated	   and	   precipitated.	   At	   pH	   4.5	   the	   protein	   maintained	   its	  solubility	  similarly	  to	  neutral	  pH.	  Protein	  purity	  was	  very	  high	  (~97%)	  and	  the	  MoPrP	  moiety	  presence	  was	  confirmed	  by	  WB	  (figure	  4.9).	  Analysis	   of	   the	   secondary	   structure	   content	   revealed	   that	   protein	   is	   folded	   similarly	   to	   the	  other	  heteropolymeric	  protein	  constructs	  (figure	  4.15)	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Figure	  4.14:	   (A)	  Expression	  trials	  of	  MoPrP	  Trx4	  	  at	  different	   times	  and	  temperature,	  on	  the	  right	  supernatant	  and	  inclusion	  bodies	  (IB)	  of	   lysed	  bacteria	  culture.	  (B)	  HiLoad	  S200	  HiPrep	  of	  solubilized	  inclusion	  bodies	  and	  relative	  SDS-­‐PAGE	  of	  highlighted	  fractions.	  (C)	  On	  the	  top	  left	  panel	  loading	  and	  refolding	  by	  linear	  gradient	  of	  MoPrP	  Trx4,	  on	  top	  right	  elution	  of	  the	  refolded	  protein	  and	  relative	  SDS-­‐PAGE	  gel	  on	  the	  bottom	  panel.	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Figure	   4.15:	   Normalized	   far-­‐UV	   CD	   spectra	   of	   MoPrP	   Trx4	   shows	   a	   αβ	   mixed	   structure	   similar	   to	   previous	  purified	  proteins.	  	  	  
	  
Figure	  4.16:	  MoPrP	  Trx4	  solubility	  at	  different	  pH	  values.	  Marker	  (MW),	  protein	  sample	  at	  pH	  8.0	  (S).	  Surnatant	  (Surn)	  and	  unsoluble	  fraction	  (Pellet)	  from	  buffer	  exchange	  at	  different	  pH	  values	  are	  loaded.	  	  	  
4.5	  Expression	  and	  purification	  of	  MoPrP	  for	  optical	  tweezers	  	  	  Expression	  of	  MoPrP(89-­‐230)	  cys92,	  cys229	  and	  MoPrP23-­‐230	  cys25,	  cys229	  was	  carried	  out	  in	  10L	   of	   Zym5052	   auto-­‐induction	   medium.	   Purification	   was	   performed	   starting	   from	  recombinant	  protein	   in	   the	   inclusion	  bodies	  using	  a	   first	   step	  of	   size-­‐exclusion,	   followed	  by	  cation	  exchange	  chromatography	  (figure	  4.17).	  Reducing	  conditions	  were	  critical	  to	  obtain	  a	  monomeric	  protein,	  which	  spontaneously	  dimerized	  via	  terminal	  cysteine	  residues	  in	  absence	  of	   DTT,	   generating	   high-­‐molecular	  weight	   products.	   Protein	   purity	  was	   very	   high	   (~	   97%)	  even	  if	  some	  multimers	  could	  be	  detected	  by	  WB	  even	  in	  presence	  of	  reducing	  agents.	  Proteins	  were	  refolded	  under	  reducing	  conditions	  and	  reacted	  with	  DTDP,	  therefore	  analysis	  of	   secondary	   structure	   content	   was	   necessary	   to	   prove	   that	   refolding	   occurred	   correctly	  (figure	   4.18).	   After	   refolding	   and	   DTDP	   reaction,	   both	   proteins	   showed	   a	   typical	   α-­‐helical	  structure,	  like	  respective	  WT	  proteins.	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Figure	  4.17:	  On	  top	  left	  panel	  HiLoad	  S200	  26/60	  column	  loaded	  with	  inclusion	  bodies,	  the	  blue	  trace	  shows	  the	  chromatogram	   without	   DTT	   in	   equilibration	   buffer,	   the	   yellow	   trace	   with	   DTT	   1mM	   in	   equilibration	   buffer:	  notice	  the	  presence	  of	  a	  peak	  at	  ~170	  ml	  typical	  of	  WT	  MoPrP;	  on	  top	  right	  panel	  HiLoad	  SP	  FF	  column	  loading	  and	  elution	  of	  MoPrP(89-­‐230)	  cys92,cys229	  from	  previous	  size-­‐exclusion	  step.	  On	  bottom	  panel	  on	  the	  left	  SDS-­‐PAGE	   relative	   to	   the	   cation	   exchange	   column:	   it	   is	   possible	   to	   notice	   several	   bands	   of	   multimers	   above	   the	  theoretical	   MW	   of	   truncated	  MoPrP;	   on	   the	   right	  WB	  with	   purified	   samples:	   wild	   type	   (wt),	   double	   cysteine	  construct	  with	  DTT	  (+DTT)	  and	  without	  DTT	  (-­‐DTT).	  	  
	  
	  
Figure	   4.18:	   Far-­‐UV	   CD	   spectra	   of	   (A)	   MoPrP(89-­‐230)	   cys92,229	   and	   (B)	   MoPrP(23-­‐230)	   cys25,229	   after	  refolding	  in	  reducing	  conditions	  (not	  reacted)	  and	  after	  DTDP	  reaction	  (DTDP	  reacted)	  	  of	  the	  same	  sample.	  After	  DTDP	  reaction	  absorbance	  diminished	  due	  to	  partial	  protein	  precipitation.	  	  	  
4.6	  Protein-­‐protein	  and	  DNA-­‐protein	  interaction	  experiments	  
	  Different	   sets	   of	   experiments	   were	   carried	   out	   in	   order	   to	   identify	   possible	   interactions	  between	  MoPrP	   proteins	   and	   their	   corresponding	   handles	   for	   AFM	   (GB1	   domains)	   and	  OT	  (dsDNA)	  .	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4.6.1	  Interaction	  analyses	  of	  MoPrP(89-­‐230)	  with	  GB1	  	  
	  Initially	  co-­‐immunoprecipitation	  experiments	  were	  performed	  by	  immunoprecipitating	  GB1x4	  incubated	  with	  MoPrP(89-­‐230)	  and	  developing	  using	  Fab	  D18	  antibody.	  Results	  showed	  that	  full-­‐length	  seems	  to	  immunoprecipitate	  with	  the	  bacterial	  protein	  domain,	  while	  a	  faint	  band	  was	  detectable	  for	  the	  truncated	  form	  (figure	  4.19).	  A	  band	  was	  detected	  when	  GB1	  was	  not	  incubated	   with	   the	   prion	   protein	   and	   GB1	   positive	   control	   without	   IP,	   indicating	   that	   the	  protein	  was	  able	  to	  bind	  secondary	  antibody	  Fc	  region.	  The	  same	  band	  was	  present	  in	  the	  full-­‐length	  sample	  incubated	  with	  GB1,	  but	  it	  could	  not	  be	  detected	  in	  the	  truncated	  one.	  	  
	  
Figure	   4.19:	  western	  blot	  developed	  with	  Fab	  D18	  antibody.	  First	   three	   lanes	  were	   loaded	  with	   recombinant	  proteins	  only,	  immunoprecipitated	  samples	  GB1,	  GB1	  and	  MoPrP(23-­‐230)	  and	  GB1	  and	  MoPrP(89-­‐230);	  in	  the	  last	  two	  lanes	  negative	  controls	  are	  loaded.	  	  	  ELISA	  experiments	  were	  performed	  by	  adsorbing	   truncated	  MoPrP	  on	   the	  wells.	  GB1x4	  was	  then	   added	   to	   the	   wells	   and	   developed	   using	   Anti	   His6	   tag	   antibody.	   Results	   showed	   that	  incubating	  MoPrP(89-­‐230)	  with	  different	   increasing	  concentrations	  of	  GB1	  did	  not	  result	   in	  significant	  increases	  in	  alkaline	  phosphatase	  signal	  (figure	  4.20).	  
	  
Figure	  4.20:	  in	  blue	  the	  samples	  with	  increasing	  molar	  concentrations	  of	  GB1x4,	  in	  red	  the	  two	  positive	  controls	  for	  PrP	  and	  GB1x4;	  in	  magenta	  the	  negative	  controls	  without	  PrP	  coating	  (-­‐D18)	  and	  PrP	  coating	  with	  Anti	  Histag	  (-­‐	  αHis).	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Non-­‐equilibrium	   “small	   zone”	   [283]	   size-­‐exclusion	   chromatography	   experiments	   were	  performed	   to	   check	   protein	   interactions	  without	   antibody	   related	   techniques.	   Firstly	   GB1x4	  construct	   only	  was	   loaded	   on	   the	   column	   and	   eluted	  with	   two	   peaks	   corresponding	   to	   the	  monomeric	  (15	  ml)	  and	  the	  dimeric	  form	  (13	  ml)	  (figure	  4.21).	  Loading	  MoPrP(89-­‐230)	  only	  resulted	   in	   appearance	   of	   a	   major	   elution	   peak	   at	   18ml	   and	   a	   smaller	   peak	   at	   15	   mL.	  	  Incubating	  MoPrP(89-­‐230)	  and	  GB1x4	  in	  a	  10:1	  stoichiometry	  at	  pH	  7.4	  significantly	  increased	  the	  13	  ml	  GB1	  elution	  peak	  intensity	  (figure	  4.21).	  Analyzing	  these	  fractions	  by	  western	  blot	  did	   not	   reveal	   the	   presence	   of	  MoPrP,	   suggesting	   that	   the	   peak	  was	   due	   to	   GB1x4	   terminal	  cysteine	   dimer.	   At	   pH	   5.5	   the	   13	   mL	   GB1	   peak	   was	   still	   present	   even	   though	   it	   was	   less	  pronounced.	  	  
	  	  
Figure	   4.21:	  On	   top	   left	  panel	  S200	  Increase	  10/300	  GL	  of	  GB1x4	   (blue	   trace)	  and	  MoPrP(89-­‐230)	  (red	   trace)	  only,	  while	  on	  the	  right	  both	  protein	  mixed	  in	  1:4	  proportion	  at	  pH	  7.4	  (blue	  trace)	  and	  pH	  5.5	  (red	  trace);	  on	  bottom	   panel	   two	   WB	   of	   the	   two	   chromatographic	   experiments:	   numbers	   are	   referred	   to	   relative	   volume	  fractions,	  which	   are	   highlighted	   in	   green	   and	   orange	   for	   simplification.	   It	   is	   possible	   to	   notice	   that	   PrP	   is	   not	  present	  in	  GB1	  fractions.	  	  	  
4.6.2	  Interaction	  analyses	  of	  MoPrP(89-­‐230)	  with	  dsDNA	  
	  Analysis	   of	   interaction	   between	   DNA	   and	   MoPrP	   for	   optical	   tweezers	   experiments	   was	  performed.	   EMSA	   experiments	   (figure	   4.22)	   did	   not	   reveal	   any	   significant	   electrophoretic	  shift	  of	  the	  dsDNA	  handle	  band	  incubated	  with	  truncated	  recombinant	  PrP,	  while	  a	  small	  shift	  occurred	  with	  the	  full-­‐length	  at	  20:1	  molar	  concentration	  ratio.	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Figure	   4.22:	   agarose	   1%	   gel	   of	   MoPrP	   mixed	   with	   dsDNA	   OT	   handles:	   handles	   as	   negative	   control	   (-­‐)	   and	  mixture	  proportions	  indicated	  as	  MoPrP:handle	  molar	  concentrations.	  Since	  the	  handles	  exposed	  a	  thiol	  group	  at	  5’,	  dimers	  could	  be	  observed	  at	  ~	  2	  kbp.	  	  	  	  
5.1	  SMFS	  experiments	  on	  GB1x8	  reference	  system	  
	  First	  of	  all	  analysis	  of	  GB1	  fingerprint	  domain	  polyprotein	  was	  achieved,	  in	  order	  to	  compare	  data	  from	  literature	  and	  confirm	  the	  robustness	  of	  our	  system.	  Simple	  unfolding	  experiments	  were	   performed	   at	   three	   different	   pH:	   neutral	   (7.4),	   acidic	   (5.5)	   and	   highly	   acidic	   (4.0).	  Typical	  sawtooth	  pattern	  curves	  were	  obtained	  (figure	  5.1,	  A)	  where	  every	  peak	  corresponds	  to	  a	  single	  GB1	  domain	  unfolding	  event	  from	  a	  single	  molecule.	  Peaks	  were	  characterized	  by	  a	  typical	  exponential	  increase	  of	  the	  force,	  followed	  by	  a	  sudden	  drop	  to	  near	  to	  zero	  values	  at	  lower	   extensions.	  Not	   all	   the	   force-­‐extension	   curves	   (FEC)	   showed	   a	   final	   peak	  with	   forces	  typical	  of	  covalent	  bond	  breakage	  (500	  pN	  –	  2nN),	  nevertheless,	  such	  curves	  where	  included	  in	   the	  analysis.	  Noticeably,	   some	  FEC	   showed	  more	   than	  eight	  GB1	  unfolding	  events	   (up	   to	  fifteen)	   suggesting	   the	   presence	   of	   dimers,	   probably	   due	   to	   C-­‐terminal	   cysteine	   oxidation	  events,	  which	  were	  not	  detected	  in	  protein	  preparation	  (paragraph	  4.1).	  Fitting	  the	  overall	  events	  with	  a	  single	  gaussian	  distribution,	  showed	  a	  mean	  Δcl	  =	  18.3	  ±	  1.4	  nm	  with	  an	  average	  force	  F	  =	  226.25	  ±	  45.85	  pN	  at	  a	  loading	  rate	  of	  2180	  nm/s	  (figure	  5.2).	  These	  values	  fit	  those	  reported	   in	   the	   literature	   for	   a	   two-­‐state	   native-­‐to-­‐unfolding	   transition	   of	   the	   GB1	   domain	  [256,284,285].	  	  
	  
Figure	  5.1:	  (A)	  Typical	  GB1x8	  FEC	  obtained	  from	  unfolding	  experiments.	  (B)	  FEC	  from	  double-­‐pulse	  experiments	  on	  a	  GB1x8	  sample:	  the	  two	  superimposable	  unfolding	  pulses	  in	  red	  and	  black	  are	  separated	  for	  clarity.	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Even	   if	   the	   majority	   of	   GB1	   unfolding	   events	   were	   found	   inside	   a	   well-­‐defined	   interval	   of	  contour	  length,	  some	  spurious	  events	  at	  different	  Δcl	  were	  detected.	  More	  in	  detail,	  events	  in	  the	  intervals	  between	  0-­‐15	  nm,	  23-­‐30	  nm	  and	  >	  30	  nm	  showed	  a	  frequency	  of	  3.8%,	  1.6%	  and	  0.1%	  respectively.	  This	  data	   indicated	   that	  every	  unfolding	  event	   inside	  15	   to	  23	  nm	  range	  can	  be	  safely	  associated	  to	  a	  GB1	  unfolding	  event.	  No	  significant	  differences	  were	  found	  between	  experiments	  at	  three	  different	  pH	  in	  terms	  of	  Δcl	  distribution,	  average	  unfolding	   force	  and	  spurious	  events	   located	  outside	  the	  GB1	  Δcl	  N-­‐>U	  window.	  
	  
Figure	   5.2:	   on	   top	   scatterplot	   from	  unfolding	   experiments	   carried	   out	   at	   pH	  7.4.	   On	   bottom,	   fitting	  with	   one	  gaussian	  distribution	  of	  the	  PDF	  function	  calculated	  on	  Δcl	  experimental	  data;	  RMSD	  =	  0.9903.	  	  	  Double-­‐pulse	  refolding	  experiments	  showed	  that	  GB1	  domains	  were	  able	  to	  refold	  after	  50	  ms	  of	  refolding	  time,	  as	  indicated	  by	  the	  appearance	  of	  peaks	  during	  the	  second	  pulse	  that	  were	  













































Min delta cl: 4.8252 nm     Max delta cl: 37.2195 nm     N°bins: 37
Min force:   82.4455 pN     Max force:    376.424 pN     N°bins. 37
Data points: 1
Mean deltacl18.1576 nm     Mean force:226.2553pN +?45.8578
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perfectly	  superposable	  to	  the	  first	  unfolding	  pulse	  (figure	  5.1,	  B).	  Even	  if	  a	  small	  number	  of	  curves	  were	  obtained,	  all	  unfolding	  events	  had	  a	  length	  between	  15	  and	  23	  nm	  interval.	  This	  was	  confirmed	  using	  multi-­‐pulse	  refolding	  experiments.	  Therefore	   in	   refolding	  experiments,	  unfolding	   peaks	   shorter	   than	   15	   nm	   and	   longer	   than	   23	   nm	   were	   not	   associated	   to	   GB1	  unfolding	  events.	  	  	  
5.2	  SMFS	  experiments	  on	  MoPrP	  Trx1	  
	  Unfolding	  experiments	  of	  MoPrP	  Trx1	  at	  three	  different	  pH	  were	  characterized	  by	  FEC	  (figure	  
5.3)	  with	   typical	   GB1	  unfolding	   events	  with	  Δcl	   =	   18	   ±	   1.7	   nm	   and	   F	   =	   208.56	   ±	   52.13	   pN.	  Unlike	   the	  GB1x8	  construct,	  a	  higher	   frequency	  of	  rupture	  events	  with	  delta	  contour	   lengths	  between	  23	  and	  30	  nm	   (23.8%)	  and	  between	  30	  and	  39	  nm	   (3%)	  was	  observed.	   FEC	  with	  such	  rupture	  events	  showed	  only	  one	  peak	  with	  these	  lengths.	  	  	  
Figure	  5.3:	  On	  top	  scatterplot	  from	  unfolding	  experiments	  carried	  out	  at	  pH	  7.4.	  On	  bottom	  the	  fitting	  of	  delta	  delta	  contour	  length	  data	  with	  kernel	  density	  estimator.	  
























































Min delta cl: 4.8252 nm     Max delta cl: 37.2195 nm     N°bins: 37
Min force:   82.4455 pN     Max force:    376.424 pN     N°bins. 37
Data points: 1
Mean deltacl18.1576 nm     Mean force:226.2553pN +?45.8578
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in delta cl: 6.1263 nm     Max delta cl: 40.6071 nm     N°bins: 17
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ean deltacl20.4107 nm     Mean force:208.006pN +?53.8181
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Unfolding	  events	  with	  Δcl	  >	  30	  nm	  were	  present	   in	  about	  18%	  of	   the	  overall	   curves	  almost	  independently	  on	  the	  pH	  of	  the	  buffer	  (figure	  5.4).	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Figure	   5.5:	   (A)	   PEG	  MoPrP	   Trx1	   unfolding	   curve:	   the	   first	  WLC	   starts	   150	   nm	   from	   the	   contact	   point,	  which	  correspond	  to	  the	  extension	  of	  1.5	  PEG	  10k	  moieties.	  In	  the	  lower	  panels	  double-­‐pulse	  refolding	  of	  MoPrP	  Trx1	  showing	  (B)	  a	  27	  nm	  peak	  before	  molecule	  detachment	  or	  (C)	  a	  “hump”	  mechanical	  feature	  inside	  the	  brown	  box.	  	  	  Multi-­‐pulse	  refolding	  experiments	  were	  carried	  out	  at	  pH	  7.4,	  since	  experiment	  efficiency	  was	  higher	   under	   these	   conditions.	   Only	   one	  molecule	  was	   refolded	   60	   times	   and	   two	   types	   of	  signals	   could	   be	   detected	   (figure	   5.6):	   low	   force	   events	   that	   could	   not	   be	   fitted	  with	  WLC	  model	  and	  GB1	  unfolding	  peaks.	  Low	  force	  events	  where	  present	  only	  in	  8%	  of	  the	  unfolding	  traces,	  prior	   to	  any	  GB1	  unfolding	  event.	  No	  pushing	  on	   the	   surface	  during	   refolding	   traces	  was	   observed,	   therefore	   it	   is	   possible	   to	   exclude	   that	   such	   events	  were	  due	   to	   non-­‐specific	  interaction	  between	  the	  tip	  and	  the	  surface.	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5.3	  SMFS	  experiments	  on	  MoPrP	  Trx2	  H-­‐T	  and	  MoPrP	  Trx2	  H-­‐H	  
	  We	   next	   analyzed	   the	   behavior	   of	   two	   dimeric	   Head-­‐to-­‐Tail	   and	   Head-­‐to-­‐Head	   constructs:	  MoPrP	  Trx1	  H-­‐T	  (“Head-­‐to-­‐Tail”)	  with	  the	  C-­‐terminal	  globular	  of	  the	  first	  MoPrP	  moiety	  linked	  to	   the	   residue	   89	   of	   the	   N-­‐terminal	   unstructured	   domain	   from	   the	   second	   MoPrP	   moiety;	  MoPrP	  Trx2	  H-­‐H	  with	  both	  C-­‐terminal	  globular	  domain	  of	  MoPrP	  moieties	  linked	  by	  a	  disulfide	  bridge.	  	  
	  
Figure	  5.7:	  FEC	  from	  unfolding	  experiments	  on	  MoPrP	  Trx2	  H-­‐T.	  (A)	  FEC	  with	  a	  peak	  of	  72	  nm	  preceding	  GB1	  rupture	   peaks	   (indicated	   by	   the	   black	   arrow).	   (B)	   FEC	   with	   the	   hump	  mechanical	   feature	   highlighted	   in	   the	  brown	  box.	  	  	  Unfolding	   experiments	   on	   MoPrP	   Trx2	   H-­‐T	   and	   MoPrP	   Trx2	   H-­‐H	   at	   neutral	   pH	   where	  characterized	  by	  FEC	  with	  a	  typical	  sawtooth	  pattern	  of	  GB1	  unfolding	  events	  (figure	  5.7,	  A).	  Differently	  from	  MoPrP	  Trx1,	  more	  than	  40	  %	  of	  the	  curves	  presented	  up	  to	  two	  peaks	  with	  Δcl	  between	   30	   and	   80	   nm	   length;	   the	   position	   of	   these	   peaks	   inside	   the	   FECs	   was	   mainly	  localized	  at	  the	  beginning	  of	  the	  curve	  and,	  less	  frequently,	  between	  GB1	  unfolding	  events	  or	  previous	   the	  molecule’s	  detachment.	  Decreasing	   the	  pH	   to	  more	  acidic	  values	   increased	   the	  number	  of	  such	  curves	  up	  to	  20%	  for	  both	  constructs	  (figure	  5.8).	   	  The	  “hump”	  mechanical	  feature	  was	  present	  in	  a	  small	  percentage	  of	  the	  curves	  (~	  2	  %),	  showing	  up	  in	  two	  different	  ways:	  preceding	  the	  unfolding	  of	  GB1	  domains	  as	  showed	  in	  paragraph	  5.2	  or	  as	  an	  enthalpic	  contribution	  during	  the	  entropic	  force	  increase	  of	  a	  peak	  (figure	  5.7,	  B).	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Analysis	   of	   Δcl	   total	   distribution	   confirmed	   the	   presence	   of	   GB1	   unfolding	   events	   cluster,	  characterized	  by	  Δcl(N-­‐>U)	  =	  18.5	  ±	  2	  nm	  ,with	  average	  unfolding	  force	  F	  =	  233.3	  ±	  50.1	  pN	  and	  F	   =	   240.8	   ±	   53.3	   pN	   for	  MoPrP	   Trx2	   H-­‐T	   and	  MoPrP	   Trx2	   H-­‐H	   constructs	   respectively.	   The	  frequency	  of	  peaks	  within	  the	  23-­‐30	  nm	  interval	  was	  7	  %	  for	  MoPrP	  Trx2	  H-­‐T	  and	  3.7	  %	  for	  the	   MoPrP	   Trx2	   H-­‐H,	   both	   values	   were	   significantly	   lower	   compared	   to	   MoPrP	   Trx1.	   The	  distribution	   of	   peaks	   with	   delta	   contour	   length	   longer	   than	   30	   nm	   was	   similar	   for	   both	  proteins	  (figure	  5.9):	  events	  with	   lower	   lengths	  were	  more	  frequent	  with	  respect	  to	   longer	  ones,	  but	  no	  clear	  clusters	  were	  present.	  Therefore,	  estimation	  of	  conformer	  populations	  by	  Gaussian	  mixture	  distribution	  could	  not	  be	  performed.	  	  
	  	  
Figure	   5.9:	   Analysis	   of	   (A)	   MoPrP	   Trx2	   H-­‐T	   and	   (B)	   MoPrP	   Trx2	   H-­‐H	   respectively.	   On	   top	   the	   scatterplot	   of	  unfolding	  experiments	  at	  pH	  7.4.	  On	  bottom	  the	  overall	  Δcl	  distribution	  (blue	  bars)	  with	  calculated	  kernel	  density	  function	  (red	  line)	  and	  distribution	  of	  Δcl	  >	  30	  nm.	  	  	  	  Since	  quantity	  and	  concentration	  of	  MoPrP	  Trx2	  H-­‐H	  samples	  were	  not	  sufficient	  for	  refolding	  experiments,	   double-­‐pulse	   refolding	   experiments	   were	   carried	   out	   on	   the	   Head-­‐to-­‐Tail	  heteropolymeric	  protein.	  Such	  experiments	  were	  performed	  at	  neutral	  pH	  to	  confirm	  that	  the	  presence	   of	   peaks	  with	   Δcl	  >	   30	   nm	  was	   not	   related	   to	   tip/surface	   non-­‐specific	   interaction	  signals	  (figure	  5.10).	  	  






























Min delta cl: 5.859 nm     Max delta cl: 80.0253 nm     N°bins: 50
Min force:   72.3009 pN     Max force:    422.2909 pN     N°bins. 29
Data points: 1
Mean deltacl20.5964 nm     Mean force:211.4988pN +?50.2791











































































Min delta cl: 5.5934 nm     Max delta cl: 75.3554 nm     N°bins: 26
Min force:   65.8099 pN     Max force:    438.5631 pN     N°bins. 21
Data points: 1
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5.4	  SMFS	  experiments	  on	  MoPrP	  Trx3	  	  In	  order	  to	  gain	  insights	  in	  the	  oligomerization	  processes	  of	  MoPrP(89-­‐230),	  single-­‐molecule	  force	  spectroscopy	  experiments	  were	  performed	  using	  MoPrP	  Trx3	  construct.	  FEC	   from	   unfolding	   experiments	   at	   neutral	   pH	   showed	   a	   more	   complex	   pattern	   of	   peaks	  compared	  to	  previous	  analyzed	  proteins	  (figure	  5.11,	  A	  and	  B),	  with	  GB1	  unfolding	  events	  preceded	  or	  followed	  by	  peaks	  with	  Δcl	  up	  to	  90	  nm.	  Scatterplot	  resulting	  from	  all	  unfolding	  experiments	  confirmed	  the	  presence	  of	  GB1	  domain	  unfolding	  transition,	  with	  typical	  Δcl(N-­‐>U)	  =	  18.5	  ±	  1.9	  nm	  and	  an	  average	  force	  F	  =	  234	  ±	  54	  pN	  (figure	  5.13).	  Unfolding	  events	  in	  the	  27-­‐30	  nm	  interval	  had	  a	  frequency	  of	  5%,	  similar	  to	  dimeric	  constructs	  discussed	  above.	  FEC	  showing	  peaks	  with	  Δcl	  >	  30	  nm	  were	  ~	  60%	  of	  the	  total	  recorded	  curves,	  but	  their	  number	  increased	  up	   to	  70%	  at	   acidic	  pH	  values	   (figure	   5.12).	   The	  distribution	  of	   such	  peaks	  was	  similar	  to	  dimeric	  constructs,	  without	  evident	  clusters	  (figure	  5.13).	  The	  “hump”	  mechanical	  features	   were	   observed,	   showing	   similar	   patterns	   of	   previous	   analyzed	   constructs	   (figure	  
5.11,	  C).	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Figure	  5.12:	  Frequency	  of	  FEC	  showing	  peaks	  with	  Δcl	  	  >	  30	  nm	  (“Peak”)	  and	  with	  hump	  feature	  only	  (“Hump”)	  respect	  to	  the	  total;	  N	  =	  197,	  115,	  112.	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5.5	  SMFS	  experiments	  on	  MoPrP	  Trx4	  	  Experiments	   using	   four	   tandem	   repeats	   of	   MoPrP(89-­‐230)	   moiety	   were	   performed	   in	   a	  similar	   fashion	   to	   previous	   recombinant	   proteins.	   As	   expected,	   FEC	   from	   unfolding	  experiments	  at	  pH	  7.4	  showed	  a	  minor	  number	  of	  GB1	  unfolding	  events,	  consistent	  with	  the	  presence	   of	   only	   four	   domains	   flanking	   the	  MoPrP	  moieties.	   Peaks	  with	   Δcl	   >	   30	   nm	  were	  observed	  mainly	  at	  the	  beginning	  or	  at	  the	  end	  of	  the	  stretched	  molecule,	  and	  more	  rarely	  in	  the	  middle	  (figure	  5.14,	  inset	  A).	  The	  frequency	  of	  FEC	  showing	  peaks	  with	  Δcl	  >	  30	  nm	  was	  higher	   compared	   to	   previous	   analyzed	   constructs.	   Their	   frequency	  was	   independent	   of	   the	  buffer	   pH,	   unlike	   the	   dimeric	   and	   trimeric	   constructs	   (figure	   5.15,	   inset	   A).	   Experiments	  carried	  out	  using	  buffer	  with	  low	  ionic	  strength	  (NaCl	  150	  mM)	  did	  not	  change	  the	  frequency	  of	  the	  Δcl	  >	  30	  nm	  peaks	  in	  FECs.	  
	  	  
Figure	  5.14:	  (A)	  FEC	  showing	  a	  peak	  with	  Δcl	  >	  30	  nm	  between	  GB1	  unfolding	  events.	  (B)	  Example	  of	  a	  FEC	  with	  “hump”	   mechanical	   feature	   within	   the	   brown	   box.	   It	   is	   possible	   to	   notice	   that	   in	   this	   FEC	   no	   non-­‐specific	  interaction	  could	  be	  observed.	  	  The	  “hump”	  mechanical	  feature	  showed	  length	  and	  forces	  that	  were	  up	  to	  three	  times	  higher	  compared	   to	   the	   same	   features	   found	   in	   MoPrP	   Trx1	   but	   their	   frequency	   was	   3-­‐5%.	  Performing	  experiments	  at	   three	  different	   loading	  rates	  changed	  the	  frequency	  of	   the	  hump	  feature	  (figure	  5.15,	  inset	  B).	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Analysis	  of	  length	  and	  forces	  revealed	  that	  GB1	  native/unfolding	  transition	  showed	  Δcl(N-­‐>U)	  =	  20.1	   ±	   1.3	   nm	   and	   average	   F	   =	   220.89	   ±	   54.03	   pN	   at	   loading	   rate	   of	   2180	   nm/s.	   The	  distribution	  of	  peaks	   longer	   than	  30	  nm	  was	  more	  widespread	   than	   the	   trimeric	   construct,	  thus	  fitting	  with	  a	  single	  or	  multiple	  gaussians	  distributions	  could	  not	  be	  performed	  (figure	  
5.16).	  	  
	  
Figure	   5.16:	   On	   top	   panel	   scatterplot	   from	  unfolding	   FEC	   at	   neutral	   pH	   of	  MoPrP	   Trx4.	   On	   bottom	  panel	   the	  distribution	  of	  all	  events	  (blue	  bars)	  with	  kernel	  fitting	  (red	  line)	  and	  peaks	  with	  Δcl	  >	  30	  nm	  (green	  bars).	  	  	  Double-­‐pulse	   refolding	   experiments	   at	   neutral	   pH	   confirmed	   the	   presence	   of	   peaks	   longer	  than	  30	  nm	   in	  70%	  of	   the	   FEC	   (figure	   5.17,	   A	   and	   B).	   Interestingly,	   performing	   the	   same	  experiments	   in	   presence	   of	   mild	   ionic	   strength	   the	   frequency	   of	   FEC	   with	   such	   peaks	  diminished	  to	  42%	  (figure	  5.17,	  C).	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Part	  IV:	  Discussion	  
	  Transmissible	   Spongiform	   Encephalopathies	   (TSE)	   are	   diseases	   characterized	   by	   different	  incubation	   times,	   symptoms,	   biological	   phenotypes	   and	   etiology	   [77,286,287].	   Stanley	   B.	  Prusiner	   proposed	   in	   1982	   that	   the	   infectious	   pathogen	   of	   TSEs	   is	   due	   to	   a	   proteinaceous	  infectious	   particle,	   named	   “prion”	   [173].	   Through	   the	   years,	   much	   evidence	   has	   led	   the	  scientific	  community	  to	  accept	   the	  “protein-­‐only”	  hypothesis.	  According	  to	  this	  hypothesis	  a	  misfolded	  form	  of	  PrPC,	  a	  glycosylated	  GPI-­‐anchored	  cellular	  protein	  [288]	  highly	  expressed	  in	  the	   brain,	   is	   the	   transmissible	   pathogen.	   The	   PrPC	   structure	   is	   characterized	   by	   a	   large	  unstructured	  N-­‐terminal	  domain	  and	  by	  a	  folded	  C-­‐terminal	  domain	  with	  three	  α-­‐helices	  and	  a	  small	  β-­‐sheet	  [127,152,153,154,155].	  Its	  infectious	  counterpart,	  PrPSc,	  is	  instead	  β-­‐sheet	  rich	  [289].	  	  The	   conversion	  between	   these	   two	   species	  was	   shown	   to	   take	  place	   in	  vitro,	   leading	   to	   the	  formation	  of	   amyloid	   species	  with	  distinct	   biochemical	   properties	   [188,290].	  More	   recently	  the	   same	   type	   of	   structural	   heterogeneity	   was	   observed	   in	   other	   proteins	   involved	   in	  neurodegenerative	   disorders	   [291,292,293].	   However	   the	   cause	   of	   this	   structural	  polymorphism	   has	   yet	   to	   be	   characterized.	   According	   to	   an	   emerging	   view,	   these	   proteins	  have	   an	   ensemble	   of	   amyloidogenic	   conformations.	   Therefore	   characterizing	   the	  monomer	  conformational	  space	  is	  required	  to	  better	  understand	  the	  aggregation	  processes.	  	  Because	   of	   this	   structural	   heterogeneity,	   gaining	   structural	   insights	   on	   these	   conformers	  using	   “in-­‐bulk”	   techniques	   is	   very	   challenging.	   Single-­‐molecule	   methodologies	   instead	   are	  well	   suited	   for	   characterizing	   such	   poorly	   populated	   conformers,	   as	   they	   obtain	   structural	  information	  at	  the	  single-­‐molecule	  level	  with	  atomic	  resolution.	  In	  our	  studies	  we	  employed	  single-­‐molecule	   force	   spectroscopy	   (SMFS)	   techniques	   to	   gain	   further	   insights	   into	   the	  conformational	  equilibria	  of	  the	  mouse	  prion	  protein	  (MoPrP).	  In	   fact,	   while	   several	   SMFS	   studies	   were	   performed	   on	   different	   proteins	   involved	   in	  neurodegenerative	   disorders	   [249,258,263,294],	   few	   were	   focused	   on	   the	   prion	   protein	  [248,270].	  	  	  
6.1	  Interaction	  analyses	  of	  MoPrP	  proteins	  with	  handles	  	  In	  SMFS	  techniques	  the	  analyte	  is	  usually	  tethered	  with	  specific	  handles,	  which	  are	  essential	  for	   molecule	   manipulation	   and	   recognition.	   Handles	   in	   AFM	   experiments	   are	   typically	  composed	   of	   tandem	   repetition	   of	   protein	   domains	   with	   well	   characterized	   mechanical	  features.	  In	  our	  studies	  we	  decided	  to	  use	  this	  approach	  as	  it	  could	  help	  us	  to	  unequivocally	  recognize	   the	   molecules	   picked	   by	   the	   AFM	   tip.	   More	   specifically,	   we	   flanked	   our	   analyte	  protein	   (MoPrP(89-­‐230))	  with	  multiple	   copies	  of	   streptococcal	  protein	  G	  domain	  B1	   (GB1),	  which	   has	   been	   extensively	   characterized	   using	   “in-­‐bulk”	   [278,284,285,295,296,297]	   and	  single-­‐molecule	  [256,257,262,298,299,300]	  techniques.	  In	  OT	  SMFS	  experiments	  instead,	  we	  the	  tethered	  MoPrP(89-­‐230)	  and	  MoPrP(23-­‐230)	  to	  double	  stranded	  DNA	  (dsDNA),	  similar	  to	  previous	  works	  [208,301].	  	  Since	  the	  handles	  are	  directly	  linked	  to	  the	  protein,	  their	  local	  concentration	  is	  very	  high	  due	  to	  kinetic	  constraints.	  This	  condition	  may	  lead	  to	  undesired	  interactions	  between	  the	  handles	  and	  the	  analyte.	  Therefore	  it	  is	  necessary	  to	  demonstrate	  that	  the	  two	  moieties	  do	  not	  interact	  each	  other.	  	  In	   SMFS	   OT	   experiments	  we	   flanked	  MoPrP	  molecules	  with	   1kbp	   dsDNA	   obtained	   by	   PCR	  from	  pET-­‐11a	  plasmid.	  Previous	  studies	  have	  shown	  that	  recombinant	  PrP	  is	  able	  to	  interact	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with	   nucleic	   acids	   [302,303,304],	   via	   electrostatic	   interactions	   in	   a	   sequence	   independent	  manner	  [305].	  It	  has	  been	  observed	  that	  DNA	  had	  an	  anti-­‐scrapie	  activity	  [306].	  Also	  DNA	  was	  able	   to	   convert	   PrP	   to	   a	   β-­‐rich	   conformation	   [307].	   According	   to	   Lims	   et	   al.	   [305]	   the	  interaction	  is	  mediated	  by	  the	  C-­‐terminal	  globular	  domain,	  which	  is	  able	  to	  bind	  short	  18	  bp	  long	   dsDNA	   sequences.	   Therefore	   at	   least	   50	   PrP	   molecules	   could	   bind	   1000	   bp	   dsDNA,	  decreasing	  its	  electrophoretic	  mobility	  by	  a	  factor	  of	  2.3.	  The	  highest	  molar	  ratio	  used	  in	  our	  experiments	  was	  20:1,	  thus	  a	  maximum	  decrease	  by	  a	  factor	  of	  1.5	  in	  the	  electrophoretic	  band	  mobility	   could	   be	   expected.	   Electrophoretic	  mobility	   shift	   assay	   (EMSA)	   showed	   that	   small	  migration	  shifts	  occurred	  only	  with	  the	  full-­‐length	  prion	  protein	  at	  20:1	  dsDNA:MoPrP	  molar	  ratios,	  while	  no	  shift	  was	  observed	  with	  the	  truncated	  form.	  A	  possible	  explanation	  could	  be	  due	   to	   the	   theoretical	   isoelectric	   points	   of	   MoPrP(89-­‐230)	   and	   MoPrP(23-­‐230),	   which	   are	  8.84	  and	  9.56	  respectively.	  At	  neutral	  pH	  both	  molecules	  are	  positively	  charged,	  so	  it	  is	  likely	  that	   electrostatic	   interactions	   with	   dsDNA	   may	   occur	   [305].	   In	   particular,	   the	   N-­‐terminal	  unstructured	   domain	   of	   the	   full-­‐length	  MoPrP	  presents	   the	   CC1	  domain,	  with	   several	   basic	  residues	   that	   can	   interact	   strongly	   with	   nucleic	   acid	   phosphate	   groups.	   In	   our	   EMSA	  experiments	  the	  presence	  of	  ionic	  strength	  in	  running	  buffer	  likely	  disrupted	  the	  interaction	  between	  the	  C-­‐terminal	  globular	  domain	  and	  dsDNA	  preventing	  the	  binding	  of	  the	  truncated	  MoPrP.	  The	  full-­‐length	  form	  instead,	  was	  still	  able	  to	  bind	  dsDNA	  reducing	  its	  electrophoretic	  mobility,	  most	  probably	  via	  its	  N-­‐terminal	  positively	  charged	  domain.	  	  	  To	  confirm	  that	  the	  GB1	  protein	  domain	  did	  not	   interact	  with	  MoPrP(89-­‐230)	  moiety/ies	  in	  our	  AFM	  constructs,	  we	  employed	  three	  different	  experimental	  approaches.	  Initially	  we	  used	  the	   co-­‐immunoprecipitation	   (Co-­‐IP)	   technique,	   since	   it	   has	   been	   widely	   used	   to	   analyze	  protein-­‐protein	   interactions	   in	  vitro,	   in	   cells	   and	   in	  vivo	   [308,309].	  Our	   results	   showed	   that	  incubating	  GB1	  with	  MoPrP(89-­‐230)	  and	  MoPrP(23-­‐230)	  resulted	  in	  co-­‐immunoprecipiation	  of	  the	  target	  protein.	  The	  effect	  was	  more	  evident	  with	  the	  full-­‐length	  form,	  which	  presented	  a	  clear	  band	  at	  the	  theoretical	  MW	  of	  GB1x4	  protein,	  indicating	  that	  the	  two	  proteins	  interacted.	  On	   the	   other	   hand	  MoPrP(89-­‐230)	   and	  MoPrP(23-­‐230)	  were	  detected	   in	   negative	   controls,	  suggesting	  that	  non-­‐specific	  interactions	  between	  the	  prion	  protein	  and	  the	  resin	  occurred.	  A	  stronger	  band	  was	  observed	   for	   the	   full-­‐length	   form	   indicating	   that	   the	  N-­‐terminal	   charged	  domain	  was	   probably	   playing	   a	  major	   role	   in	   this	   interaction.	   Thus,	   it	   was	   not	   possible	   to	  conclude	  that	  the	  immunoprecipitation	  was	  due	  exclusively	  to	  protein-­‐protein	  interactions	  or	  to	  protein-­‐resin	  interactions.	  For	   this	   reason	   further	   experiments	  were	  performed,	   using	  ELISA	  methodology.	   Incubating	  increasing	  amounts	  of	  GB1	  in	  MoPrP	  adsorbed	  wells	  did	  not	  result	  in	  a	  significant	  increase	  of	  alkaline	   phosphatase	   signal,	   indicating	   that	   GB1	   did	   not	   interact	   with	   PrP.	   In	   fact,	   if	   an	  interaction	  occurred,	  a	  titration	  curve	  with	  a	  saturation	  asymptote	  would	  have	  been	  expected.	  Positive	  and	  negative	  controls	  confirmed	  that	  under	   the	  experimental	  conditions	  antibodies	  worked	  correctly.	  The	  major	  disadvantage	  of	  surface	  and	  antibody	  based	  methods	  is	  the	  possibility	  to	  cover	  the	  protein	   interacting	   surfaces	   with	   the	   antigene-­‐antibody	   complex,	   hindering	   a	   possible	  interaction.	   These	   experimental	   limitations	   could	   be	   circumvented	   using	   free-­‐solution	  methods	   such	   as	   size-­‐exclusion	   chromatography	   [310,311].	   This	   technique	   has	   several	  advantages:	  i)	  it	  is	  possible	  to	  use	  simple	  buffers,	  avoiding	  the	  use	  of	  detergents	  or	  salts	  that	  may	   interfere	  with	   the	  binding	  of	   the	   two	  proteins;	   ii)	   there	   is	  no	  steric	  hindrance	  due	   to	  a	  surface	  or	  antibody	  between	  the	  two	  analytes;	  iii)	  in	  case	  the	  two	  protein	  theoretical	  MW	  and	  experimental	   Stokes	   radius	   are	   similar,	   it	   is	   possible	   to	   check	   on	   SDS-­‐PAGE	   the	   eluted	  fractions.	  Results	  showed	  that	  loading	  MoPrP(89-­‐230)	  and	  GB1x4	  did	  not	  result	  in	  co-­‐elution	  of	  the	  prion	  protein	  in	  GB1	  fractions,	  while	  small	  amounts	  of	  the	  latter	  were	  detected	  in	  PrP	  fractions.	   This	   can	  be	   explained	   considering	   that	   typically	   the	  profile	   of	   elution	  peaks	   from	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SEC	   experiments,	   present	   a	   sharper	   initial	   tail	   and	   a	   more	   prolonged	   tail	   in	   the	   end.	   No	  interaction	  was	  detected	  either	  at	  neutral	  or	  at	  slightly	  acidic	  pH	  values.	  However,	  it	  has	  to	  be	  noticed	   that	  developing	  WB	  with	  Fab	  D18	  antibody	   resulted	   in	  a	  band	  at	   the	  MW	  of	  GB1x4,	  indicating	   that	   the	   bacterial	   protein	   domain	   is	   able	   to	   bind	   the	   Fc	   region	   of	   the	   secondary	  antibody.	  	  Nevertheless,	  these	  techniques	  required	  that	  GB1	  and	  MoPrP	  proteins	  were	  free	  in	  solution,	  while	   in	   AFM	   constructs	   these	   proteins	   are	   covalently	   tethered	   to	   each	   other.	   Thus,	   it	   is	  possible	  that	  interactions	  occurred	  only	  in	  the	  heteropolymeric	  protein	  constructs.	  	  
	  
Figure	   6.1:	   overlay	   between	   Δcl	   distributions	   of	   unfolding	   experiments	   at	   pH7.4	   from	   GB1x8	   (red	   bars)	   and	  MoPrP	  Trx1	  (blue	  bars)	  overall	  rupture	  events.	  	  	  In	  AFM	  SMFS	  experiments	  a	  possible	  GB1	  and	  PrP	  interaction	  could	  be	  observed	  as	  a	  different	  Δcl	  or	   force	   distribution	   of	   their	   corresponding	   unfolding	   transitions.	   Since	  MoPrP(89-­‐230)	  was	  never	  characterized	  previously	  using	  such	  technique,	  we	  compared	  GB1	  unfolding	  with	  or	  without	  one	  MoPrP	  moiety	  in	  unfolding	  experiments.	  Figure	  6.1	  shows	  the	  overlay	  of	  Δcl	  distribution	   of	   unfolding	   events	   at	   neutral	   pH	   from	  GB1x8	   and	  MoPrP	  Trx1	   constructs.	   Both	  distributions	   match	   each	   other,	   without	   any	   shift	   in	   the	   average	   Δcl	   values	   of	   the	   GB1	  unfolding	   transition.	   Average	   unfolding	   forces	   were	   comparable,	   indicating	   that	   no	  mechanical	   variations	   of	   the	   GB1	   moieties	   occurred.	   On	   the	   other	   hand,	   MoPrP	   Trx1	   Δcl	  distribution	  was	  less	  sharp	  in	  the	  interval	  between	  22	  and	  30	  nm,	  due	  to	  the	  presence	  of	  more	  rupture	   events,	  which	  were	   absent	   in	   the	  GB1x8	   construct.	   This	   aspect	  will	   be	   discussed	   in	  
paragraph	  6.2.	  	  It	   has	   to	   be	   noted	   that	   in	   the	  MoPrP	  Trx1	   construct	   the	  GB1:MoPrP	  moieties	   ratio	  was	   8:1.	  Thus	  if	  interactions	  between	  the	  two	  protein	  moieties	  occurred,	  only	  one	  or	  two	  GB1	  modules	  unfolding	  transitions	  would	  have	  changed	  due	  to	  the	  possible	  interaction.	  As	  a	  result,	  only	  a	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small	   fraction	   of	   the	   overall	   recorded	   rupture	   events	   would	   have	   been	   changed,	   without	  modifying	   significantly	   the	   average	   unfolding	   parameters	   values.	   Also	   with	   unfolding	  experiments	  it	  has	  been	  possible	  to	  analyze	  only	  native	  to	  unfolding	  (N-­‐>U)	  transitions,	  while	  it	   could	   be	   possible	   that	   structures	   generated	   from	   protein-­‐protein	   interactions	   were	  accessible	  only	  from	  their	  U	  state.	  Double-­‐pulse	  and	  multi-­‐pulse	  refolding	  experiments	  clearly	  showed	  that	  GB1	  domains	  within	  one	  molecule	  were	  able	  to	  refold	  independently	  (figure	  5.6).	  WLC	  fitting	  of	  each	  rupture	  event	  were	  superimposable	  after	  each	  unfolding/refolding	  cycle,	  without	   any	   change	   in	   peak	   rupture	   lengths.	   This	   confirmed	   that	   interaction	   between	   the	  mouse	  prion	  protein	  and	  GB1	  domain	  did	  not	  occur	  even	  from	  U-­‐>N	  pathway.	  	  	  
6.2	  Conformational	  ensemble	  of	  MoPrP(89-­‐230)	  at	  the	  monomeric	  level	  	  The	   first	   part	   of	   the	   work	   was	   gaining	   insights	   into	   the	   conformational	   ensemble	   of	   the	  murine	  prion	  protein	  at	  the	  monomeric	  level.	  Multiple	  Gaussian	  fitting	  of	  Δcl	  distribution	  from	  overall	  FEC	  showed	  the	  presence	  of	  two	  major	  distributions:	  the	  first	  one	  centred	  at	  19.3	  ±	  1.5	  nm,	  which	   is	   relative	   to	   the	   unfolding	   of	   GB1	   domains,	   and	   a	   second	   one	   at	   27.2	   ±	   2.1	   nm	  (figure	  6.2).	  A	  possible	  third	  small	  population	  at	  ~	  13	  nm	  seem	  to	  be	  present	  but	  data	  was	  not	  sufficient	  for	  a	  statistically	  significant	  characterization.	  	  
	  
Figure	   6.2:	   fitting	  with	   two	  Gaussian	  distributions	  of	   the	  PDF	   function	  calculated	  on	  Δcl	   experimental	  data	  of	  MoPrP	  Trx1;	  RMSD	  =	  0.9833.	  	  	  The	  27	  nm	  distribution	  could	  be	  associated	  to	  the	  native/unfolding	  (N-­‐>U)	  transition	  of	  the	  C-­‐terminal	   globular	   domain	   of	   MoPrP.	   Considering	   Met128	   and	   Ser229	   as	   the	   first	   and	   last	  residues	   involved	   in	   the	   structure	   of	   the	   C-­‐terminal	   globular	   domain	   [152],	   the	   average	  theoretical	   unfolding	   length	   is	   26.3	   nm.	   If	   we	   consider	   instead	   that	   GB1	   unfolding	   events	  could	  not	  be	  longer	  than	  23	  nm,	  reducing	  the	  fitting	  window	  of	  the	  GB1	  Gaussian	  distribution,	  the	   fitting	   of	   the	   PrP	   unfolding	   distribution	   is	   Δcl(N-­‐>U)	  =	   26.12	   ±	   2.01	   nm.	   This	   distribution	  represents	   almost	   15%	   of	   the	   overall	   rupture	   events,	   one	   event	   for	   every	   six	   of	   GB1.	   The	  average	  unfolding	  force	  of	  these	  events	  was	  198.13	  ±	  45.42	  pN.	  Previous	  studies	  on	  ShaPrP91-­‐231	  using	  OT	  [270,271]	   found	  that	  ShaPrP(N-­‐>U)	  =	  34	  nm,	  but	   the	  protein	  oxidation	  state	  was	  not	   confirmed.	   Since	   the	   production	   of	   such	   a	   construct	   required	   protein	   refolding	   under	  reducing	  conditions,	  it	  is	  likely	  that	  the	  native	  disulfide	  bridge	  of	  Cys178	  and	  Cys213	  (mouse	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numeration)	   was	   reduced	   under	   pulling	   experiments.	   This	   hypothesis	   is	   supported	   by	  observations	  of	   the	  same	  group	  on	  ShaPrP	  construct	  with	  Cys-­‐>Ala	  mutations,	  which	   led	   to	  the	  identification	  of	  the	  same	  transition	  length.	  	  The	  N-­‐>U	  transition	  observed	  in	  our	  experiments	  showed	  up	  as	  a	  single	  peak,	  therefore	  the	  unfolding	  of	   the	   three	  α-­‐helices	  and	   the	  β-­‐sheet	  occurred	   in	  a	   cooperative	  manner,	  without	  visible	   unfolding	   intermediates.	   These	   results	   pointed	   out	   that	   C-­‐terminal	   domain	   PrP	  unfolding	   is	   a	   two	   state	   transition.	   This	   hypothesis	   is	   in	   agreement	   with	   previous	   studies	  using	  urea	  unfolding	  CD	  studies	  and	  tryptophan	  fluorescence	  techniques	  [156,157,171].	  In	  17%	  of	  the	  FEC,	  we	  observed	  peaks	  longer	  than	  30	  nm	  but	  shorter	  than	  the	  total	  unfolding	  length	  of	  the	  oxidized	  molecule	  (39.7	  nm).	  These	  events	  could	  not	  be	  considered	  MoPrP(89-­‐230)	   (N-­‐>U)	   transition	   of	   the	   folded	   domain,	   rather	   conformers	   with	   structures	   that	  encompassed	   also	   residues	   from	   89	   to	   127.	   Structural	   studies	   have	   been	   carried	   out	   on	  truncated	  prion	  proteins	  from	  different	  species,	  showing	  that	  they	  share	  a	  common	  structure	  [154,155].	  The	   folded	  domain	   encompassed	   residues	  129	   to	  230,	   however	   residues	  89-­‐127	  (in	  mouse	   numeration)	  were	   always	   observed	   as	   intrinsically	   disordered.	   Considering	   that	  the	  30-­‐40	  nm	  unfolding	  transitions	  were	  present	  only	  when	  the	  C-­‐terminal	  domain	  unfolding	  transition	  was	  not	  identified,	  we	  conclude	  that	  these	  two	  structures	  are	  competitive	  one	  with	  the	   other.	   Even	   if	   the	   data	   points	   relative	   to	   peaks	   in	   the	   30-­‐40	   nm	   intervals	   are	   few,	   it	   is	  possible	  to	  notice	  that	  they	  have	  different	  lengths	  and	  the	  average	  unfolding	  force	  is	  152.38	  ±	  47.86	  pN,	   indicating	   that	  such	  structures	  are	  more	  heterogeneous	  and	  weaker	  compared	   to	  the	  native	  structure.	  	  Such	   long	   conformers	   could	   represent	   extended	   conformers	   of	   the	  MoPrP(89-­‐230)	   protein	  moiety,	  which	  could	  be	  involved	  in	  protein	  aggregation.	  This	  data	  is	  consistent	  with	  previous	  works	   where	   the	   unstructured	   region	   of	   the	   truncated	   protein	   could	   adopt	   β-­‐sheets	  secondary	   structures	   [166].	   H/D	   exchange	   experiments	   showed	   that	   this	   region	   may	   be	  exchanging	  between	  structured	  or	  collapsed	  states	  [158].	  Moreover,	  the	  amyloid	  core	  of	  PrPSc	  encompasses	  all	  the	  truncated	  prion	  protein	  sequence	  [148,312].	  On	  the	  other	  hand,	  previous	  studies	  shown	  that	  monomeric	  truncated	  HuPrP	  is	  not	  able	  to	  adopt	  extended	  structures,	  but	  rather	  partially	  unfolded	  structures	   [313]	  after	   its	  unfolding	   [158,270].	  Some	  of	   these	  were	  thermodynamically	  more	  stable	  than	  the	  native	  state,	  showing	  a	  classical	  β-­‐sheet	  rich	  spectra	  [314].	   Recently,	   Yu	   et	   al.	   [270]	   shown	   by	   force-­‐clamp	   OT	   force	   spectroscopy	   that	   three	  misfolded	   conformations	   of	   ShaPrP	   are	   accessible	   only	   from	   the	  U	   state.	   These	   conformers	  possessed	  a	   shorter	   structure	   compared	   to	   the	  native	  one	  and	   they	  were	  poorly	  populated,	  which	  is	  not	  consistent	  with	  our	  data,	  since	  the	  frequency	  of	  such	  events	  in	  our	  construct	  was	  higher.	   These	  misfolded	   forms	  were	   thermodynamically	   less	   stable	   compared	   to	   the	   native	  structure,	  similarly	  to	  what	  we	  observed.	  It	  may	  be	  pointed	  out	  that	  the	  events	  we	  observed	  were	   due	   to	   tip/surface	   non-­‐specific	   interaction	   or	   interaction	   between	   GB1	   domains	   and	  MoPrP	  moieties.	  We	  exclude	  the	  first	  possibility	  because	  double-­‐pulse	  refolding	  experiments	  showed	   that	   these	   conformers	   could	  be	  observed	  after	   refolding	   the	  protein	  molecules.	  We	  also	  rule	  out	  the	  latter,	  considering	  that	  no	  interaction	  between	  GB1	  and	  MoPrP	  moieties	  has	  been	  detected,	  as	  discussed	  in	  paragraph	  6.1.	  	  Lowering	   pH	   during	   unfolding	   experiments	   did	   not	   change	   significantly	   the	   percentage	   of	  curves	  with	  peaks	  Δcl	  >	  30	  nm,	  while	   in	  double-­‐pulse	  experiments	  a	  decrease	  was	  observed	  only	  at	  pH	  4.0	  (figure	  5.4).	  A	  possible	  explanation	  of	  this	  behaviour	  could	  be	  due	  to	  the	  lower	  stability	  of	  such	  extended	  conformers	  at	  acidic	  pH	  values.	  During	  these	  latter	  experiments	  we	  observed	   one	   FEC	  with	   a	  mechanical	   feature	   characterized	   by	   a	   non-­‐entropic	   increase	   and	  decrease	   of	   force,	   before	   GB1	   rupture	   events.	   This	   type	   of	   mechanical	   feature	   was	   named	  “hump”	   and	   it	   could	   not	   be	   fitted	   with	   the	  WLC	  model.	   Since	   only	   one	   curve	   showed	   this	  feature,	  a	  more	  detailed	  analysis	  could	  not	  be	  performed.	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Finally,	   using	   multi-­‐pulse	   refolding	   protocol	   we	   could	   not	   detect	   signals	   related	   to	   PrP	  structures.	  A	  possible	  explanation	  could	  be	  that,	  the	  contact	  point	  was	  calculated	  in	  the	  fetch	  curve,	   so	   it	  was	   possible	   that	   during	   refolding	   cycles	   the	   piezoelectric	   stage	   drifted.	   In	   this	  manner	  the	  tethered	  molecule	  would	  have	  been	  kept	  under	  tension	  with	  forces	  in	  the	  order	  of	  tens	   of	   piconewtons,	   below	   our	   force	   resolution	   limit.	   PrP	   has	   a	   fast	   two-­‐state	   folding	  mechanism	  [156],	  with	  folding	  rate	  kfold	  at	  zero	  force	  of	  5×103±1	  s-­‐1	  [271],	  while	  at	  10	  pN	  force	  the	  kfold	  is	  3.67	  ×10-­‐1	  	  s-­‐1.	  GB1	  instead	  is	  able	  to	  fold	  efficiently	  even	  at	  residual	  forces	  of	  10	  pN	  (kfold	   =	   720	   s-­‐1)	   [256].	   Therefore	   if	   residual	   forces	   acted	   on	   the	   protein	   molecules	   during	  refolding,	  GB1	  domains	  were	  still	  able	  to	  refold	  while	  the	  MoPrP	  moiety	  could	  not.	  From	  the	  data	  discussed	  above,	  we	  conclude	  that	   the	  monomeric	  MoPrP(89-­‐230)	   inside	  the	  hetero-­‐polymeric	  construct	  is	  folded	  in	  the	  native	  state.	  This	  is	  supported	  by	  the	  presence	  of	  an	  unfolding	  transition	  of	  27	  nm,	  which	  was	  present	  in	  almost	  83%	  of	  the	  interpretable	  FEC.	  In	  ~	  17%	  of	  the	  remaining	  FEC,	  the	  prion	  protein	  adopts	  a	  more	  extended	  folded	  structure,	  which	  requires	  a	  conformational	  rearrangement	  of	  the	  unstructured	  region	  from	  residues	  89	  to	  128.	  The	  length	  of	  these	  structures	  is	  very	  heterogeneous	  and	  their	  average	  force	  is	  lower	  compared	   to	   the	   native	   structure,	   indicating	   a	   lower	   stability.	   These	   conformers	   might	   be	  related	  to	  subsequent	  protein	  aggregation	  processes.	  
	  
	  
6.3	  Complex	  conformational	  equilibria	  between	  multiple	  PrP	  molecules	  	  The	   second	   part	   of	   the	   work	   was	   focused	   on	   the	   first	   steps	   of	   prion	   protein	   aggregation	  processes.	   Aggregation	   into	   disordered	   or	   high-­‐ordered	   structures	   requires	   protein	  oligomerization,	  meaning	  that	   two	  or	  more	  protein	  monomers	  generate	  a	  new	  structure	  via	  intermolecular	   bonds	   [315].	   In	   order	   to	   build	   a	   model	   of	   such	   mechanisms	   for	   MoPrP	  aggregation,	  we	  used	   the	   same	   approach	   of	   heteropolymeric	   protein	   constructs,	   but	   in	   this	  case	  we	  cloned	  more	  than	  one	  PrP	  molecule	  on	  the	  same	  polypeptide	  sequence.	  We	  expressed	  two	  dimeric	  constructs	  with	  different	  MoPrP	  protein	  orientations	  on	  the	  polypeptide	  chain,	  to	  find	   out	   how	   their	   relative	   orientations	   may	   affect	   the	   formation	   of	   intermolecular	  associations.	  We	   also	   expressed	   one	   trimeric	   and	   one	   tetrameric	   constructs,	   to	   understand	  how	   the	   associations	   are	   influenced	   by	   the	   number	   of	  MoPrP	  moieties,	   similarly	   to	   recent	  studies	  on	  α-­‐synuclein	  [267].	  	  
	  
6.3.1	  Protein	  orientation	  dependence	  on	  PrP	  oligomerization	  	  
	  In	  the	  first	  dimeric	  construct	  the	  two	  prion	  protein	  moieties	  were	  in	  a	  head-­‐to-­‐tail	  orientation	  (MoPrP	  Trx2	  H-­‐T)	  with	  the	  C-­‐terminal	  globular	  domain	  of	  the	  first	  one	  linked	  to	  the	  N-­‐terminal	  unstructured	   domain	   of	   the	   second.	   In	   the	   second	   dimeric	   construct	   the	   two	   C-­‐terminal	  globular	   domains	   of	  MoPrP	  moieties	  were	   adjacent	   instead	   (MoPrP	   Trx2	   H-­‐H),	   linked	   via	  a	  disulfide	  bridge.	  	  MoPrP	  Trx2	  H-­‐T	  and	  MoPrP	  Trx2	  H-­‐H	  unfolding	  scatterplots	  at	  neutral	  pH	  showed	   that	  both	  proteins	   had	   a	  more	   complex	   pattern	   of	   unfolding	  with	   respect	   to	  MoPrP	   Trx1.	   Two	  major	  difference	  were	  observed	  with	   respect	   to	   the	  monomeric	   construct:	   i)	   the	  27	  nm	   transition	  was	  less	  frequent,	  as	  these	  events	  in	  the	  23-­‐30	  nm	  interval	  represented	  only	  3.7	  %	  and	  7	  %	  of	  the	  total	  events	  for	  the	  H-­‐H	  and	  H-­‐T	  constructs	  respectively;	  ii)	  the	  frequency	  of	  FEC	  showing	  events	  with	  Δcl	  >	  30	  was	  two	  times	  higher	  with	  respect	  to	  the	  monomeric	  construct.	  The	  fact	  that	  at	  least	  40%	  of	  these	  events	  with	  respect	  to	  the	  total,	  were	  longer	  than	  the	  total	  length	  of	  the	  unfolded	  monomer	  (39.7	  nm),	  suggests	  that	  these	  structures	  could	  have	  been	  generated	  only	  from	  the	  association	  of	  the	  two	  prion	  protein	  moieties.	  More	  interestingly,	  lowering	  the	  pH	  value	  resulted	  in	  the	  increase	  of	  the	  frequency	  of	  FEC	  with	  Δcl	  >	  30	  nm	  events.	  This	  data	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confirmed	   that	   PrP	   behaviour	   is	   strongly	   related	   to	   the	   surrounding	   environment;	   in	   fact	  upon	   lowering	   the	   pH	   the	   protein	   aggregation	   propensity	   increases.	   As	   discussed	   in	  
paragraph	  1.2.4,	  PrP	  native	  structure	  stability	  is	  lower	  at	  acidic	  pH	  [163,164,316],	  therefore	  the	  protein	  can	  more	  easily	  unfold	  and	  subsequently	  aggregate	  under	  these	  conditions.	  This	  type	   of	   pH-­‐dependent	   behaviour	   has	   been	   observed	   in	   other	   proteins	   involved	   in	  neurodegenerative	  disorders	  [250,317].	  	  An	   increase	   in	   the	   number	   of	   MoPrP(89-­‐230)	   molecules	   could	   lead	   to	   a	   more	   evident	  interaction	  with	  GB1	  handles,	  since	  in	  this	  case	  the	  GB1:MoPrP	  moieties	  ratio	  is	  4:1.	  It	  is	  also	  possible	   that	   prion	   protein	   associations	   could	   involve	   GB1	   domains.	   To	   rule	   out	   this	  possibility,	   we	   compared	   the	   GB1	   unfolding	   events	   from	   FEC	   with	   and	   without	   unfolding	  events	  that	  showed	  a	  Δcl	  >	  30	  nm.	  As	  shown	  in	  figure	  6.3	  the	  Δcl	  and	  force	  distributions	  of	  the	  two	  types	  of	  curves	  are	  comparable.	  Moreover,	  these	  two	  distributions	  are	  comparable	  to	  the	  distribution	   of	   GB1	   unfolding	   events	   from	   GB1x8	   construct,	   confirming	   that	   intermolecular	  PrP	  associations	  did	  not	  involve	  GB1	  domains	  as	  a	  result	  of	  a	  possible	  interaction.	  	  	  
	  
Figure	  6.3:	  Unfolding	  events	  from	  FEC	  showing	  peaks	  with	  Δcl	  >	  30	  nm	  (blue)	  or	  without	  them	  (in	  red).	  Data	  is	  referred	  to	  (A)	  MoPrP	  Trx2	  H-­‐T	  and	  (B)	  MoPrP	  Trx2	  H-­‐H	  proteins.	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A	  more	  detailed	  analysis	  was	  performed	  considering	  only	  FEC	  showing	  unfolding	  events	  with	  Δcl	  >	  30	  nm.	  In	  ~	  85	  %	  of	  these	  curves	  only	  one	  peak	  with	  Δcl	  >	  30	  nm	  was	  detected	  (“single	  peak	  curves”),	  while	   in	   the	  remaining	  15	  %	  of	   the	  curves	  two	  peaks	  (“double	  peak	  curves”)	  were	  observed	  (figure	   6.4,	   panel	   1).	  As	  expected,	   the	  maximum	  lengths	  of	   these	  unfolding	  events	   from	  single	  and	  double	  peak	  curves	  were	   lower	   than	   the	   total	   length	  of	   the	   two	  PrP	  moieties	  of	  the	  construct	  (79.4	  nm).	  In	  order	  to	  gain	  more	  detailed	  structural	  information	  of	  PrP	   conformers,	   it	   is	   important	   to	   remember	   that	   the	  measured	   contour	   length	   extensions	  cannot	   be	   related	   to	   the	   absolute	   position	   of	   the	   residues	   of	   the	   unfolded	   structures.	   It	   is	  possible	   that	   an	   association	   between	   two	   PrP	   molecules	   can	   be	   shorter	   or	   equal	   to	   the	  theoretical	   unfolding	   length	   of	   a	   PrP	   monomer.	   Therefore,	   associations	   between	   two	   PrP	  molecules	   can	  be	  unequivocally	   identified	  only	   if	   their	  unfolding	  Δcl	   is	   longer	   than	   the	   fully	  stretched	  monomer	  length	  (39.7	  nm).	  	  Unfolding	  events	  were	   counted	   inside	   the	  30-­‐40	  nm	  and	  40-­‐80	  nm	   length	   intervals	   (figure	  
6.4,	   panel	   2).	   Interestingly,	   the	  H-­‐T	   construct	   showed	   a	  major	  propensity	   to	   adopt	   “short”	  conformers	  (30-­‐40	  nm	  interval),	  while	  the	  H-­‐H	  showed	  a	  prevalence	  of	  associations	  between	  two	   PrP	  molecules	   (40-­‐80	   nm	   interval).	   Considering	   that	   the	   sample	   size	   of	   H-­‐T	   construct	  FECs	  was	  two	  times	  larger	  than	  the	  H-­‐H	  one,	  bootstrapping	  was	  performed	  in	  order	  to	  obtain	  comparable	   data	   sets.	   This	   procedure	   was	   also	   used	   to	   confirm	   that	   the	   sub-­‐population	  sample	  was	   statistically	   representative	   of	   the	   total	   population.	   Results	   from	   500	   iterations	  showed	  that	  in	  the	  H-­‐T	  construct,	  unfolding	  events	  in	  the	  two	  intervals	  were	  maintained,	  with	  a	  frequency	  of	  60.7	  ±	  3.7	  %	  in	  the	  30-­‐40	  nm	  and	  38.7	  ±	  3.7	  %	  in	  the	  40-­‐80	  nm	  intervals.	  This	  confirms	   the	   difference	   in	   the	   association	   processes	   between	   the	   two	   dimeric	   protein	  constructs.	  Considering	  that	  the	  number	  of	  FEC	  showing	  peaks	  with	  Δcl	  >	  30	  nm	  with	  respect	  to	  the	  total	  interpretable	   curves	   is	   identical	   for	   both	   constructs,	   it	   can	   be	   inferred	   that	   the	   orientation	  does	  not	  affect	  the	  frequency	  of	  PrP	  associations,	  but	  rather	  their	  length.	  Focusing	   on	   the	   27	   nm	   transition,	   its	   frequency	   was	   3.7	  %	   and	   7	  %	   for	   the	   H-­‐H	   and	   H-­‐T	  constructs	   respectively.	   These	   unfolding	   transition	   frequencies	   were	   significantly	   lower	  compared	   to	   the	   one	   observed	   from	   MoPrP	   Trx1	   (15%).	   Moreover	   in	   the	   dimeric	   H-­‐H	  construct,	  the	  frequency	  of	  the	  native	  state	  unfolding	  transition	  was	  almost	  half	  with	  respect	  to	  the	  H-­‐T	  construct.	  Considering	  the	  associations	  between	  the	  two	  PrP	  moieties	  were	  more	  frequent	   in	   the	   H-­‐H	   construct,	   it	   might	   be	   possible	   that	   they	   required	   the	   structural	  rearrangement	  of	  the	  C-­‐terminal	  folded	  domain.	  Double-­‐pulse	   refolding	   experiments	   at	   neutral	   pH	   showed	   that	   even	   PrP	   associations	  were	  able	   to	   refold	   but	   with	   a	   lower	   frequency.	   A	   possible	   explanation	   could	   be	   that	   50	   ms	  refolding	  time	  may	  not	  be	  sufficient	  for	  the	  formation	  of	  some	  of	  these	  associations.	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Figure	  6.4:	  Analysis	  of	  curves	  showing	  associations	  peaks	  from	  (A)	  MoPrP	  Trx2	  H-­‐T	  and	  (B)	  MoPrP	  Trx2	  H-­‐H.	  (1)	  Frequency	  of	  curves	  with	  one	  or	  more	  peaks	  with	  Δcl	  >	  30	  nm.	  (2)	  Scatterplot	  of	  FEC	  only	  with	  one	  or	  two	  peaks	  from	  MoPrP	  unfolding	  events	  and	  relative	  frequency	  inside	  intervals.	  Intervals	  are	  indicated	  in	  integer	  values	  for	  clarity.	  	  	  Finally	  statistical	  analysis	  was	  performed	  by	  calculating	   the	  median	  and	   interquartile	   range	  (IQR)	  of	  force	  and	  Δcl	  values	  from	  the	  unfolding	  events	  within	  the	  two	  Δcl	  intervals.	  As	  shown	  in	   figure	   6.5	  differences	  between	   the	   two	  protein	  constructs	  with	  conformers	   in	   the	  30-­‐40	  nm	  range	  cannot	  be	  detected,	  while	   in	   the	  40-­‐80	  nm	  interval	   the	  H-­‐H	  protein	  shows	   longer	  structures.	  Median	   values	   of	   forces	   are	   comparable	   for	   both	   proteins	   at	   both	   intervals,	   but	  higher	  force	  events	  are	  more	  frequent	  in	  the	  H-­‐H	  protein.	  This	  indicates	  that	  H-­‐H	  orientation	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of	   the	  C-­‐terminal	   folded	  domain	   leads	   to	   longer	  and	  mechanically	  more	  resistant	  structures	  with	  respect	  to	  the	  H-­‐T	  orientation.	  	  	  
	  	  
Figure	  6.5:	  Median	  and	  IQR	  for	  events	  from	  MoPrP	  Trx2	  H-­‐T	  (green)	  and	  MoPrP	  Trx2	  H-­‐H	  (orange)	  within	  the	  30-­‐40	  nm	  and	  40-­‐80	  nm	  intervals.	  The	  cross	  indicates	  the	  median	  values,	  while	  IQR	  was	  calculated	  from	  the	  1st	  and	  3rd	  quartile.	  Whiskers	  are	  not	  shown.	  	  	  	  
6.3.2	  Protein	  number	  affects	  PrP	  oligomerization	  	  The	   formation	   of	   large	   oligomers	   requires	   the	   associations	   of	   more	   than	   two	   MoPrP	  monomers,	   therefore	  we	   increased	   the	  number	  of	   tandem	  MoPrP(89-­‐230)	  molecules	   inside	  our	  AFM	  constructs	  up	  to	  four	  to	  simulate	  this	  phenomenon.	  	  In	  order	  to	  rule	  out	  that	  increasing	  the	  number	  of	  PrP	  moieties	  and	  their	  associations	  did	  not	  involved	   also	   GB1	   domains,	   FEC	  without	   events	  with	   Δcl	   >30	   nm	  were	   separated	   from	   the	  ones	   that	   presented	   them.	   Comparing	   these	   curves	   from	   MoPrP	   Trx3	   unfolding	   events	   at	  neutral	  pH,	  showed	  that	  the	  GB1	  unfolding	  Δcl	  and	  force	  distributions	  were	  similar,	  regardless	  the	   formation	  of	   structures	  with	  Δcl	  >	  30	  nm.	  This	  confirms	   that	  an	   interaction	  between	   the	  two	  protein	  domains	  did	  not	  occur	  (figure	  6.6,	  A).	  PrP	  related	  events	  which	  had	  a	  Δcl	  >	  30	  nm	  usually	  presented	  in	  FECs	  as	  one	  (76%),	  two	  (22%)	  or	  three	  (2%)	  unfolding	  peaks,	  as	  a	  result	  of	  prion	  protein	  intra-­‐molecular	  associations	  (figure	  6.6,	  B,	  panel	  1).	  The	  curves	  that	  showed	  only	  one	  of	  these	  events	  were	  also	  the	  ones	  with	  the	  longest	  peaks	  (up	  to	  97	  nm).	  As	  expected,	  increasing	  their	  number	  on	  the	  same	  FEC	  decreased	  their	  related	  length	  (figure	  6.6,	  B,	  panel	  
2).	  	  The	   frequency	   of	   the	   30-­‐40	   nm	   conformers	  was	   higher	   (54%)	   compared	   to	   the	   40-­‐80	   nm	  conformers	   (43%).	  These	  values	  are	  comparable	  with	   those	  obtained	   from	  MoPrP	  Trx2	  H-­‐T.	  This	  is	  expected,	  as	  the	  orientations	  of	  MoPrP	  moieties	  in	  the	  two	  constructs	  are	  the	  same.	  A	  small	   percentage	   of	   80-­‐120	   nm	   conformers	   (3%)	   in	   the	   trimeric	   construct	  were	   observed.	  These	  events	  correspond	  unequivocally	  to	  associations	  between	  all	  three	  PrP	  moieties.	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Figure	  6.6:	  (A)	  Scatterplot	  with	  relative	  frequency	  histograms	  of	  FECs	  with	  (blue)	  and	  without	  (red)	  peaks	  with	  Δcl	  >	  30	  nm.	  Data	  is	  obtained	  from	  MoPrP	  Trx3	  unfolding	  experiments	  at	  neutral	  pH.	  (B)	  Analysis	  of	  FECs	  showing	  unfolding	  events	  with	  Δcl	  >	  30	  nm:	  (1)	  FECs	  with	  one	  or	  more	  PrP	  peaks	  with	  Δcl	  >	  30	  nm,	  (2)	  scatterplot	  with	  relative	  frequency	  of	  unfolding	  events	  inside	  intervals.	  Intervals	  are	  indicated	  in	  integer	  values	  for	  clarity.	  	  	  Finally,	  tetrameric	  MoPrP	  construct	  was	  analyzed	  in	  the	  same	  manner.	  This	  construct	  has	  the	  lowest	   GB1:MoPrP	  moieties	   ratio	   (1:1)	   compared	   to	   previous	   analyzed	   proteins,	   therefore	  comparing	  FEC	  with	  or	  without	  PrP	  events	  with	  Δcl	  >	  30	  nm	  was	  necessary	  to	  prove	  that	  PrP	  interactions	  did	  not	  involve	  GB1	  domains.	  As	  shown	  in	  figure	  6.7,	  A	  no	  differences	  between	  the	  two	  type	  of	  curves	  was	  observed.	  On	  the	  other	  hand	  distributions	  of	  the	  GB1	  delta	  contour	  length	  of	  MoPrP	  Trx4	  presented	  a	  slight	  shift	  of	  +1.8	  nm	  of	  the	  average	  value	  with	  respect	  to	  the	   distribution	   obtained	   from	   GB1x8	   unfolding,	   while	   the	   force	   values	   instead	   were	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comparable.	   Nevertheless	   the	   GB1	   unfolding	   transition	   we	   observed	   was	   comparable	   to	  previous	  studies	  [226,256,257,262].	  	  	  
	  
Figure	   6.7:	   (A)	   Scatterplot	   and	   relative	   frequency	  histograms	  of	  FEC	  with	   (blue)	  and	  without	   (red)	  unfolding	  events	  with	  Δcl	  >	  30	  nm.	  Data	  is	  relative	  to	  MoPrP	  Trx4	  unfolding	  experiments	  at	  neutral	  pH.	  (B)	  Analysis	  of	  FECs	  showing	  unfolding	  events	  with	  Δcl	  >	  30	  nm:	  (1)	  FEC	  with	  one	  or	  more	  PrP	  peaks	  with	  Δcl	  >	  30	  nm,	  (2)	  scatterplot	  with	  relative	  frequency	  of	  unfolding	  events	  inside	  intervals.	  Intervals	  are	  indicated	  in	  integer	  values	  for	  clarity.	  	  The	  number	  of	  MoPrP	  association	  unfolding	  peaks	  within	  one	  FEC	  was	  similar	  to	  previously	  analyzed	  proteins.	  A	  higher	  frequency	  of	  single	  PrP-­‐related	  events	  was	  observed,	  followed	  by	  double	  and	   triple	   events	   (figure	   6.7,	   B,	   panel	   1).	  The	   frequency	  of	  double	  and	   triple	  peak	  FECs	  increased	  compared	  to	  MoPrP	  Trx3.	  Only	  one	  FEC	  showed	  a	  very	  long	  rupture	  event	  (up	  to	   138	  nm)	   indicating	   that	   the	   first	   and	   the	   last	  MoPrP	  moieties	   formed	   a	   stable	   structure.	  Strikingly	  the	  frequency	  of	  peaks	  in	  the	  40-­‐80	  nm	  interval	  was	  higher	  compared	  to	  the	  30-­‐40	  nm	   one,	   in	   a	   similar	   fashion	   of	   MoPrP	   Trx2	   H-­‐H	   (figure	   6.7,	   B,	   panel	   2).	   Long	   range	  associations	   (Δcl	   >	   80	   nm)	   were	   more	   frequent	   compared	   to	   MoPrP	   Trx3.	   A	   possible	  explanation	  of	  this	  behaviour	  could	  be	  that	  elongation	  of	  the	  polypeptide	  chain	  upon	  a	  certain	  threshold,	   favours	   longer	   associations.	   As	   a	   result,	   bigger	   structures	   from	   PrP	   associations	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could	  be	  established.	  MoPrP	  associations	  were	   strongly	   abolished	   in	  double-­‐pulse	   refolding	  experiments	   in	   the	   presence	   of	   ionic	   strength	   (150mM)	   at	   neutral	   pH,	   respect	   to	   simple	  unfolding	  experiments	  in	  the	  same	  conditions.	  Therefore	  during	  the	  first	  50	  ms	  of	  folding,	  salt	  bridges	  play	  an	  important	  role	  in	  the	  stabilization	  of	  these	  associations.	  Subsequently,	  other	  type	  of	   interactions	   (i.e	   hydrophobic	   interactions)	  may	   contribute	   to	   further	   stabilize	   these	  structures.	   This	   result	   is	   corroborated	   by	   a	   wide	   array	   of	   literature	   that	   shows	   how	   ionic	  strength	  can	  influence	  strongly	  the	  stability	  [318]	  and	  solubility	  [319,320]	  of	  proteins.	  More	  in	   detail,	   experiments	   carried	   out	   on	   monomeric	   PrP	   have	   shown	   that	   its	   thermodynamic	  stability	   was	   strongly	   dependent	   on	   salt	   concentration	   [321].	   It	   has	   also	   been	   shown	   that	  oligomerization	  and	  fibrillation	  can	  be	  modulated	  by	  ionic	  strength	  [322,323,324].	  	  Finally,	  using	  multi-­‐pulse	  refolding,	  the	  presence	  of	  rupture	  events	  from	  MoPrP	  associations	  was	   confirmed,	   excluding	   the	   possibility	   that	   these	   events	   were	   due	   to	   non-­‐specific	  interactions.	   Also	   in	   this	   case	   the	   frequency	   of	   PrP	   related	   rupture	   events	   was	   lower	  compared	   to	   double-­‐pulse	   and	   unfolding	   experiments.	   MoPrP	   association	   peaks	   had	   Δcl	  shorter	   than	   60	   nm	  both	   at	   neutral	   and	   acidic	   pH,	   but	   their	   frequency	   and	   unfolding	   force	  increased	  at	  acidic	  pH	  value.	  	  	  
6.3.3	  Associations’	  complexity	  increases	  by	  increasing	  the	  number	  of	  MoPrP	  molecules	  	  A	  more	  detailed	  comparison	  of	  all	  four	  “head-­‐to-­‐tail”	  constructs,	  including	  the	  monomeric	  one,	  can	   provide	   insights	   on	   PrP	   aggregation	   processes.	   First	   of	   all,	   increasing	   the	   number	   of	  MoPrP	  moieties	   results	   in	   a	   linear	   increase	  of	   the	  number	  of	   curves	   at	  neutral	  pH	   showing	  rupture	  events	  with	  Δcl	  >	  30	  nm	  of	  ~	  20%	  for	  every	  MoPrP	  moiety	  added	  (figure	  6.8).	  This	  type	  of	  behaviour	  is	  in	  sharp	  contrast	  with	  recent	  studies	  using	  the	  same	  approach	  to	  study	  α-­‐synuclein	   oligomerization	   with	   OT	   SMFS,	   where	   increasing	   the	   number	   of	   α-­‐synuclein	  moieties	  did	  not	   change	   the	   frequency	  of	   FEC	   showing	   association	   events	   [267].	  A	  possible	  explanation	   of	   this	   difference	   could	   be	   related	   to	   the	   different	   association	   structures	  generated	  by	  the	  two	  proteins:	  while	  for	  α-­‐synuclein	  associations	  were	  considered	  metastable,	  PrP	  associations	  are	  likely	  more	  stable.	  	  Also,	   multimeric	   constructs	   display	   a	   strong	   pH	   dependence	   behaviour,	   increasing	   the	  association	   events	   upon	   lowering	   the	   pH.	   As	   a	   consequence,	   we	   observed	   a	   macroscopic	  aggregation	  of	  the	  tetrameric	  construct	  at	  pH	  values	  lower	  than	  7.0	  (figure	  4.16).	  This	  data	  is	  in	   agreement	   with	   previous	   works,	   confirming	   that	   low	   pH	   is	   probably	   the	   most	   relevant	  environmental	   factor	   that	   induces	  PrPC	   conversion	   to	   PrPSc	   both	   in	  vitro	   [165,176,325,326]	  and	  in	  vivo	  [327,328].	  In	  fact	  it	  has	  been	  reported	  that	  low	  pH	  destabilizes	  the	  native	  structure	  of	   the	   PrPC	   C-­‐terminal	   globular	   domain	   [164],	   increasing	   its	   unfolding	   rate.	   Then,	   from	   the	  unfolded	   state,	   the	   protein	   can	   more	   easily	   access	   to	   misfolded	   states	   that	   are	   related	   to	  protein	  oligomerization	  and	  fibrillation	  [270].	  We	  confirmed	  this	  using	  multi-­‐pulse	  refolding	  experiments	  where,	  as	  respect	  to	  neutral	  pH,	  at	  pH	  5.5	  associations	  were	  more	  frequent	  and	  with	  a	  higher	  unfolding	  force.	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Figure	   6.9:	   Comparison	   of	   peaks	   with	   Δcl	  >	   30	   nm	   from	   all	   analyzed	   constructs	   in	   unfolding	   experiments	   at	  neutral	   pH.	   In	   black	   the	  monomer,	   in	   green	   the	   dimer	   H-­‐T,	   in	   yellow	   the	   trimer	   and	   in	   purple	   the	   tetramer	  constructs.	  	  
	  	  
Figure	  6.10:	  Median	  and	  IQR	  of	  events	  from	  MoPrP	  Trx1	  (black),	  Trx2	  H-­‐T	  (green),	  Trx3	  (yellow)	  and	  Trx4	  (purple)	  within	  the	  intervals.	  The	  cross	  indicates	  the	  median	  values,	  while	  IQR	  was	  calculated	  from	  the	  1st	  and	  3rd	  quartile.	  Whiskers	  are	  not	  showed	  for	  clarity.	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Correlating	  PrP	  association	   structures	  with	  models	  of	  oligomers	  or	  high	  ordered	   structures	  like	  amyloids	   is	  not	   feasible	  since	  no	  structural	  evidence	  at	   the	  atomic	   level	  are	  present	   for	  the	  oligomers.	  While	  for	  amyloids	  some	  structural	  data	  is	  present	  [63],	  it	  is	  debated	  whether	  oligomers	  are	  on-­‐pathway	  intermediate	  for	  fibrils.	  However,	  some	  correlations	  can	  be	  found.	  PrP	  associations	  unfolding	  forces	  were	  in	  the	  order	  of	  magnitude	  of	  β-­‐sheets	  rupture	  events	  [223],	   with	   antiparallel	   topology	   [224,225].	   Models	   of	   amyloid	   fibrils	   from	   low	   resolution	  experiments	  of	  HuPrP	  [197]	  and	  from	  HET	  fungal	  prion	  domains	  [75],	  showed	  a	  common	  fold	  of	  stacked	  monomers	  with	  β-­‐sheets	  orthogonal	   to	  the	   fibril	  axis.	  Moreover,	  our	   force	  values	  are	   lower	   but	   in	   the	   same	   order	   of	   magnitude	   of	   previous	   works	   of	   SMFS	   performed	   on	  amyloid	   fibrils	   [248,269].	   Thus,	   it	   is	   possible	   that	   associations	   of	   PrP	   moieties	   in	   our	  constructs	  reflected	  the	  monomer	  interactions	  within	  amyloid	  fibrils	  with	  beta-­‐like	  structures.	  On	  the	  other	  hand,	  it	  has	  to	  be	  considered	  that	  rupture	  force	  is	  dependent	  on	  loading	  rate	  and	  on	   tertiary	   structures.	   Therefore	   it	   is	   not	   possible	   to	   demonstrate	   that	   PrP	   association	  unfolding	  transitions	  came	  exclusively	  from	  β-­‐sheet	  rich	  structures.	  	  Finally,	   we	   observed	   an	   unusual	   family	   of	   mechanical	   transition	   that	   we	   called	   “hump”.	   It	  comprised	   of	   a	   very	   heterogeneous	   group	   of	   signals,	   which	   were	   not	   observed	   on	   GB1x8	  construct,	   indicating	   that	   their	   nature	   was	   PrP	   dependent.	   Curves	   of	   this	   type	   were	   more	  frequent	   in	  multimeric	   PrP	   constructs	   rather	   than	  monomeric	   ones,	   showing	   higher	   forces	  and	   longer	   lengths	  by	   increasing	   the	  number	  of	  PrP	  moieties	  on	   the	   construct.	  The	   “hump”	  feature	   was	   first	   observed	   experimentally	   in	   AFM	   SMFS	   by	   Marszalek	   et	   al.	   [221],	   as	   an	  unfolding	  intermediate	  of	   I27	  protein	  domain.	  The	  same	  type	  of	  transition	  was	  observed	  on	  GFP	  [246].	  In	  both	  cases	  the	  “hump”	  preceded	  the	  unfolding	  of	  the	  protein	  domain.	  In	  our	  case	  this	  transition	  occurred	  mainly	  in	  three	  ways:	  i)	  on	  the	  entropic	  force	  rise	  of	  a	  GB1	  peak,	  ii)	  on	  the	  entropic	  force	  rise	  of	  a	  peak	  with	  Δcl	  >	  30	  nm,	  or	  iii)	  before	  GB1	  unfolding	  events,	  as	  a	  non-­‐exponential	  increase	  of	  force	  followed	  by	  an	  identical	  decrease.	  Regarding	  the	  first	  two,	  their	  similarity	  with	  previous	  works	  suggests	  that	  they	  may	  be	  unfolding	  intermediates	  of	  GB1	  and	  of	  PrP	  associations,	  respectively.	  This	  can	  be	  possible	  for	  the	  latter,	  while	  for	  GB1	  it	  has	  been	  suggested	  that	  the	  domain	  present	  unfolding	  intermediates	  [295],	  but	  evidences	  at	  the	  single	  molecule	   level	   are	   still	   lacking.	  Finally,	   regarding	   the	   third	   type	  of	   “hump”,	  we	  exclude	   that	  such	  feature	  can	  be	  due	  to	  systematic	  instrumental	  noise	  since	  it	  would	  have	  appeared	  with	  the	  same	  frequency	  in	  FEC	  from	  all	  the	  experiments	  that	  have	  been	  performed.	  Nevertheless,	  more	  data	  is	  required	  to	  build	  up	  a	  model	  for	  such	  a	  feature.	  A	  final	  important	  consideration	  is	  that	  dimeric,	  trimeric	  and	  tetrameric	  constructs	  had	  a	  very	  high	   local	   concentration	   of	   the	   prion	   protein	   due	   to	   bond	   constraints,	   suggesting	   that	   this	  model	   is	   very	   dissimilar	   to	   PrPC	   in	   physiological	   conditions.	   Nonetheless	   it	   is	   important	   to	  remember	   that	   the	   cellular	   environment	   is	   very	   crowded,	   with	   an	   estimated	   protein	  concentration	  in	  the	  order	  of	  hundreds	  of	  mg/mL.	  In	  these	  conditions	  it	  has	  been	  estimated	  that	   the	  diffusion	  coefficient	  of	  molecules	   is	  10	  fold	   lower	  with	  respect	   to	  non-­‐concentrated	  aqueous	  solutions	  and,	  as	  a	  consequence,	  it	  increases	  the	  tendency	  of	  protein	  oligomerization	  [1].	  Furthermore	  it	  has	  been	  shown	  that	  molecular	  crowding	  is	  strongly	  correlated	  to	  protein	  aggregation,	   increasing	   its	  propensity	  [329,330].	  Finally,	  another	   important	  aspect	   is	   that	   in	  its	   biological	   environment,	   PrPC	   is	   highly	   concentrated	   in	   lipid	   rafts	   [331].	   This	   limits	   the	  diffusion	  of	  the	  protein	  to	  two	  dimensions	  in	  a	  limited	  space	  (20-­‐100	  nm),	  increasing	  its	  local	  concentration.	  For	  the	  above	  cited	  reasons	  we	  can	  conclude	  that	  the	  constructs	  we	  employed	  in	   our	   research	   can	   be	   considered	   valuable	  models	   to	   characterize	   the	   early	   steps	   of	   prion	  protein	  aggregation.	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Conclusions	  	  Understanding	   the	   initial	   oligomerization	   steps	   of	   proteins	   involved	   in	   neurodegenerative	  diseases	   is	   crucial	   for	   gaining	   insights	   into	   the	   pathological	   mechanisms	   underlying	   these	  disorders.	  These	  maladies	  are	  characterized	  by	  the	  presence	  of	  oligomers	  and	  amyloid	  fibrils	  possessing	   high	   biochemical	   heterogeneity.	   Their	   biochemical	   charateristics	   reflect	   the	  protein	   monomer	   heterogeneous	   structural	   ensembles.	   Thus,	   gaining	   insights	   into	   this	  structural	   heterogeneity	   at	   the	  monomeric	   level	   is	   critical	   for	   understanding	   the	  molecular	  basis	   of	   these	   pathologies.	   	   However	   obtaining	   structural	   information	   on	   heterogeneous	  ensembles	  of	  protein	  conformers	  using	  classical	  “in-­‐bulk”	  techniques	  can	  be	  very	  challenging.	  In	  fact,	  these	  techniques	  can	  only	  provide	  an	  enseble-­‐averaged	  structural	  information.	  Instead,	  single-­‐molecule	   methods	   provide	   powerful	   tools	   for	   probing	   complex	   folding	   pathways	  because	  they	  allow	  detection	  of	  rare	  and	  transient	  events.	  	  The	   work	   described	   in	   this	   thesis	   has	   been	   focused	   on	   recombinant	   MoPrP(89-­‐230)	  conformational	   equilibria	   at	   the	   monomeric	   and	   oligomeric	   levels	   using	   atomic	   force	  microscopy	   (AFM)	   single-­‐molecule	   force	   spectroscopy	   (SMFS).	   This	   technique	   has	   been	  previously	   employed	   to	   study	   conformational	   equilibrium	   of	   other	   amyloidogenic	   proteins	  such	  as	  α-­‐synuclein,	  Aβ	  1-­‐42	  and	  Sup35	  NM[258,	  259,	  263,	  264].	  To	   achieve	   this	   aim	   we	   designed,	   expressed	   and	   purified	   six	   different	   heteropolyprotein	  constructs,	  with	  one	  or	  multiple	  MoPrP	  moiety/moieties	  flanked	  by	  GB1	  domains.	  The	  first	  critical	  step	  was	  to	  show	  that	  PrP	  folding	  was	  not	  perturbed	  by	  the	  presence	  of	  the	  flanking	  GB1	  domains.	  Using	  standard	  biochemical	   techniques,	  we	  showed	   that	   interactions	  between	   the	   two	   protein	   moieties	   were	   not	   present.	   Furthermore,	   unfolding	   experiments	  with	   AFM	   SMFS	   confirmed	   this	   hypothesis,	   since	   the	   average	   unfolding	   parameters	   of	   GB1	  domains	  were	  not	  altered	  by	  the	  presence	  of	  one	  or	  more	  PrP	  moieties.	  We	   then	   focused	   our	   attention	   on	   PrP	   monomeric	   construct	   in	   order	   to	   obtain	  structural	  information	  on	  its	  conformational	  equilibrium.	  Our	  results	  showed	  that	  the	  protein	  inside	  the	  construct	  was	  natively	  folded	  and	  the	  C-­‐terminal	  globular	  domain	  N-­‐>U	  transition	  was	   characterized	   in	   terms	   of	   force	   and	   length.	   The	   unfolding	   of	   the	   secondary	   structures	  occurred	   in	   a	   cooperative	   manner,	   without	   any	   intermediate.	   However,	   a	   fraction	   of	   the	  analyzed	  molecules	  presented	  longer	  rupture	  events	  (Δcl	  >	  30	  nm)	  which	  could	  not	  be	  related	  to	  GB1	  or	  to	  MoPrP	  N-­‐>U	  transitions	  alone.	  The	  length	  of	  these	  conformers	  was	  longer	  than	  the	   unfolding	   length	   of	   the	   C-­‐terminal	   folded	   domain.	   Therefore	   these	   structures	  encompassed	  also	   residues	  of	   the	  N-­‐terminal	  unstructured	   region.	  The	  unfolding	   lengths	  of	  these	   strutures	  were	   extremely	   heterogeneous	   and	   their	   unfolding	   force	   showed	   that	   they	  were	   less	   mechanically	   stable	   compared	   to	   the	   native	   structure.	   We	   concluded	   that	   these	  conformers	   could	   be	   related	   to	   PrP	   aggregation	   processes.	   To	   confirm	   this	   hypothesis,	   we	  purified	   and	   produced	   MoPrP	   constructs	   for	   optical-­‐tweezers	   (OT)	   force	   spectroscopy	  experiments.	   By	   OT	   force-­‐clamp	   force	   spectroscopy	   we	   will	   confirm	   whether	   these	  conformers	  are	  on-­‐folding	  or	  off-­‐folding	  pathway	  intermediates.	  	  Analysis	  of	  dimeric	  constructs	  with	  MoPrP(89-­‐230)	  moieties	  arranged	  in	  two	  different	  orientations,	   showed	   that	   associations	   between	   the	   two	   PrP	  moieties	   occurred,	   due	   to	   the	  presence	  of	  rupture	  events	   longer	  than	  the	  theoretical	  unfolding	  length	  of	  a	  monomer	  (39.7	  nm).	   The	   different	   orientation	   of	   the	   PrP	  moieties	   shifted	   the	   conformational	   equilibria	   to	  longer	   associations	   (40-­‐80	   nm	   interval)	   with	   higher	   unfolding	   forces	   in	   the	   head-­‐to-­‐head	  dimer,	   compared	   to	   the	   head-­‐to-­‐tail	   one.	   Nevertheless,	   in	   both	   cases	  we	   could	   not	   identify	  preferred	  conformers,	  as	  a	  result	  of	   the	  absence	  of	  Δcl	  clusters.	   Interestingly	  the	  presence	  of	  such	  conformers	  correlated	  to	  the	  absence	  of	   the	  N-­‐>U	  transition	  of	   the	  C-­‐terminal	  globular	  
	   94	  
domain,	  indicating	  that	  these	  structures	  required	  the	  unfolding	  of	  the	  native	  structure,	  and	  its	  subsequent	   conformational	   rearrangement.	   Decreasing	   pH	   led	   to	   increased	   frequency	   of	  associations	   between	   the	   two	   PrP	   moietes.	   These	   results	   showed	   for	   the	   first	   time	   that	  protein	   orientation	   could	   induce	   different	   structural	   rearrangements	   during	   protein	  aggregation	  processes.	  Further	   analysis	   carried	   out	   on	   trimeric	   and	   tetrameric	   constructs	   revealed	   a	   more	  complex	   behaviour,	   increasing	   the	   frequency	   of	   associations	   between	   two	   or	   more	   prion	  protein	  molecules.	  The	  trimer	  showed	  a	  distribution	  of	  unfolding	  peaks	  from	  force-­‐extension	  curves	   similar	   to	   the	   dimer	   in	   the	   head-­‐to-­‐tail	   orientation,	   with	   short	   associations	   more	  frequent	   than	   long	  ones.	  The	  tetramer	  resembled	  the	  dimer	   in	   the	  head-­‐to-­‐head	  orientation	  instead,	  with	  more	  events	  in	  the	  40-­‐80	  nm	  interval.	  This	  indicated	  that	  increasing	  the	  number	  of	  MoPrP	  moieties	  to	  four	  made	  long	  range	  contacts	  surprisingly	  more	  favourable	  than	  short	  ones.	   Lowering	   the	   pH	   gave	   similar	   results	   compared	   to	   dimeric	   constructs,	   increasing	   the	  frequency	  of	  force-­‐extension	  curves	  with	  PrP	  moieties	  associations.	  On	  the	  other	  hand,	  ionic	  strength	   was	   able	   to	   modulate	   the	   formation	   of	   PrP	   associations,	   by	   decreasing	   their	  occurrence	   only	   at	   early	   stages	   (50	   ms).	   Our	   results	   showed	   that	   salt	   bridges	   play	   an	  important	  role	  in	  early	  oligomerization	  processes.	  	  Comparing	  the	  monomeric	  and	  the	  multimeric	  constructs	  with	  head-­‐to-­‐tail	  orientation	  we	  observed	  that	  increasing	  the	  number	  of	  PrP	  moieties	  resulted	  in	  a	  higher	  frequency	  inter-­‐PrP	   structures.	   Thus,	   the	   local	   concentration	   of	   PrP	  molecules	  may	   play	   an	   important	   role	  during	   the	   initial	   stages	   of	   aggregation	   also	   in	   vivo.	   The	   common	   effect	   of	   pH	   on	   the	  multimeric	  constructs	  identified	  its	  importance	  in	  PrP	  oligomerization	  steps,	  confirming	  that	  prion	   protein	   aggregation	   occurs	   most	   likely	   in	   the	   endosomal	   compartment.	   The	   force	  required	   to	   unfold	   inter-­‐PrP	   structures	   was	   in	   the	   same	   order	   of	   magnitude	   of	   monomer	  unfolding	  in	  synthetic	  amyloid	  fibrils.	  This	  suggests	  that	  inter-­‐PrP	  structures	  observed	  in	  our	  constructs	  could	  be	  on-­‐pathway	  in	  the	  formation	  of	  high	  ordered	  oligomeric	  molecules.	  Concluding,	  we	  managed	  to	  directly	  observe	  the	  high	  intrinsic	  structural	  heterogeneity	  of	  MoPrP	   both	   at	   the	  monomeric	   and	   at	   the	   oligomeric	   level.	   These	   data	   corroborated	   the	  hypothesis	   that	   the	   conformational	   heterogeneity	   of	   the	   monomer	   is	   responsible	   for	   the	  structural	   diversity	   of	   PrP	   aggregation	   species.	   Thus,	   single-­‐molecule	   methodologies	  represent	  very	  powerful	  tools	  to	  unravel	  amyloidogenic	  protein	  complex	  energy	  landscapes,	  with	  the	  possibility	  to	  build	  models	  of	  their	  early	  mechanisms	  of	  aggregation.	  	  Further	  experiments	  will	  be	  performed	  to	  better	  understand	  these	  observations.	  We	  will	  also	  investigate	  how	  the	  inter-­‐PrP	  structures	  changes	  with	  pH	  and	  ionic	  strength.	  Finally,	  the	  role	  of	   the	   N-­‐terminal	   unstructured	   domain	   in	   MoPrP	   conformational	   equilibrium	   will	   be	  investigate.	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